Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3020013	s-afsuol3	U/l (u/l)	910	1062	0.00%
3020013	s-afsuol1	U/l (u/l)	901	1051	0.00%
3020013	suolis-is	U/l (u/l)	560	619	0.00%
3020013	afossuoli	U/l (u/l)	420	478	18.20%
3020013	afossuoli	— (—)	367	400	100.00%	Distribution not available
3020013	s-afsuoli	U/l (u/l)	160	189	0.00%
3020013	s-afsuol1	— (—)	148	158	100.00%	Distribution not available
3020013	s-suoli	U/l (u/l)	104	115	0.00%
3020013	s-afsuol1	U/l_______ (u/l)	13	13	0.00%
3020013	s-afsuol3	U/l_______ (u/l)	13	13	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diseases of liver

487

851

5.85

264.85

1.7

1.5

6.57

7.10

u/l

0.26

380

683

ILD medications: immunosuppressive drugs

643

1317

4.48

250.51

1.7

1.5

6.39

7.44

u/l

0.87

516

1022

Dialysis, with operation codes

246

247

10.37

217.98

1.8

1.6

12.07

6.85

u/l

2.47

213

199

Chronic kidney disease

402

704

5.60

206.32

1.7

1.6

10.02

6.43

u/l

2.73

336

538

Care involving dialysis

190

148

13.54

199.33

1.7

1.6

14.80

5.36

u/l

5.01

171

120

Autoimmune diseases excluding thyroid diseases, strict definition

787

1170

3.69

199.26

1.6

1.5

7.03

6.35

u/l

0.56

644

933

Autoimmune diseases excluding thyroid diseases

808

1222

3.61

198.61

1.6

1.5

7.09

6.37

u/l

0.60

660

971

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

813

1660

3.33

191.95

1.6

1.5

7.75

6.54

u/l

1.00

637

1325

Renal failure

511

1009

4.38

189.54

1.6

1.5

9.18

6.67

u/l

1.99

423

780

Nephropathy related operations

229

259

9.20

185.68

1.8

1.6

12.28

6.15

u/l

3.13

197

208

All chronic kidney diseases

536

1051

4.12

180.09

1.7

1.5

9.18

6.84

u/l

1.85

447

812

Autoimmune diseases related-to ILD

708

1838

3.24

171.32

1.6

1.5

6.46

7.10

u/l

0.50

569

1457

First line medication for Crohn's disease

791

1313

3.26

167.82

1.6

1.5

6.16

7.52

u/l

1.51

654

1011

Anaemias

227

131

11.27

166.94

1.7

1.4

7.23

6.68

u/l

0.15

180

109

Other diseases of liver

278

454

6.29

162.50

1.7

1.5

6.52

6.91

u/l

0.13

210

370

ILD medications

812

1417

3.11

160.03

1.7

1.5

6.27

7.29

u/l

1.00

662

1102

Renal tubulo-interstitial diseases

713

1668

3.16

159.17

1.6

1.5

8.68

6.36

u/l

2.69

583

1304

Any gastric operation

469

489

4.84

158.32

1.6

1.5

6.67

5.70

u/l

0.64

382

363

GASTRO-related operations

469

489

4.84

158.32

1.6

1.5

6.67

5.70

u/l

0.64

382

363

ILD medications: prednisolone, methylprednisolone, prednisone

771

1412

3.06

149.45

1.7

1.5

6.28

7.31

u/l

0.99

631

1098

Inflammatory bowel disease treatment related agents

816

1566

2.91

145.70

1.6

1.5

6.30

7.24

u/l

0.91

667

1221

Abnormal findings on examination of blood, without diagnosis

449

1074

3.83

142.53

1.5

1.6

8.89

6.91

u/l

1.14

349

855

Other bacterial diseases

725

1640

2.95

140.25

1.7

1.5

7.90

6.57

u/l

1.13

590

1286

All kidney diseases

726

1674

2.93

139.03

1.6

1.5

8.17

6.42

u/l

1.76

589

1310

Autoimmune diseases

736

1237

3.04

136.99

1.6

1.5

7.41

6.37

u/l

0.87

586

984

Primary biliary cholangitis, wide definition

27.06

136.16

1.9

1.4

5.36

2.86

u/l

0.99

Fibrosis and cirrhosis of liver

161

173

9.74

135.97

1.8

1.5

8.54

6.29

u/l

0.59

135

141

IBD patients in KELA-register

257

468

5.59

133.87

1.8

1.5

5.55

7.02

u/l

0.95

215

372

Transplanted organ and tissue status

164

184

9.23

133.72

2.0

1.5

8.27

5.93

u/l

0.71

138

144

Extracorporeal dialysis

136

121

11.85

131.29

1.7

1.6

15.19

6.71

u/l

2.98

120

101

Fever of other and unknown origin

464

1143

3.55

130.58

1.7

1.5

6.91

6.83

u/l

0.03

363

921

Noninfective enteritis and colitis

416

1159

3.63

125.54

1.7

1.5

5.78

6.95

u/l

0.98

346

913

Inflammatory bowel disease, strict (require KELA)

257

497

5.26

125.30

1.8

1.5

5.55

6.69

u/l

0.69

215

396

Primary biliary cholangitis (PBC)

26.42

122.26

1.9

1.4

5.17

3.00

u/l

0.78

Second line medication for Crohn's disease

495

1576

3.17

120.82

1.6

1.5

6.28

7.00

u/l

0.48

408

1236

Used for control exclusion in common control thyroid runs

658

1108

3.01

120.60

1.6

1.5

7.06

6.39

u/l

0.48

532

886

Other septicaemia

352

841

4.00

120.08

1.6

1.5

9.03

6.61

u/l

1.38

289

665

Other bacterial diseases, including avohilmo

716

1642

2.74

119.50

1.7

1.5

7.65

6.56

u/l

0.87

582

1290

Bacterial infection, other or unspecified

457

1155

3.37

118.02

1.7

1.5

7.48

6.80

u/l

0.36

384

904

Septicaemia

376

916

3.78

117.85

1.7

1.5

8.74

6.61

u/l

1.24

307

724

Other septicaemia, including avohilmo

355

865

3.90

116.94

1.6

1.5

8.98

6.63

u/l

1.34

291

682

Bacterial infection, other or unspecified, including avohilmo

481

1225

3.25

116.17

1.7

1.5

7.31

6.85

u/l

0.24

402

961

L04AD Calcineurin inhibitors

170

237

7.40

115.68

1.9

1.5

7.02

6.46

u/l

0.13

143

192

Inflammatory bowel disease

312

754

4.20

115.62

1.8

1.5

5.37

6.95

u/l

1.31

266

597

L04AA Selective immunosuppressants

261

552

4.82

114.76

1.8

1.5

6.70

7.15

u/l

0.14

203

445

5-aminosalicylic acid

227

425

5.43

114.75

1.8

1.5

5.49

7.27

u/l

1.06

189

334

Abnormal serum enzyme levels

294

654

4.40

114.64

1.5

1.6

9.40

6.91

u/l

1.19

232

513

Explicit Sepsis

386

988

3.60

112.37

1.6

1.5

8.95

6.61

u/l

1.46

315

790

Explicit Sepsis, including avohilmo

390

1006

3.55

111.28

1.6

1.5

8.88

6.55

u/l

1.47

318

805

Oral corticosteroids

703

1552

2.67

109.95

1.6

1.5

6.75

7.25

u/l

0.36

566

1210

ILD medications: azathioprine

176

270

6.66

109.34

1.8

1.5

6.27

6.77

u/l

0.13

147

207

Secondary hypertension

131

139

9.58

109.33

1.6

1.5

13.64

5.56

u/l

3.53

105

110

L04AX Other immunosuppressants

468

1543

3.06

107.76

1.6

1.5

6.27

7.02

u/l

0.48

383

1213

Ulcerative colitis

247

539

4.65

104.45

1.8

1.5

5.34

6.69

u/l

0.91

208

431

Glomerular diseases

213

417

5.22

102.62

1.7

1.5

11.91

6.77

u/l

2.75

178

335

Bacterial Sepsis

400

997

3.35

101.80

1.7

1.5

8.13

6.90

u/l

0.72

326

795

Primary Sclerosing Cholangitis, IBD and UDCA required

20.55

101.61

2.0

1.4

3.00

8.44

u/l

1.19

Azathioprine

176

291

6.17

101.61

1.8

1.5

6.27

6.73

u/l

0.12

147

223

Glomerular disorders in diseases classified elsewhere

159

242

6.75

99.73

1.7

1.5

12.12

6.22

u/l

3.18

138

199

Reimbursement for rheumatic diseases

464

1581

2.94

99.69

1.6

1.5

6.01

6.87

u/l

0.67

370

1248

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

185

331

5.70

98.40

1.8

1.5

5.87

6.10

u/l

0.08

155

271

Implicit bacterial Sepsis

363

908

3.46

98.28

1.7

1.5

8.13

6.67

u/l

0.89

294

720

Ulcerative colitis (strict definition, require KELA)

188

342

5.60

98.22

1.8

1.5

5.84

5.98

u/l

0.05

156

280

Aplastic and other anaemias

402

1161

3.20

97.74

1.6

1.5

8.87

6.50

u/l

1.48

308

928

Insulin, fast-acting

315

866

3.68

97.30

1.6

11.64

6.04

u/l

5.22

244

690

Implicit Sepsis

552

1500

2.73

96.08

1.6

1.5

7.76

6.46

u/l

1.06

438

1189

Implicit bacterial Sepsis, including avohilmo

383

972

3.31

95.87

1.7

1.5

7.94

6.96

u/l

0.52

308

772

Cholangitis (primary sclerosing, PSC)

113

122

9.62

95.01

1.9

1.5

4.36

5.47

u/l

0.31

Polyarthropathies

508

1133

2.90

94.92

1.6

7.79

6.76

u/l

0.60

396

889

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

191

368

5.28

93.65

1.8

1.5

5.86

5.97

u/l

0.04

159

300

Insulin, fast-acting or short human

316

896

3.57

93.20

1.6

11.59

6.08

u/l

5.09

245

719

Osteopathies and chondropathies

460

1474

2.88

93.08

1.6

1.5

7.25

6.88

u/l

0.17

373

1171

Mucosal proctocolitis

148

226

6.69

92.42

1.9

1.5

3.66

6.48

u/l

2.03

123

185

Kidney transplant status

103

102

10.56

92.36

2.0

1.5

9.18

5.22

u/l

1.36

Disorders of gallbladder, biliary tract and pancreas

671

1707

2.46

90.89

1.6

1.5

6.82

6.97

u/l

0.09

520

1362

Acute renal failure

219

486

4.58

90.79

1.6

1.5

8.30

6.34

u/l

0.89

171

370

Hernia of abdominal wall, postoperative

144

215

6.73

90.77

1.5

8.96

5.30

u/l

1.15

111

161

Budesonide

167

303

5.62

87.56

1.9

1.5

5.10

6.78

u/l

0.84

148

235

Crohn disease

148

241

6.27

86.82

1.8

1.5

5.13

5.79

u/l

0.23

122

194

Disorders of parathyroid gland

237

574

4.15

86.19

1.6

1.5

7.60

6.74

u/l

0.29

193

459

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

630

1648

2.43

83.48

1.6

1.5

7.53

6.60

u/l

0.71

495

1318

Dialysis

12.26

83.05

1.7

1.6

21.85

5.20

u/l

4.62

Hyperparathyroidism

214

496

4.35

82.62

1.7

1.5

7.97

6.60

u/l

0.47

175

394

Nonalcoholic fatty liver disease

146

247

6.08

82.59

1.5

6.56

6.22

u/l

0.10

105

201

Type 1 diabetes, wide definition, subgroup 1

187

394

4.81

82.46

1.6

1.5

13.29

6.20

u/l

4.19

149

326

Other and unspecified anaemias

358

1101

3.08

82.37

1.6

1.5

8.18

6.44

u/l

0.88

271

877

Other anaemias

360

1114

3.05

81.49

1.6

1.5

8.15

6.53

u/l

0.80

272

888

Implicit Sepsis, including avohilmo

553

1591

2.50

80.31

1.6

1.5

7.63

6.52

u/l

0.87

438

1259

Any reimbursement code in KELA

271

323

4.23

79.26

1.6

1.4

6.44

5.72

u/l

0.32

224

258

Insulin, intermediate and long-acting

402

1392

2.81

78.96

1.6

1.5

10.75

6.51

u/l

4.29

319

1109

Ulcer of lower limb, not elsewhere classified

166

330

5.13

78.68

1.8

1.5

7.71

7.28

u/l

0.11

137

260

Heart failure, not strict

518

1364

2.57

78.40

1.6

1.5

8.94

6.49

u/l

1.97

416

1088

Insulin, combination of fast acting with intermediate-acting or long-acting

439

1497

2.68

77.72

1.7

1.6

10.35

6.36

u/l

4.28

350

1193

Other dialysis

12.41

77.20

1.7

1.6

21.77

5.61

u/l

4.20

Disorders of other endocrine glands

349

1165

2.98

76.47

1.6

1.5

7.51

6.53

u/l

0.47

276

928

Condition for Implicit Sepsis (Organ dysfunction codes)

557

1592

2.44

76.28

1.6

1.5

7.64

6.47

u/l

0.94

442

1262

Insulin medication

439

1370

2.68

76.08

1.7

1.6

10.35

6.28

u/l

4.37

350

1110

Type 1 diabetes

210

522

4.06

74.90

1.6

1.5

12.17

6.04

u/l

3.97

168

429

Type 1 diabetes, wide definition

188

438

4.34

73.16

1.6

1.5

13.23

6.26

u/l

4.16

150

365

Tramadol

504

1199

2.54

72.45

1.7

1.5

6.81

6.92

u/l

0.05

392

961

Ulcerative colitis, NAS

144

272

5.39

72.30

1.7

1.6

5.21

6.14

u/l

0.39

119

221

Diabetic nephropathy, excluding more controls

178

312

4.75

71.76

1.6

12.00

7.26

u/l

2.39

148

235

Disorders resulting from impaired renal tubular function

10.79

69.03

1.8

1.6

7.92

7.33

u/l

0.08

Pneumonias (Asthma/COPD co-morbidities)

621

1828

2.23

68.68

1.7

1.5

6.80

7.00

u/l

0.10

495

1457

Unspecified kidney failure

121

204

6.06

68.64

1.6

8.96

5.68

u/l

0.86

105

160

All pneumoniae

624

1832

2.22

68.49

1.7

1.5

6.96

6.92

u/l

0.02

497

1460

Pneumonia, organism unspecified

573

1734

2.28

67.45

1.7

1.5

7.07

6.97

u/l

0.05

456

1379

Persons encountering health services for specific procedures and health care

642

1731

2.20

66.98

1.7

1.5

8.22

6.55

u/l

1.48

530

1341

Diabetic nephropathy

179

426

4.23

66.75

1.6

1.5

11.92

7.96

u/l

1.84

149

321

Influenza and pneumonia

632

1790

2.19

65.96

1.7

1.5

7.03

6.91

u/l

0.06

503

1424

Ulcerative colitis (strict definition, all Crohn cases excluded)

139

277

5.10

65.71

1.7

1.5

6.02

6.33

u/l

0.10

120

227

Metabolic disorders

586

1563

2.26

65.53

1.6

1.5

8.15

6.44

u/l

1.44

457

1240

Osteoporosis

260

742

3.26

65.34

1.5

7.21

6.68

u/l

0.18

202

598

General symptoms and signs

587

1294

2.28

63.78

1.6

1.5

6.67

6.78

u/l

0.06

452

1041

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

541

1609

2.28

63.70

1.6

1.5

7.64

6.48

u/l

0.87

427

1272

Cholangitis (primary sclerosing, PSC), with reimbursement 202

15.98

62.81

2.0

1.5

3.56

4.50

u/l

0.20

Certain infectious and parasitic diseases

535

1139

2.36

62.77

1.6

1.5

6.91

6.43

u/l

0.30

425

888

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

599

1851

2.16

62.09

1.7

1.5

6.76

7.00

u/l

0.13

480

1472

Diseases of oesophagus, stomach and duodenum

631

1749

2.14

61.66

1.6

7.64

6.74

u/l

0.65

507

1381

Dental caries

204

534

3.64

61.45

1.9

1.5

5.69

6.90

u/l

0.59

172

434

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

544

1416

2.26

60.24

1.7

1.5

6.61

6.86

u/l

0.13

432

1131

544

1416

2.26

60.24

1.7

1.5

6.61

6.86

u/l

0.13

432

1131

Malaise and fatigue

341

995

2.71

60.14

1.6

1.5

6.12

7.04

u/l

0.54

265

799

Nutritional anaemias

364

1361

2.57

60.04

1.6

1.5

6.02

6.91

u/l

0.50

298

1073

Sub-endpoint used in defining T1D endpoints

218

637

3.40

59.84

1.6

1.5

12.05

6.16

u/l

3.93

173

510

Acute tubulo-interstitial nephritis

399

1364

2.48

59.83

1.6

1.5

7.95

6.53

u/l

0.90

320

1064

Malignant neoplasm of breast, HER2-negative

337

783

2.80

59.48

1.6

1.5

5.85

6.96

u/l

0.81

279

615

Malignant neoplasm of breast

337

783

2.80

59.45

1.6

1.5

5.85

6.96

u/l

0.81

279

615

Malignant neoplasm of breast, HER2-negative, including Hilmo

339

788

2.78

58.93

1.6

1.5

5.87

6.97

u/l

0.80

281

619

Malignant neoplasm of breast, including Hilmo

339

788

2.78

58.92

1.6

1.5

5.87

6.97

u/l

0.80

281

619

Erysipelas

361

1220

2.57

58.27

1.7

1.5

6.54

6.92

u/l

0.19

278

962

Other disorders of fluid, electrolyte and acid-base balance

250

768

3.10

58.23

1.6

1.5

8.98

6.52

u/l

1.24

196

607

Other disorders of skin and subcutaneous tissue

487

1841

2.25

58.22

1.6

1.5

7.66

6.90

u/l

0.45

395

1453

Complications of surgical and medical care, not elsewhere classified

606

1939

2.09

57.89

1.7

1.5

8.21

6.59

u/l

1.56

479

1542

Caries of dentine

184

485

3.70

57.04

1.8

1.5

6.01

6.76

u/l

0.28

154

393

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

144

333

4.40

56.90

1.8

1.5

10.31

7.16

u/l

0.86

118

258

Malignant neoplasm

497

1284

2.28

56.36

1.6

1.5

7.02

7.24

u/l

0.11

404

1018

Iron deficiency anaemia

319

1192

2.65

56.24

1.6

1.5

6.02

6.92

u/l

0.45

263

944

Malignant neoplasm

496

1282

2.28

56.18

1.6

1.5

7.01

7.25

u/l

0.12

403

1016

Oedema, not elsewhere classified

240

769

3.07

55.83

1.6

1.5

7.65

6.53

u/l

0.49

192

626

Hypertensive diseases (excluding secondary)

315

647

2.85

55.71

1.6

1.5

7.94

5.93

u/l

1.33

247

539

Malignant neoplasm of breast, HER-positive

276

712

2.92

54.54

1.6

1.5

6.36

6.94

u/l

0.28

237

560

Cholelithiasis, broad definition with cholecystitis

523

1616

2.16

54.30

1.5

1.6

6.96

7.00

u/l

0.02

410

1285

Malignant neoplasm of breast, ER-positive, including Hilmo

276

713

2.91

54.27

1.6

1.5

6.36

6.93

u/l

0.28

237

561

Implicit viral Sepsis, including avohilmo

227

739

3.09

53.64

1.6

1.5

7.64

6.42

u/l

0.48

181

588

Malignant neoplasm, wide definition

491

1291

2.22

52.64

1.6

1.5

6.79

7.26

u/l

0.26

400

1023

Heart failure,strict

335

906

2.60

52.62

1.6

1.5

8.53

7.04

u/l

0.68

264

715

Malignant neoplasm, including Hilmo

490

1290

2.22

52.45

1.6

1.5

6.78

7.28

u/l

0.29

400

1020

Persons encountering health services for other counselling and medical advice, not elsewhere classified

621

1627

2.04

52.10

1.6

1.5

8.23

6.21

u/l

1.91

525

1279

Erysipelas, including avohilmo

436

1434

2.26

51.79

1.6

1.5

7.47

6.62

u/l

0.53

340

1116

Persons encountering health services in other circumstances, wide

638

1635

2.01

51.52

1.6

1.5

7.83

6.21

u/l

1.61

519

1284

Insulin, fast-acting (human)

118

252

4.75

51.47

1.8

1.5

11.60

5.05

u/l

2.68

101

204

Finngen Rheumatological endpoints

525

1394

2.15

51.35

1.5

1.6

7.01

6.58

u/l

0.26

416

1109

Cholelithiasis

499

1595

2.14

51.05

1.6

6.67

7.01

u/l

0.19

393

1269

Solid cancers

477

1266

2.22

51.00

1.6

1.5

7.12

7.28

u/l

0.07

385

1002

Implicit viral Sepsis

169

476

3.59

50.72

1.6

1.5

8.62

6.70

u/l

0.63

136

373

Viral Sepsis

169

476

3.59

50.71

1.6

1.5

8.62

6.70

u/l

0.63

136

373

Diarrhoea and gastroenteritis of presumed infectious origin

425

1716

2.22

50.27

1.7

1.5

7.96

6.94

u/l

0.50

342

1356

Hypertension

442

1096

2.28

50.04

1.6

1.5

8.40

5.99

u/l

2.24

344

887

Gout, FINNGEN

206

658

3.14

49.90

1.5

1.6

9.34

6.88

u/l

0.88

158

519

Other Crohn's disease

123

6.65

49.80

1.8

1.5

3.66

6.20

u/l

0.89

100

Hypertensive diseases

441

1096

2.28

49.69

1.6

1.5

8.40

5.99

u/l

2.24

344

887

Gout

206

559

3.19

49.45

1.5

1.6

9.34

6.87

u/l

0.86

158

435

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

431

1720

2.19

49.06

1.5

8.18

6.83

u/l

0.81

340

1363

Hypertension, essential

434

1080

2.28

49.04

1.5

8.66

6.06

u/l

2.40

337

875

Other noninfective gastroenteritis and colitis

192

603

3.21

48.44

1.7

1.5

6.07

6.87

u/l

0.33

152

473

Intestinal infectious diseases

548

2032

2.01

48.42

1.7

1.5

7.24

6.87

u/l

0.19

445

1608

Solid cancers, including Hilmo

473

1283

2.16

47.25

1.6

1.5

6.91

7.25

u/l

0.18

383

1017

Other inflammatory liver diseases

124

6.44

47.05

1.7

1.5

6.49

5.63

u/l

0.19

101

Crohn's disease NAS

118

6.50

45.69

1.7

1.5

5.97

6.59

u/l

0.12

Infections, IBD-co-morbidities

111

157

5.02

45.57

1.7

1.5

6.01

5.87

u/l

0.03

128

Other diseases of intestines

565

1586

1.99

45.37

1.6

1.5

6.63

7.09

u/l

0.29

443

1258

Autoimmune hepatitis, wide definition

8.14

45.32

1.7

1.5

5.11

5.03

u/l

0.01

Oxycodone

270

889

2.61

45.30

1.7

1.5

8.16

6.98

u/l

0.58

222

708

Any event in cancer register

487

1365

2.09

45.10

1.6

1.5

6.73

7.16

u/l

0.24

392

1083

Other and unspecified iron deficiency

249

938

2.67

45.06

1.6

1.5

5.68

6.79

u/l

0.64

208

746

Disorders of mineral metabolism

194

5.05

44.86

1.7

1.6

6.19

6.20

u/l

0.00

161

Crohn's disease of small intestine

124

6.26

44.67

1.9

1.5

5.27

6.38

u/l

0.27

100

Intestinal infectious diseases, including avohilmo, including avohilmo

639

1887

1.89

44.34

1.7

1.5

6.86

6.89

u/l

0.02

518

1490

Abnormal results of function studies

195

4.97

43.59

1.5

10.32

6.03

u/l

0.85

157

Diseases of arteries, arterioles and capillaries (FINNGEN)

177

367

3.36

43.24

1.7

1.5

10.32

5.88

u/l

1.96

150

309

Chronic hepatitis, not elsewhere classified

8.54

43.03

2.0

1.4

6.52

7.21

u/l

0.09

Heart failure, strict

360

1103

2.28

42.98

1.6

1.5

8.29

7.16

u/l

0.50

281

876

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

535

1611

1.98

42.85

1.5

1.6

9.69

6.04

u/l

4.49

415

1298

Cirrhosis of liver, NAS

120

6.26

42.69

1.7

1.6

12.22

5.84

u/l

1.14

103

Ulcerative ileocolitis

7.91

42.67

1.5

4.30

5.60

u/l

0.37

Hyperkalaemia

117

6.30

42.53

1.7

1.5

7.17

7.23

u/l

0.01

Presence of other functional implants

375

1159

2.23

42.20

1.4

1.5

9.62

6.62

u/l

2.63

266

927

L02BG Aromatase inhibitors

248

958

2.58

41.78

1.6

1.5

5.84

6.88

u/l

0.75

212

751

Nausea and vomiting

198

671

2.90

41.75

1.6

1.5

10.26

6.28

u/l

2.15

161

535

Diseases of the digestive system

298

1264

2.35

41.34

1.7

1.5

7.37

6.70

u/l

0.26

235

1011

Diabetes, varying definitions

553

1667

1.93

41.14

1.6

8.56

6.08

u/l

2.69

422

1342

Biological medication for rheuma

141

406

3.51

41.04

1.6

5.13

5.91

u/l

0.33

112

327

Sulfasalazine

190

655

2.92

40.91

1.7

1.5

4.78

7.58

u/l

2.48

148

512

Diabetic maculopathy, excluding more controls

214

4.60

40.78

1.5

1.6

17.56

6.38

u/l

4.02

180

Crohn's disease of large intestine

100

6.67

40.52

1.7

1.5

4.13

6.05

u/l

0.47

Diabetes mellitus

553

1670

1.92

40.43

1.6

8.74

6.03

u/l

3.11

421

1344

All-cause Heart Failure

351

1094

2.24

40.39

1.6

1.5

8.19

7.22

u/l

0.41

272

868

Medicines for HER+ breast cancer

278

1080

2.42

40.33

1.6

1.5

6.33

6.58

u/l

0.12

238

849

Persons encountering health services in other circumstances

252

1000

2.51

40.20

1.3

1.5

10.22

6.00

u/l

3.68

174

780

Heart failure and antihypertensive medication

166

325

3.35

39.62

1.5

10.29

5.69

u/l

1.83

125

245

Other heart diseases

258

654

2.58

39.39

1.6

1.5

7.82

5.75

u/l

1.16

205

544

Diabetes, insulin treatment (Kela reimbursement)

564

1790

1.88

39.20

1.6

9.38

6.07

u/l

4.16

441

1436

Gastrointestinal diseases

253

471

2.70

39.04

1.6

1.5

5.29

6.63

u/l

0.71

212

370

Constipation

519

1845

1.91

39.03

1.5

1.6

7.78

6.68

u/l

0.73

408

1475

Gout, unspecified

150

467

3.25

38.59

1.5

1.6

9.32

6.52

u/l

0.81

117

361

Other disorders of kidney and ureter

115

302

3.87

38.42

1.8

1.5

8.57

6.94

u/l

0.34

103

245

Gout, strict definition

137

405

3.42

38.32

1.5

1.6

9.99

6.47

u/l

0.94

107

313

Pain in limb

450

1431

2.01

38.20

1.6

7.96

6.32

u/l

1.38

365

1111

Anaemia in chronic diseases classified elsewhere

10.67

38.00

1.6

15.21

5.35

u/l

1.76

Complications of medical and surgical care

437

2000

1.97

37.97

1.7

1.5

8.50

6.73

u/l

1.35

354

1584

Diabetic retinopathy, strict definition

151

416

3.27

37.97

1.5

1.6

14.48

7.42

u/l

3.80

125

320

Gastro-oesophageal reflux disease

396

1636

2.05

37.93

1.6

8.23

6.79

u/l

1.07

324

1294

Diseases of the skin and subcutaneous tissue

496

1266

1.97

37.87

1.6

1.5

7.24

6.22

u/l

0.76

400

1007

Dermatitis and eczema

604

1978

1.81

37.42

1.6

1.5

7.77

6.67

u/l

0.81

480

1574

Complications of procedures, not elsewhere classified

457

1902

1.94

37.31

1.7

1.5

7.87

6.68

u/l

0.81

358

1513

Hypothyroidism (congenital or acquired)

109

133

4.61

37.27

1.6

1.4

7.93

6.63

u/l

0.37

112

Hypothyroidism, strict autoimmune

343

1027

2.20

37.25

1.5

9.05

6.50

u/l

1.46

252

815

Acute peritonitis

134

5.49

36.98

1.6

1.5

19.29

6.98

u/l

2.31

111

Diabetes medication

559

1772

1.85

36.70

1.6

9.41

6.08

u/l

4.02

430

1425

Hypothyroidism and >3 levothyroxin purchases

108

133

4.57

36.62

1.6

1.4

8.03

6.63

u/l

0.41

112

Hypothyroidism, levothyroxine purchases

108

133

4.57

36.62

1.6

1.4

8.03

6.63

u/l

0.41

112

Other diseases of biliary tract

197

4.55

36.41

2.0

1.5

3.37

6.00

u/l

1.46

158

Opioids

478

1261

1.96

36.38

1.6

1.5

6.85

6.79

u/l

0.03

381

1011

Bleeding

472

1729

1.92

36.29

1.6

1.5

7.66

6.95

u/l

0.37

372

1379

Exposure to unspecified factor

550

2058

1.82

35.79

1.6

5.95

7.16

u/l

1.14

406

1666

Endocrine, nutritional and metabolic diseases

354

818

2.19

35.54

1.6

6.49

5.60

u/l

0.57

281

666

Gout, idiopatic and unspecified

170

598

2.87

35.39

1.5

1.6

9.79

6.81

u/l

0.95

131

460

Asthma, unspecified (mode), excluding more controls

276

848

2.34

35.33

1.6

1.5

5.91

6.64

u/l

0.41

218

670

Codeine

451

1247

1.96

34.63

1.6

1.5

7.08

6.85

u/l

0.11

352

998

Other ulcerative colitis

100

6.12

34.57

1.7

1.5

6.86

7.08

u/l

0.04

Tumor necrosis factor alpha inhibitors

122

358

3.45

34.57

1.6

4.73

5.62

u/l

0.36

292

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

135

5.28

34.56

1.7

1.6

4.67

5.55

u/l

0.24

111

Other heart diseases, wide

474

1513

1.90

34.28

1.6

7.78

6.61

u/l

0.80

368

1227

Other soft tissue disorders, not elsewhere classified

483

1453

1.90

34.14

1.6

7.58

6.26

u/l

1.08

389

1132

Other retinal disorders

384

1460

2.01

34.05

1.5

9.49

6.79

u/l

2.23

291

1173

Osteomyelitis

117

5.58

33.51

1.9

1.5

9.19

6.38

u/l

0.49

Diseases of peritoneum

245

3.98

33.47

1.6

1.5

16.34

6.41

u/l

2.43

198

Dermatitis

364

1789

2.00

33.46

1.6

1.5

8.66

6.87

u/l

1.04

281

1424

Crohn disease (strict definition, require KELA, min 2 HDR)

128

5.34

33.44

1.7

1.5

4.76

5.85

u/l

0.30

105

Crohn disease (strict definition, require KELA)

128

5.34

33.44

1.7

1.5

4.76

5.85

u/l

0.30

105

Cardiovascular diseases (excluding rheumatic etc)

292

739

2.27

32.97

1.7

1.5

6.77

5.82

u/l

0.52

240

610

Type 2 diabetes, wide definition

444

1470

1.91

32.93

1.6

9.24

6.32

u/l

2.80

348

1180

Type 2 diabetes

513

1627

1.83

32.71

1.5

1.6

8.67

6.10

u/l

2.88

396

1310

COPD/asthma/ILD related infections

519

1416

1.84

32.51

1.6

1.5

6.46

6.86

u/l

0.22

409

1131

COPD/asthma related infections

519

1416

1.84

32.51

1.6

1.5

6.46

6.86

u/l

0.22

409

1131

Disorders of calcium metabolism

143

4.99

32.40

1.8

1.5

5.71

6.13

u/l

0.08

117

Diseases of arteries, arterioles and capillaries

385

1437

1.97

32.35

1.7

1.5

8.83

7.00

u/l

1.13

323

1127

Peripheral artery operations in Hilmo

101

276

3.70

31.88

1.7

1.6

12.12

6.57

u/l

1.81

216

Examination and observation for other reasons

308

797

2.19

31.88

1.9

1.5

4.21

6.33

u/l

2.05

269

587

Spondyloarthritis

113

333

3.42

31.80

1.6

1.5

6.07

6.90

u/l

0.27

259

Certain infectious and parasitic diseases, including avohilmo

343

815

2.12

31.62

1.5

6.51

6.33

u/l

0.09

275

635

Primary hyperparathyroidism

109

316

3.51

31.60

1.4

1.5

6.99

6.01

u/l

0.32

255

Abnormalities of breathing

444

1342

1.90

31.57

1.5

1.6

6.70

6.56

u/l

0.08

342

1080

Other and unspecified dermatitis

310

1505

2.07

31.55

1.6

1.5

9.12

6.85

u/l

1.26

245

1194

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

531

1924

1.77

31.36

1.7

1.5

7.31

6.87

u/l

0.23

433

1519

Seropositive rheumatoid arthritis

171

640

2.68

31.31

1.5

5.93

6.40

u/l

0.18

137

507

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

354

1771

1.97

31.22

1.6

1.5

8.99

6.71

u/l

1.66

291

1400

Other arthritis (FG)

191

761

2.53

31.15

1.6

5.59

6.42

u/l

0.45

153

604

Rheumatoid arthritis

216

799

2.41

31.01

1.5

1.6

5.85

6.68

u/l

0.41

171

628

Noninfectious colitis NAS

103

292

3.57

30.82

1.7

1.5

7.21

6.88

u/l

0.08

233

Asthma, unspecified (mode)

281

932

2.18

30.82

1.6

1.5

5.97

6.76

u/l

0.45

222

734

Amputation

218

4.00

30.26

1.7

1.6

11.51

7.13

u/l

1.19

175

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

164

4.53

30.13

1.6

1.5

5.12

5.85

u/l

0.17

129

Other diseases of blood and blood-forming organs, wide

161

601

2.71

30.05

1.6

1.5

5.93

6.78

u/l

0.34

122

478

Disorders of choroid and retina

455

1754

1.82

29.86

1.5

1.6

9.15

6.73

u/l

2.13

343

1414

Ulcerative rectosigmoiditis

139

4.82

29.45

1.8

1.5

5.02

6.72

u/l

0.53

114

Hypothyroidism, drug reimbursement

105

4.89

29.26

1.5

1.4

3.27

6.43

u/l

1.82

Other diseases of the digestive system

200

840

2.40

29.13

1.6

1.5

8.10

6.61

u/l

0.48

154

660

Peripheral artery disease

263

961

2.17

29.06

1.7

1.5

10.07

6.96

u/l

1.69

226

747

Benzodiazepine use

524

2045

1.73

28.94

1.6

6.63

7.07

u/l

0.30

408

1629

Infections of the skin and subcutaneous tissue

316

1568

1.99

28.88

1.6

7.72

6.76

u/l

0.44

244

1254

Polyneuropathies and other disorders of the peripheral nervous system

149

549

2.74

28.55

1.7

1.5

8.58

6.61

u/l

0.65

120

425

Neoplasms

320

816

2.06

28.13

1.6

1.5

5.95

7.21

u/l

0.83

254

642

Heart failure and bmi 25plus

215

607

2.38

28.11

1.6

1.5

7.60

6.96

u/l

0.19

168

480

Liquid cancers, including Hilmo

205

771

2.36

28.10

1.6

1.5

6.30

7.62

u/l

0.49

163

621

Pain, not elsewhere classified

165

646

2.57

27.96

1.8

1.5

5.35

6.62

u/l

0.74

143

529

Dyspnoea

476

1966

1.75

27.67

1.5

1.6

6.85

7.02

u/l

0.09

368

1567

Amputation of toe

143

4.62

27.57

1.7

1.6

9.53

6.43

u/l

0.89

114

Other specified/unspecified arthritis

173

698

2.50

27.56

1.7

1.6

5.55

6.98

u/l

0.88

138

545

Other and unspecified polyneuropathies, also in other diseases

134

476

2.84

27.55

1.7

1.5

8.61

6.99

u/l

0.45

108

371

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

6.37

27.53

1.6

1.5

12.14

4.90

u/l

1.26

GI-bleeding

195

831

2.36

27.51

1.6

1.5

7.74

6.69

u/l

0.30

148

654

Asthma, excluding more controls

340

875

2.00

27.40

1.5

6.15

6.56

u/l

0.22

270

691

Cardiac arrhythmias

294

916

2.06

27.28

1.6

6.83

5.65

u/l

0.62

223

744

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

152

564

2.63

26.84

1.8

1.5

6.56

7.61

u/l

0.36

121

453

Any death

359

1328

1.90

26.83

1.7

1.5

9.27

6.94

u/l

1.30

299

1038

Systemic connective tissue disorders

225

1030

2.20

26.82

1.6

1.5

5.26

6.76

u/l

1.02

173

817

Ascites

163

4.30

26.75

1.8

1.7

9.25

5.18

u/l

0.76

141

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

118

4.43

26.58

1.5

8.15

6.11

u/l

0.45

Liquid cancers

171

657

2.48

26.57

1.5

6.54

7.63

u/l

0.33

139

529

Non-rheumatic valve diseases

263

893

2.11

26.50

1.6

1.5

8.63

6.88

u/l

0.71

211

721

Valvular heart disease excluding rheumatic fever

263

895

2.11

26.40

1.6

1.5

8.63

6.86

u/l

0.72

211

723

Disorders of thyroid, IBD co-morbidities

173

3.70

26.39

1.5

1.6

5.67

5.78

u/l

0.03

140

Chronic pancreatitis

255

3.53

26.29

1.7

1.6

8.30

6.36

u/l

0.44

206

Osteoporosis with pathological fracture (FG)

175

4.13

26.06

1.4

1.6

10.72

7.05

u/l

0.49

141

Volume depletion

197

3.90

25.98

1.6

1.5

11.90

6.56

u/l

0.78

157

Codeine or tramadol medication

555

1804

1.68

25.90

1.6

1.5

7.25

6.95

u/l

0.16

423

1441

Asthma

357

960

1.92

25.85

1.6

1.5

6.16

6.68

u/l

0.30

285

756

Excluding asthma or asthma-COPD overlap

368

971

1.90

25.69

1.6

1.5

6.59

6.66

u/l

0.03

302

766

Glomerulonephritis

214

3.74

25.40

1.7

1.5

10.11

6.16

u/l

0.68

173

Cholecystectomy

390

1854

1.79

25.27

1.6

6.69

6.76

u/l

0.03

306

1476

Vocal cord dysfunction

176

3.88

25.25

1.5

1.4

6.98

5.28

u/l

0.56

138

Other functional intestinal disorders

256

1140

2.05

25.08

1.5

7.10

6.50

u/l

0.25

208

905

Other diseases of pleura

258

1100

2.05

25.02

1.5

1.6

7.74

7.16

u/l

0.24

196

873

Symptoms and signs involving the digestive system and abdomen

472

1359

1.74

25.02

1.5

7.71

6.49

u/l

0.88

377

1069

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

322

1715

1.88

25.01

1.6

1.5

9.37

6.67

u/l

1.96

264

1355

Disorders of lens

371

1249

1.85

24.97

1.7

1.6

7.91

6.52

u/l

0.83

307

998

Asthma (only as main-diagnosis), excluding more controls

312

875

1.98

24.90

1.6

1.5

5.66

6.56

u/l

0.59

251

691

Other pulmonary diagnosis

365

971

1.89

24.89

1.6

1.5

6.94

6.66

u/l

0.13

300

766

Pain in joint

290

891

2.01

24.73

1.7

1.5

6.51

6.50

u/l

0.00

242

705

Explicit bacterial Sepsis, including avohilmo

204

3.76

24.73

1.9

1.6

7.51

7.12

u/l

0.07

164

COPD differential diagnosis

363

968

1.88

24.60

1.6

1.5

6.55

6.70

u/l

0.07

299

762

ILD differential diagnosis

363

968

1.88

24.59

1.6

1.5

6.55

6.70

u/l

0.07

299

762

Complications of internal orthopaedic prosthetic devices, implants and grafts

153

617

2.50

24.49

1.7

1.5

8.22

6.54

u/l

0.71

125

481

Iron deficiency anaemia secondary to blood loss (chronic)

113

391

2.92

24.44

1.7

1.5

5.64

7.07

u/l

0.34

311

Collagenous colitis

206

3.74

24.43

1.6

1.5

5.03

6.94

u/l

0.62

164

Explicit bacterial Sepsis

202

3.75

24.29

1.9

1.6

7.61

7.07

u/l

0.10

162

Cardiovascular diseases

251

628

2.13

24.03

1.7

1.5

6.42

5.97

u/l

0.20

204

518

Pain in throat and chest

400

1327

1.79

24.03

1.6

6.40

6.54

u/l

0.07

315

1068

Covid-19 confirmed case

216

1016

2.14

23.99

1.6

1.5

7.55

6.80

u/l

0.25

168

808

Heart failure and coronary heart disease

247

837

2.08

23.81

1.6

1.5

9.52

6.38

u/l

1.45

191

650

Oesophageal varices

5.41

23.80

1.8

1.6

9.63

6.17

u/l

0.36

Diabetic retinopathy, excluding more controls

178

409

2.46

23.77

1.5

1.6

12.19

7.48

u/l

2.34

145

312

UC patients in KELA-register (code 208), prior to 1994

5.61

23.74

2.1

1.5

4.68

6.75

u/l

0.41

Other medical care

271

1155

1.98

23.73

1.6

1.5

7.60

6.79

u/l

0.38

220

896

Rheumatoid arthritis, including avohilmo

233

1136

2.06

23.66

1.5

5.94

6.96

u/l

0.58

181

897

Artificial opening status

112

4.82

23.65

1.9

1.5

4.18

5.69

u/l

0.50

Cutaneous abscess, furuncle and carbuncle

154

633

2.45

23.65

1.6

1.5

6.32

6.56

u/l

0.07

124

512

Antihypertensive medication - note that there are other indications

245

602

2.13

23.52

1.7

1.6

6.70

5.60

u/l

0.56

203

474

Adjustment and management of implanted device

117

422

2.80

23.44

1.6

1.5

3.92

6.10

u/l

1.09

325

Coagulation defects, purpura and other haemorrhagic conditions

128

487

2.65

23.12

1.7

1.5

6.37

6.52

u/l

0.04

102

391

All influenza

148

604

2.47

23.08

1.7

1.5

7.60

6.85

u/l

0.20

122

477

Syncope and collapse

224

895

2.10

23.06

1.6

1.5

6.98

7.12

u/l

0.05

182

721

Certain disorders involving the immune mechanism

128

488

2.65

23.05

1.6

1.5

7.77

6.64

u/l

0.21

101

395

Low back pain

392

1507

1.76

22.99

1.6

1.5

6.51

6.96

u/l

0.23

317

1184

Asthma (mode)

343

968

1.87

22.91

1.5

6.14

6.70

u/l

0.32

271

762

Atherosclerosis, excluding cerebral and coronary sclerosis

236

904

2.06

22.87

1.7

1.5

10.05

6.75

u/l

1.69

204

695

Other systemic involvement of connective tissue (FG)

156

643

2.40

22.79

1.6

1.5

5.30

6.33

u/l

0.41

119

508

Other disorders of urethra and urinary system

371

1454

1.78

22.74

1.6

1.5

8.47

6.53

u/l

1.30

297

1156

Asthma (only as main-diagnosis)

322

960

1.88

22.36

1.6

1.5

5.57

6.68

u/l

0.83

260

756

Hypo-osmolality and hyponatraemia

116

430

2.70

21.72

1.5

9.19

5.87

u/l

0.95

339

Other nutritional deficiencies

346

1796

1.77

21.65

1.6

6.49

7.10

u/l

0.38

270

1426

559

1776

1.60

21.55

1.6

1.5

6.92

6.99

u/l

0.04

442

1413

Atrial fibrillation and flutter

168

463

2.35

21.49

1.6

1.5

8.21

5.76

u/l

0.99

124

389

Streptococcal septicaemia

160

3.92

21.39

1.9

1.5

6.20

6.78

u/l

0.11

127

Streptococcal septicaemia, including avohilmo

165

3.86

21.30

1.9

1.5

6.10

6.73

u/l

0.13

128

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

141

268

2.65

21.28

1.5

6.20

5.97

u/l

0.06

113

224

Hypertensive heart and/or renal disease

143

424

2.48

21.08

1.7

1.5

9.37

6.04

u/l

1.12

118

335

Fungal Sepsis

5.22

21.04

1.9

1.5

9.21

8.18

u/l

0.11

Cough

225

1052

2.00

20.96

1.6

6.46

6.72

u/l

0.11

179

845

Other specific joint derangements/joint disorders

340

1184

1.79

20.95

1.6

6.79

6.73

u/l

0.03

279

932

Other/unspecified seropositive rheumatoid arthritis

170

771

2.22

20.90

1.5

5.97

6.75

u/l

0.34

136

621

Diabetic retinopathy

221

664

2.08

20.80

1.5

1.6

11.81

7.57

u/l

2.59

179

505

Seropositive rheumatoid arthritis, wide

171

779

2.21

20.79

1.5

5.93

6.75

u/l

0.37

137

627

Purpura and other haemorrhagic conditions

317

2.96

20.74

1.7

1.6

7.81

6.65

u/l

0.29

259

Chronic apical periodontitis

532

1876

1.59

20.72

1.6

7.96

6.65

u/l

1.05

421

1493

Chronic gastritis

159

704

2.27

20.70

1.6

1.5

4.90

6.72

u/l

1.25

130

554

Psoriatic and enteropathic arthropathies

245

3.26

20.69

1.6

1.5

8.08

5.92

u/l

0.54

197

Chronic tubulo-interstitial nephritis

5.37

20.66

1.7

8.08

6.26

u/l

0.31

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

207

618

2.12

20.61

1.7

1.5

5.68

6.03

u/l

0.12

175

515

Diabetic maculopathy

307

2.93

20.19

1.5

1.6

16.76

6.83

u/l

3.74

232

Follow-up examination after treatment for conditions other than malignant neoplasms

220

721

2.04

20.12

1.6

1.5

6.16

6.49

u/l

0.14

189

529

Intestinal stricture

186

889

2.11

20.02

1.7

1.5

6.03

6.64

u/l

0.24

154

698

Abdominal and pelvic pain

448

1359

1.66

19.98

1.6

1.5

7.41

6.49

u/l

0.58

355

1069

Senile cataract

332

1136

1.78

19.95

1.7

1.5

7.85

6.58

u/l

0.67

277

900

Haemorrhage from respiratory passages

186

781

2.12

19.92

1.7

1.6

7.01

6.56

u/l

0.11

146

630

Sleep apnoea

473

1855

1.61

19.77

1.4

1.6

6.99

7.02

u/l

0.02

359

1492

Irritable bowel syndrome

157

706

2.24

19.71

1.5

8.04

6.45

u/l

0.61

117

573

Other diseases of intestine

102

376

2.74

19.69

1.9

1.5

4.58

6.16

u/l

0.72

300

Medical observation and evaluation for suspected diseases and conditions

292

799

1.87

19.68

1.6

1.5

7.19

6.32

u/l

0.47

250

588

Ulcerative proctitis

109

4.46

19.64

2.0

1.5

6.70

6.62

u/l

0.01

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

165

759

2.19

19.62

1.6

1.5

6.08

6.79

u/l

0.29

132

613

Other diseases of arteries and capillaries

214

3.36

19.52

1.8

1.5

6.73

6.14

u/l

0.13

174

Other bacterial intestinal infections

112

435

2.59

19.50

1.7

1.5

6.44

6.43

u/l

0.00

344

Paralytic ileus and intestinal obstruction

152

677

2.26

19.49

1.8

1.5

5.40

6.63

u/l

0.54

129

538

Fracture of femur

161

657

2.22

19.49

1.7

1.5

5.77

7.11

u/l

0.66

111

521

Implicit fungal Sepsis, including avohilmo

153

3.84

19.46

1.7

1.5

9.21

7.22

u/l

0.30

126

Arthropathies

403

1205

1.69

19.46

1.6

6.36

6.66

u/l

0.16

332

949

Peripheral arterial reconstruction

104

390

2.69

19.42

1.6

12.42

6.34

u/l

2.04

299

Fracture of lumbar spine and pelvis

140

606

2.32

19.15

1.6

1.5

7.85

7.21

u/l

0.18

109

472

Total colectomy

4.98

19.03

2.1

1.5

5.03

6.63

u/l

0.28

Total colectomy operation

4.98

19.03

2.1

1.5

5.03

6.63

u/l

0.28

Enterocolitis due to Clostridium difficile

248

3.14

18.99

1.7

1.5

7.19

6.45

u/l

0.13

198

L04AC Interleukin inhibitors

138

3.97

18.95

1.5

6.50

5.90

u/l

0.13

109

Injuries to the hip and thigh

262

1280

1.84

18.91

1.7

1.5

5.61

6.81

u/l

0.90

193

1032

Implicit fungal Sepsis

5.16

18.88

1.8

1.5

9.19

8.43

u/l

0.08

Other or unspecified ileus, impaction or obstruction

110

434

2.55

18.54

1.9

1.5

4.89

6.24

u/l

0.61

340

Other bacterial intestinal infections, including avohilmo

136

593

2.31

18.42

1.7

1.5

6.24

6.75

u/l

0.14

105

467

Fall on same level

525

1801

1.56

18.41

1.6

6.41

7.08

u/l

0.42

396

1460

Hypothyroidism, other/unspecified

421

1708

1.62

18.39

1.5

1.6

8.34

6.62

u/l

1.08

313

1375

Other disorders of skin and subcutaneous tissue, not elsewhere classified

347

2.73

18.15

1.4

1.5

7.67

6.24

u/l

0.52

277

Disorders of the thyroid gland

443

1805

1.60

17.96

1.5

1.6

7.99

6.68

u/l

0.77

334

1455

Other diseases of urinary system

462

1634

1.59

17.96

1.6

1.5

7.87

6.82

u/l

0.63

371

1298

Pleural effusion

366

2.67

17.95

1.5

8.07

7.28

u/l

0.19

287

Psoriasis

165

787

2.11

17.92

1.5

8.67

6.61

u/l

0.71

129

624

Abnormal findings on diagnostic imaging of lung

256

1339

1.82

17.91

1.5

7.51

7.07

u/l

0.17

207

1058

Other cataract

240

952

1.88

17.90

1.6

1.5

8.85

6.44

u/l

1.33

186

751

Symptoms and signs involving the circulatory and respiratory systems

434

1343

1.62

17.84

1.6

6.61

6.55

u/l

0.03

346

1081

Immunodeficiencies

4.59

17.78

1.6

1.5

5.37

6.61

u/l

0.16

Alcoholic liver disease

197

3.33

17.73

1.7

1.5

11.26

7.52

u/l

0.70

159

Invasive ventilation

154

3.68

17.73

1.7

1.5

4.69

6.37

u/l

0.43

124

Parasetamol

295

830

1.80

17.63

1.5

1.6

6.10

7.16

u/l

0.61

229

686

Bacterial intestinal infections, IBD co-morbidities

115

476

2.43

17.56

1.7

1.5

6.68

6.67

u/l

0.00

377

Hyperlipidaemia, other/unspecified

201

927

1.96

17.49

1.5

1.6

9.52

6.78

u/l

1.38

152

732

Sleep apnoea, including avohilmo

482

1874

1.56

17.47

1.4

1.6

7.02

7.05

u/l

0.02

374

1501

Hypothyreosis and Thyroxine purchase for inclusion criteria

437

1808

1.59

17.37

1.6

8.04

6.60

u/l

0.88

326

1455

Disorders of lipoprotein metabolism and other lipidaemias

391

1456

1.64

17.37

1.6

1.5

8.33

6.45

u/l

1.39

321

1158

Other diseases of pancreas

190

3.36

17.35

1.6

7.88

6.32

u/l

0.27

156

Obesity and other hyperalimentation

316

1759

1.69

17.29

1.5

1.6

6.57

7.17

u/l

0.37

245

1400

Gastroduodenal ulcer

140

634

2.21

17.21

1.6

7.92

6.53

u/l

0.35

114

491

AV-block

324

2.63

17.15

1.5

8.10

7.03

u/l

0.23

263

Obesity

314

1753

1.69

17.10

1.5

1.6

6.42

7.18

u/l

0.51

244

1394

Obesity due to excess calories

238

1308

1.83

17.10

1.5

1.6

6.99

6.82

u/l

0.07

179

1057

Depression medications

140

3.10

17.06

1.5

1.4

4.58

6.47

u/l

0.83

117

Adalimumab

207

3.22

17.05

1.6

1.5

5.59

4.99

u/l

0.14

168

Other systemic involvement of connective tissue

161

776

2.09

17.04

1.6

1.5

5.19

6.67

u/l

0.71

124

627

Other CVD (FINNGEN)

174

3.18

17.02

1.6

1.5

7.97

5.93

u/l

0.50

143

Benign neoplasm of colon, rectum, anus and anal canal

334

1697

1.67

17.01

1.6

1.5

6.49

7.14

u/l

0.34

268

1347

Arthropathies in other diseases classified elsewhere

5.62

17.00

1.7

1.5

12.36

8.07

u/l

0.36

Hypokalaemia

281

2.87

16.99

1.5

10.17

6.32

u/l

1.53

227

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

434

2160

1.57

16.91

1.6

7.08

6.91

u/l

0.08

344

1719

Bronchitis

515

2030

1.52

16.91

1.6

1.5

6.52

6.90

u/l

0.24

405

1619

Symptoms and signs involving the urinary system

376

1751

1.62

16.88

1.4

1.6

8.40

6.83

u/l

1.11

315

1376

Elevated blood glucose level

161

3.52

16.61

1.6

5.45

6.02

u/l

0.11

132

Mycoses

157

758

2.08

16.56

1.7

1.5

7.10

7.22

u/l

0.03

127

599

Papulosquamous disorders

212

1136

1.88

16.55

1.5

8.52

6.42

u/l

0.97

169

905

Vitreous haemorrhage

238

3.02

16.42

1.7

1.5

11.01

7.33

u/l

0.77

196

General examination and investigation of persons without complaint and reported diagnosis

275

798

1.79

16.38

1.4

1.5

10.92

6.33

u/l

4.04

236

587

Headache

275

1219

1.75

16.34

1.6

1.5

6.00

6.74

u/l

0.47

213

983

Diseases of the respiratory system

291

829

1.76

16.25

1.5

6.48

6.64

u/l

0.07

237

655

Acute upper respiratory infections

497

1962

1.52

16.17

1.6

1.5

7.08

6.88

u/l

0.11

404

1552

Cerebrovascular diseases (FINNGEN)

151

495

2.15

16.08

1.6

1.5

8.01

5.59

u/l

1.27

124

415

Urinary track infection

298

859

1.74

15.99

1.6

1.5

6.37

6.13

u/l

0.11

239

693

Idiopathic gout

185

3.28

15.97

1.6

10.16

7.49

u/l

0.30

148

Injuries to the abdomen, lower back, lumbar spine and pelvis

210

1118

1.86

15.95

1.7

1.5

6.72

6.81

u/l

0.03

166

888

Thrombocytopenia, unspecified

156

3.51

15.92

1.7

1.5

7.81

6.21

u/l

0.29

126

Hypercalcemia

106

4.13

15.92

1.8

1.5

7.68

6.23

u/l

0.23

Codes for special purposes

262

1500

1.74

15.90

1.7

1.5

7.36

6.76

u/l

0.23

210

1195

Benign neoplasm: Colon

289

1606

1.69

15.88

1.6

1.5

6.50

7.20

u/l

0.34

233

1267

Other diseases of stomach and duodenum

133

3.73

15.85

1.5

1.6

8.62

5.17

u/l

0.74

108

Viral pneumonia

282

2.79

15.73

1.8

1.5

7.24

6.67

u/l

0.10

230

Spondylopathies

381

1406

1.61

15.68

1.6

1.5

5.91

6.89

u/l

0.69

288

1106

Intestinal malabsorption

103

4.15

15.65

1.8

1.5

8.83

5.03

u/l

0.73

Agranulocytosis

284

2.77

15.55

1.6

1.5

5.77

6.29

u/l

0.16

230

Cellulitis

124

560

2.23

15.54

1.8

1.5

7.29

6.24

u/l

0.33

450

Benign neoplasm of other and ill-defined parts of digestive system

114

498

2.31

15.49

1.7

1.5

4.52

6.93

u/l

1.58

396

Diverticular disease of intestine

344

1311

1.64

15.47

1.6

1.5

6.86

6.81

u/l

0.02

270

1037

Benign neoplasms

427

1489

1.56

15.45

1.6

6.46

7.17

u/l

0.40

348

1171

Intracranial trauma

258

991

1.76

15.44

1.5

1.6

7.31

7.03

u/l

0.10

192

807

Hypertensive Heart Disease

121

402

2.29

15.39

1.7

1.5

8.59

5.90

u/l

0.91

315

Provisional assignment of new diseases of uncertain etiology

260

1500

1.72

15.38

1.7

1.5

7.43

6.75

u/l

0.26

208

1195

ILD, hospital admission 2, with pulmonary infections

200

3.13

15.33

1.5

8.41

8.26

u/l

0.03

160

Chronic nephritic syndrome

4.81

15.22

1.6

8.58

6.24

u/l

0.35

Lower back pain or/and sciatica

498

2071

1.50

15.20

1.6

1.5

7.02

7.00

u/l

0.01

396

1641

Acute pancreatitis

104

441

2.37

15.12

1.7

1.5

6.14

6.54

u/l

0.11

348

Other CVD

118

530

2.24

15.00

1.6

1.5

6.77

7.10

u/l

0.09

411

Other respiratory diseases principally affecting the interstitium

105

449

2.36

14.99

1.5

9.87

6.91

u/l

1.12

350

Hydronephrosis

224

2.97

14.95

1.5

1.6

10.18

6.06

u/l

1.34

177

Immunodeficiency with predominantly antibody defects

5.62

14.83

1.7

1.5

2.70

5.05

u/l

0.77

Depression

444

1956

1.52

14.80

1.6

1.5

7.78

6.79

u/l

0.61

344

1562

Non-ischemic cardiomyopathy

169

683

1.97

14.77

1.5

7.72

6.67

u/l

0.30

130

541

ILD, hospital admissions 3, with pneumonia sepsis

179

3.22

14.76

1.5

1.6

8.12

7.72

u/l

0.07

142

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

4.32

14.57

1.7

1.4

4.16

7.08

u/l

0.66

Other pleural conditions

228

2.92

14.52

1.7

1.6

7.44

7.51

u/l

0.01

180

Postprocedural disorders of digestive system, not elsewhere classified

4.62

14.51

2.3

1.5

1.19

5.13

u/l

3.06

Atrial fibrillation and flutter with reimbursement

131

377

2.20

14.48

1.6

1.5

8.75

5.66

u/l

0.98

316

Other (not insulin) diabetes medications

444

1717

1.52

14.45

1.5

1.6

8.09

6.19

u/l

1.65

340

1380

Viral pneumonia (unknown virus, not influenza)

137

3.54

14.45

1.8

1.5

4.45

6.27

u/l

0.41

116

Other antidepressants

458

1541

1.52

14.44

1.5

1.6

6.32

7.04

u/l

0.50

361

1238

Malignant neoplasm of digestive organs, including Hilmo

203

811

1.85

14.41

1.6

1.5

5.95

7.48

u/l

0.76

159

644

Nephrotic syndrome

5.10

14.36

1.7

1.6

10.95

6.60

u/l

0.47

Recurrent or chronic depression

194

719

1.88

14.34

1.6

7.17

6.44

u/l

0.29

147

594

Other joint disorders

367

1204

1.59

14.27

1.6

5.66

6.67

u/l

0.85

300

948

Methotrexate

327

2.56

14.18

1.6

1.5

6.20

6.59

u/l

0.08

251

Other reaction to severe stress, and adjustment disorders

175

929

1.89

14.10

1.7

1.5

7.21

6.58

u/l

0.21

138

760

Other diseases of anus and rectum

159

816

1.95

14.06

1.7

1.5

5.27

6.34

u/l

0.66

122

646

Spondylopathies (FG)

249

2.79

14.00

1.6

1.5

6.46

5.62

u/l

0.21

201

Depression or dysthymia

310

1029

1.65

14.00

1.6

7.14

6.85

u/l

0.11

240

842

L01XE Protein kinase inhibitors

108

3.85

13.89

1.6

6.18

6.42

u/l

0.03

Ulcerative enterocolitis

4.93

13.83

1.6

1.5

6.46

7.22

u/l

0.10

Enlarged lymph nodes

343

2.49

13.81

1.6

1.5

5.97

6.27

u/l

0.08

282

Viral and other specified intestinal infections, including avohilmo

121

545

2.14

13.81

1.8

1.6

5.54

6.20

u/l

0.25

437

Mood disorders, excluding more controls

426

1652

1.52

13.80

1.6

7.78

6.79

u/l

0.58

326

1341

Soft tissue disorders

434

1464

1.52

13.77

1.6

7.12

6.25

u/l

0.61

347

1142

Asthma-related infections

283

1691

1.64

13.77

1.6

5.10

7.08

u/l

2.06

229

1343

Asthma, hospital admission 2, infections

283

1691

1.64

13.77

1.6

5.10

7.08

u/l

2.06

229

1343

Sleep disorders (combined)

498

1767

1.47

13.69

1.5

1.6

6.36

7.07

u/l

0.59

382

1425

Chronic ulcer of skin, not elsewhere classified

142

3.42

13.69

1.6

1.5

7.69

6.74

u/l

0.18

118

Calcific aortic valvular stenosis, including rheumatic fever

151

741

1.97

13.65

1.6

1.5

7.30

7.34

u/l

0.01

122

576

Lichen simplex chronicus and prurigo

139

3.42

13.43

1.6

1.5

6.37

6.59

u/l

0.04

116

Operations 2 for CAVS

150

740

1.96

13.41

1.6

1.5

7.26

7.37

u/l

0.02

121

575

Calcific aortic valvular stenosis, diagnosis (helper)

150

740

1.96

13.41

1.6

1.5

7.26

7.37

u/l

0.02

121

575

Calcific aortic valvular stenosis

150

741

1.96

13.36

1.6

1.5

7.26

7.36

u/l

0.02

121

576

Calcific aortic valvular stenosis, operated

150

741

1.96

13.36

1.6

1.5

7.26

7.36

u/l

0.02

121

576

Mood [affective] disorders

466

2028

1.47

13.35

1.6

7.71

6.75

u/l

0.61

361

1621

Vascular disorders of the intestines

130

3.50

13.31

1.7

1.6

7.72

5.74

u/l

0.35

105

Gingivitis and periodontal diseases

448

1549

1.50

13.22

1.5

1.6

6.22

7.11

u/l

0.71

359

1214

Primary_lymphoid and hematopoietic malignant neoplasms

130

639

2.05

13.19

1.6

1.5

6.13

7.20

u/l

0.39

104

490

Mood disorders

466

2031

1.47

13.14

1.6

7.71

6.78

u/l

0.58

361

1624

Type 2 diabetes, strict (exclude DM1)

419

1622

1.51

13.07

1.5

1.6

7.36

6.22

u/l

0.86

324

1306

Other metabolic disorders

329

2.48

13.02

1.7

1.5

4.18

5.88

u/l

0.75

268

Diseases of the musculoskeletal system and connective tissue

201

549

1.84

13.01

1.6

5.33

6.28

u/l

0.45

167

419

Dipeptidyl peptidase 4 (DPP-4) inhibitors

280

1351

1.63

13.01

1.5

1.6

8.74

6.64

u/l

1.50

222

1090

Anxiety disorders, excluding more controls

374

1560

1.53

12.98

1.6

6.12

6.53

u/l

0.24

286

1271

Type 2 diabetes, definitions combined

414

1601

1.51

12.98

1.5

1.6

7.35

6.11

u/l

0.96

319

1292

Acute bronchitis

202

1129

1.76

12.95

1.6

1.5

5.99

6.82

u/l

0.40

158

900

Myocardial infarction

237

972

1.71

12.91

1.5

1.6

8.90

6.41

u/l

1.10

191

774

284

2.59

12.83

1.9

1.5

3.50

5.46

u/l

1.04

232

Any mental disorder

486

1666

1.46

12.79

1.5

1.6

7.83

6.76

u/l

0.69

370

1353

Other disorders of white blood cells

110

3.68

12.76

1.5

8.48

7.44

u/l

0.12

Ischemic heart diseases

396

1560

1.51

12.76

1.5

1.6

8.94

6.18

u/l

2.26

302

1252

Other diseases of pericardium

4.23

12.72

1.6

1.4

13.32

6.43

u/l

0.58

Hard cardiovascular diseases

393

1536

1.51

12.67

1.5

1.6

8.18

6.46

u/l

1.22

312

1226

Hypothyroidism, strict autoimmune, 3 medication purchases required

386

1719

1.51

12.63

1.5

1.6

8.83

6.49

u/l

1.46

285

1384

Diabetic neuropathy

309

2.50

12.59

1.6

12.48

7.93

u/l

1.16

236

Periodontitis

459

2006

1.46

12.57

1.6

1.5

7.22

6.99

u/l

0.11

369

1589

Viral and other specified intestinal infections

362

2.35

12.50

1.8

1.5

5.45

6.45

u/l

0.33

289

Chronic periodontitis, including avohilmo

458

2006

1.46

12.49

1.6

1.5

7.24

6.99

u/l

0.13

368

1589

Hypocalcemia

5.12

12.47

1.8

1.6

2.10

4.58

u/l

1.01

All influenza (not pneumonia)

294

2.53

12.46

1.9

1.5

5.93

7.33

u/l

0.31

246

Pain (limb, back, neck, head abdominally)

295

911

1.63

12.44

1.5

7.28

6.37

u/l

0.48

232

722

Use of hypnotics and sedatives

476

1876

1.45

12.41

1.7

1.5

6.62

7.11

u/l

0.32

372

1490

Persons encountering health services for specific procedures, not carried out

172

3.05

12.39

2.1

1.5

2.47

5.94

u/l

1.20

140

Hypoparathyroidism

4.15

12.34

1.7

1.5

3.78

6.48

u/l

0.69

Acute upper respiratory infections of multiple and unspecified sites

350

1672

1.53

12.31

1.7

1.5

6.83

6.91

u/l

0.03

280

1319

Diseases of the eye and adnexa

314

988

1.60

12.28

1.6

6.76

6.01

u/l

0.41

256

796

Myocardial infarction, strict

220

909

1.72

12.28

1.6

1.5

8.63

6.50

u/l

0.83

175

723

Other acute lower respiratory infections

246

1428

1.64

12.26

1.6

6.44

6.94

u/l

0.22

192

1139

Chronic lower respiratory diseases

528

1955

1.42

12.21

1.6

6.55

7.24

u/l

0.50

415

1555

Asthma (diagnoses ohter than nonallergic)

397

2167

1.48

12.21

1.6

5.61

7.14

u/l

1.70

317

1719

Gastric ulcer

420

2.25

12.20

1.5

10.00

6.27

u/l

0.87

320

Postmenopausal osteoporosis with pathological fracture

174

3.03

12.19

1.4

1.5

6.99

7.20

u/l

0.04

140

Type 2 diabetes, definitions combined, including avohilmo

412

1604

1.49

12.16

1.5

1.6

7.80

6.11

u/l

1.45

320

1290

Symptoms and signs concerning food and fluid intake

217

2.78

12.14

1.6

1.5

4.85

6.37

u/l

0.51

179

Chronic periodontitis, complicated

278

1710

1.59

12.08

1.7

1.5

7.18

7.12

u/l

0.02

224

1352

Neurological diseases

357

1168

1.54

11.94

1.6

7.32

6.87

u/l

0.21

280

943

Hypotension

424

2.23

11.94

1.6

1.5

7.35

6.97

u/l

0.08

330

208

1215

1.70

11.93

1.7

1.5

5.28

6.96

u/l

1.18

171

960

Hepatocellular carcinoma, including Hilmo

5.43

11.85

1.6

1.4

1.65

7.01

u/l

2.49

Nerve, nerve root and plexus disorders

478

2004

1.43

11.82

1.6

7.88

6.82

u/l

0.76

386

1581

Neurotic, stress-related and somatoform disorders

398

1857

1.48

11.81

1.7

1.5

6.44

6.94

u/l

0.27

303

1494

Diseases of pulp and periapical tissues, including avohilmo

450

1599

1.46

11.75

1.5

1.6

7.60

6.50

u/l

0.79

363

1273

Type 1 diabetes, definitions combined

141

3.20

11.68

1.8

1.5

8.76

5.02

u/l

0.63

121

Pyogenic arthritis

117

3.45

11.65

1.8

1.5

4.80

7.46

u/l

0.76

Type 1 diabetes, strict (exclude DM2)

142

3.18

11.55

1.8

1.5

8.76

4.98

u/l

0.64

121

Cystitis

378

1506

1.50

11.55

1.6

1.5

7.35

6.66

u/l

0.37

292

1197

Bronchiectasis

185

2.90

11.54

1.7

1.5

5.33

7.19

u/l

0.55

150

Disorders of synovium and tendon

247

1294

1.62

11.51

1.5

1.6

7.50

6.51

u/l

0.44

192

1008

Statin medication

291

1034

1.59

11.49

1.6

7.29

6.47

u/l

0.39

232

824

Viral infections characterized by skin and mucous membrane lesions

203

1200

1.70

11.49

1.6

1.5

8.75

7.02

u/l

0.70

164

956

Malignant neoplasm of digestive organs

175

751

1.79

11.40

1.6

1.5

6.71

7.62

u/l

0.30

136

603

Other arrhythmias

284

1351

1.57

11.39

1.5

6.66

6.76

u/l

0.03

220

1097

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

3.88

11.38

1.6

1.5

4.68

8.72

u/l

0.74

Persons with potential health hazards related to communicable diseases

157

857

1.82

11.37

1.7

1.5

6.73

6.78

u/l

0.01

115

690

Asthma-related pneumonia or sepsis

183

1052

1.74

11.36

1.7

1.5

4.95

6.81

u/l

1.27

150

834

Asthma, hospital admissions 3, pneumonia

183

1052

1.74

11.36

1.7

1.5

4.95

6.81

u/l

1.27

150

834

Malignant neoplasm of liver and intrahepatic bile ducts

4.97

11.23

1.6

1.4

5.76

6.48

u/l

0.07

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

120

3.37

11.22

1.6

1.5

4.29

7.05

u/l

0.61

102

Isolated proteinuria

4.65

11.22

1.4

1.6

10.53

4.94

u/l

0.58

Acute pancreatitis (for exclusion)

104

501

2.09

11.22

1.7

1.5

6.14

6.85

u/l

0.20

392

Myocardial infarction, without ST-elevation

192

1012

1.72

11.22

1.6

1.5

8.63

6.99

u/l

0.50

159

793

Pure hypercholesterolaemia

331

1384

1.52

11.13

1.6

1.5

7.48

6.49

u/l

0.50

277

1097

Asthma-related pneumonia

182

1051

1.73

11.13

1.7

1.5

4.98

6.82

u/l

1.24

149

833

Cardiodefibrillation

170

964

1.77

11.11

1.6

1.5

6.41

7.21

u/l

0.28

122

763

Concussion

212

982

1.68

11.10

1.5

1.6

6.37

7.06

u/l

0.29

162

801

Other gastritis (incl. Duodenitis)

112

557

2.02

11.09

1.7

1.5

8.07

6.58

u/l

0.38

438

Anxiety disorders

399

1880

1.46

11.06

1.7

1.5

6.45

6.97

u/l

0.28

304

1510

Percutaneous Coronary Intervention

369

1515

1.48

10.94

1.5

1.6

9.05

6.27

u/l

1.95

292

1213

Exclusions for E4_PCOS_BROAD

402

2.20

10.86

1.6

1.5

7.33

5.99

u/l

0.43

328

Other infectious diseases

170

2.91

10.80

1.7

1.5

5.88

6.26

u/l

0.06

139

Presence of cardiac and vascular implants and grafts

188

804

1.72

10.79

1.6

1.5

7.38

6.63

u/l

0.29

167

635

Seronegative rheumatoid arthritis

261

2.51

10.79

1.5

7.42

6.42

u/l

0.21

209

Vasculitis limited to skin, not elsewhere classified

4.98

10.77

1.8

1.6

6.25

6.66

u/l

0.04

Zoster [herpes zoster], including avohilmo

257

1581

1.57

10.75

1.5

7.69

6.67

u/l

0.42

197

1265

Falls/tendency to fall

442

1543

1.44

10.70

1.6

1.5

6.34

7.13

u/l

0.57

331

1253

Congenital malformations, deformations and chromosomal abnormalities

250

1505

1.58

10.60

1.7

1.5

6.40

6.87

u/l

0.23

202

1198

Sequelae of external causes of morbidity and mortality

135

727

1.87

10.60

1.7

1.5

6.69

6.59

u/l

0.03

108

574

Retention of urine

150

671

1.81

10.40

1.5

1.6

7.66

7.25

u/l

0.12

122

524

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

3.67

10.25

1.7

1.5

4.40

7.39

u/l

0.51

STROKE

250

1064

1.59

10.24

1.5

7.39

5.95

u/l

0.94

205

848

Accidents

336

1122

1.50

10.22

1.6

1.5

5.85

7.38

u/l

1.31

265

909

Other external causes of accidental injury

336

1122

1.50

10.22

1.6

1.5

6.06

7.38

u/l

1.00

264

909

Other disorders of adrenal gland

3.59

10.22

1.3

1.5

7.91

5.69

u/l

0.33

Major coronary heart disease event

389

1610

1.45

10.19

1.5

1.6

8.11

6.34

u/l

1.26

305

1279

Colectomy operation

441

2.10

10.11

1.9

1.5

5.57

6.79

u/l

0.31

348

Symptoms and signs involving cognition, perception, emotional state and behaviour

428

2024

1.41

10.10

1.6

6.48

7.02

u/l

0.34

335

1614

Obesity, other/unspecified

158

906

1.75

10.09

1.6

5.46

6.62

u/l

0.73

128

741

Intestinal adhesions without obstruction

177

2.79

10.05

1.8

1.6

3.67

6.26

u/l

0.97

145

Emergency coronary revascularization (for ACS)

393

1650

1.44

10.05

1.5

8.95

6.41

u/l

1.78

310

1314

Pacemaker

172

937

1.71

10.03

1.5

1.6

6.90

6.92

u/l

0.01

128

730

Psoriasis vulgaris

469

2.06

10.03

1.5

1.6

8.29

6.64

u/l

0.47

378

Disorders of vitreous body and globe

262

1613

1.54

10.00

1.6

1.5

7.73

6.92

u/l

0.34

206

1282

Malignant neoplasm of skin, including Hilmo

228

950

1.61

9.99

1.6

1.5

8.39

7.33

u/l

0.34

181

752

L02BA Anti-estrogens

101

504

2.02

9.97

1.9

1.5

6.28

6.52

u/l

0.05

406

Thyrotoxicosis, other and/or unspecified

108

552

1.97

9.95

1.5

6.10

6.91

u/l

0.27

451

Neurological diseases, wide definition

199

2.25

9.94

1.5

1.6

5.77

5.73

u/l

0.01

160

COPD (mode)

133

560

1.86

9.93

1.6

1.5

6.07

7.08

u/l

0.29

104

440

Pruritus

278

2.39

9.92

1.4

1.5

13.96

6.06

u/l

1.99

224

Psoriatic arthropathies

230

2.54

9.91

1.5

10.27

7.37

u/l

0.56

188

Coronary revascularization (ANGIO or CABG)

363

1515

1.46

9.91

1.5

1.6

8.68

6.27

u/l

1.77

287

1213

Seropositive rheumatoid arthritis, strict definition

412

2.13

9.89

1.6

1.5

6.14

6.33

u/l

0.05

332

Other interstitial pulmonary diseases

386

2.16

9.87

1.4

1.5

8.20

6.95

u/l

0.36

307

Mycoses, including avohilmo

405

2179

1.42

9.86

1.6

6.74

6.99

u/l

0.13

318

1736

Other necrotizing vasculopathies (FG)

115

3.25

9.86

1.6

1.5

7.03

5.93

u/l

0.15

Other and unspecified vasculitis limited to skin

4.97

9.82

1.9

1.6

5.93

6.99

u/l

0.09

Anxiety (asthma-related co-morbidities)

255

1251

1.55

9.78

1.6

6.17

6.47

u/l

0.12

192

1008

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

274

1647

1.52

9.77

1.7

1.6

6.18

6.78

u/l

0.33

218

1299

Acute sinusitis

229

1321

1.58

9.74

1.6

1.5

6.32

6.86

u/l

0.27

193

1038

ILD, hospital admissions

382

2.16

9.72

1.5

1.6

8.31

7.06

u/l

0.35

307

Other general symptoms and signs

3.70

9.71

1.4

1.5

4.59

5.34

u/l

0.12

Episodal and paroxysmal disorders

463

1682

1.40

9.71

1.5

1.6

6.58

6.87

u/l

0.17

368

1337

Dorsalgia

411

1530

1.43

9.70

1.6

1.5

6.55

6.87

u/l

0.16

331

1204

Interstitial lung disease

389

2.15

9.69

1.4

1.5

8.20

7.07

u/l

0.32

310

Interstitial lung disease endpoints

389

2.15

9.69

1.4

1.5

8.20

7.07

u/l

0.32

310

Unspecified haematuria

187

918

1.66

9.63

1.5

1.6

6.69

7.30

u/l

0.20

153

722

Abnormal findings on diagnostic imaging of other body structures

377

2.16

9.63

1.4

1.5

8.03

6.39

u/l

0.34

307

Malignant neoplasm of breast, HER-negative

106

522

1.96

9.62

1.8

1.5

5.22

7.11

u/l

0.93

413

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

425

1916

1.40

9.54

1.7

1.5

5.17

7.27

u/l

2.45

338

1520

Other disorders of glucose regulation and pancreatic internal secretion

171

2.77

9.53

1.9

1.5

9.13

6.46

u/l

0.48

140

Disorders of vitreous body

255

1588

1.53

9.53

1.6

1.5

7.78

6.88

u/l

0.38

202

1265

Other diseases of blood and blood-forming organs

144

2.94

9.50

1.6

3.24

6.58

u/l

1.41

119

Drug-induced neutropenia

183

2.71

9.48

1.6

3.66

6.13

u/l

1.37

152

Sicca syndrome [Sjögren]

224

2.52

9.44

1.5

6.84

6.20

u/l

0.11

180

Injuries to the head

481

2079

1.37

9.41

1.6

6.10

7.10

u/l

0.84

355

1678

Malignant neoplasm of skin

217

918

1.60

9.38

1.6

1.5

8.91

7.39

u/l

0.50

173

729

Arthropathic psoriasis

273

2.36

9.38

1.5

1.6

12.36

6.27

u/l

1.10

224

Other infectious diseases, including avohilmo

207

2.58

9.37

1.7

1.5

5.57

6.01

u/l

0.08

165

Spondylosis

259

1326

1.53

9.36

1.6

1.5

6.09

6.95

u/l

0.47

191

1042

Injuries to the thorax

209

1315

1.59

9.35

1.6

1.5

5.22

7.34

u/l

1.82

155

1058

ILD, hospital admissions 1, main diag only

330

2.23

9.34

1.5

1.6

8.64

7.05

u/l

0.43

265

Functional dyspepsia

127

700

1.82

9.31

1.5

8.71

6.55

u/l

0.77

558

malignant neoplasm of male genital organs

105

316

2.01

9.31

1.9

1.5

5.90

8.35

u/l

1.19

255

Disorders of sclera, cornea, iris and ciliary body

248

1627

1.53

9.26

1.6

1.5

6.69

7.03

u/l

0.15

201

1285

Unspecified privation

238

2.45

9.25

1.7

1.5

3.77

6.20

u/l

1.06

193

All anxiety disorders

260

1326

1.52

9.25

1.6

6.22

6.80

u/l

0.26

196

1072

Exposure to other specified factors

351

2110

1.43

9.20

1.6

6.20

7.17

u/l

0.70

286

1672

Other (seronegative) rheumatoid arthritis, wide

104

540

1.94

9.20

1.5

5.61

6.77

u/l

0.41

427

Sequelae with surgical and medical care as external cause

106

554

1.92

9.19

1.7

1.5

6.95

6.68

u/l

0.07

437

Other necrotizing vasculopathies

164

2.77

9.13

1.6

1.5

6.35

6.97

u/l

0.09

136

Cholecystitis

314

2.24

9.12

1.4

1.6

7.31

6.44

u/l

0.25

243

Diaphragmatic hernia

181

1108

1.64

9.12

1.6

5.91

6.86

u/l

0.43

147

884

Postprocedural endocrine and metabolic disorders, not elsewhere classified

308

2.25

9.11

1.7

1.5

3.79

6.04

u/l

1.18

253

Hernia of abdominal wall

204

1287

1.59

9.08

1.6

8.96

6.80

u/l

0.80

156

1034

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

165

988

1.68

9.06

1.6

1.5

5.51

6.84

u/l

0.77

134

794

Other special examinations and investigations of persons without complaint or reported diagnosis

246

799

1.56

9.00

1.5

7.22

6.32

u/l

0.40

192

588

Coxarthrosis [arthrosis of hip](FG)

239

1066

1.55

8.90

1.5

1.6

7.46

6.41

u/l

0.55

192

850

Other/unspecified dorsalgia

176

1063

1.64

8.89

1.6

1.5

6.61

6.93

u/l

0.11

143

829

Malignant neoplasm of prostate

101

300

2.00

8.84

1.9

1.5

6.57

8.63

u/l

0.82

241

Care involving use of rehabilitation procedures

266

1605

1.49

8.80

1.7

1.5

5.71

6.64

u/l

0.51

228

1240

Thyroiditis, ILD-related definition

238

2.41

8.78

1.5

9.70

5.92

u/l

0.56

192

Vitamin B12 deficiency anaemia

232

2.43

8.77

1.5

10.07

6.57

u/l

0.68

185

Unspecified misadventure during surgical and medical care

124

3.02

8.74

2.1

1.5

6.07

6.85

u/l

0.10

105

External causes of morbidity and mortality

266

876

1.52

8.74

1.6

1.5

5.64

6.91

u/l

0.89

212

704

Sarcoidosis

327

2.19

8.71

1.5

10.06

6.55

u/l

0.48

270

Other malignant neoplasms of skin (=non-melanoma skin cancer)

199

843

1.61

8.70

1.5

9.23

7.45

u/l

0.55

154

662

Conduction disorders

131

590

1.78

8.70

1.5

7.43

6.75

u/l

0.18

103

480

Malignant neoplasm of breast, ER-negative, including Hilmo

110

553

1.87

8.69

1.7

1.5

5.28

6.84

u/l

0.74

436

Early onset COPD, excluding more controls

426

2.03

8.68

1.6

1.5

4.45

7.11

u/l

1.82

340

Factors influencing health status and contact with health services

105

266

1.99

8.67

1.5

6.25

4.74

u/l

0.49

197

Type 1 diabetes, strict definition, subgroup 1

3.46

8.60

1.8

1.5

9.41

4.53

u/l

0.68

Urticaria and erythema

166

1011

1.65

8.56

1.6

6.86

6.69

u/l

0.06

133

808

Major coronary heart disease event excluding revascularizations

273

1212

1.49

8.50

1.5

7.04

6.35

u/l

0.36

218

955

Other specified/unspecified systemic involvement of connective tissue

137

2.88

8.49

1.7

1.5

3.91

5.75

u/l

0.50

111

Personality disorders, excluding more controls

104

554

1.88

8.47

1.6

7.58

6.26

u/l

0.41

462

Diseases of oral cavity, salivary glands and jaws

235

781

1.55

8.46

1.5

1.6

7.03

6.74

u/l

0.11

191

627

Genitourinary diseases

195

602

1.63

8.46

1.5

1.6

8.21

5.98

u/l

1.06

156

476

Zoster [herpes zoster]

100

528

1.90

8.45

1.6

1.5

9.24

6.94

u/l

0.52

425

Selective serotonin reuptake inhibitors

412

1544

1.39

8.45

1.5

1.6

6.35

7.03

u/l

0.45

309

1240

Gonarthrosis [arthrosis of knee](FG)

306

1208

1.46

8.42

1.5

1.6

6.17

6.37

u/l

0.10

234

965

Injuries to the elbow and forearm

320

1922

1.43

8.42

1.6

7.14

6.72

u/l

0.20

250

1536

Abnormal findings on examination of urine, without diagnosis

3.41

8.36

1.4

1.6

10.05

7.18

u/l

0.27

Open wound of ankle and foot

220

2.42

8.29

1.8

1.5

9.33

6.78

u/l

0.49

181

Persons encountering health services for examination and investigation

244

799

1.53

8.28

1.5

6.70

6.32

u/l

0.16

197

588

Substance abuse, excluding more controls

224

1228

1.53

8.20

1.6

8.55

6.83

u/l

0.72

168

1005

Bacterial pneumoniae

169

914

1.63

8.18

1.8

1.5

4.42

6.92

u/l

1.74

142

726

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

222

2.40

8.14

1.9

1.5

4.68

6.00

u/l

0.36

183

Psoriatic arthropathies, ICD10

253

2.31

8.13

1.5

1.6

10.27

5.19

u/l

1.29

207

Problems related to lifestyle

163

2.65

8.11

1.4

1.6

10.86

5.78

u/l

0.61

134

Graves disease, strict definition

254

2.30

8.06

1.5

1.6

6.49

5.99

u/l

0.11

211

Unspecified fall

228

1490

1.51

7.99

1.6

5.44

6.93

u/l

1.14

181

1188

Venous thromboembolism

243

1578

1.49

7.98

1.7

1.5

4.15

7.28

u/l

4.93

191

1260

Valvular operations

287

2.21

7.96

1.9

1.5

4.16

7.31

u/l

1.63

233

Chronic lymphocytic leukaemia

4.31

7.96

1.5

2.33

8.21

u/l

1.44

Chronic lymphocytic leukaemia, helper endpoint

4.31

7.96

1.5

2.33

8.21

u/l

1.44

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.31

7.96

1.5

2.33

8.21

u/l

1.44

Misadventures to patients during surgical and medical care

353

2.08

7.94

1.8

1.5

6.30

5.99

u/l

0.07

287

Other local infections of skin and subcutaneous tissue

237

2.34

7.94

1.6

13.44

6.07

u/l

0.93

197

Alcohol use disorder, Swedish definition

222

1335

1.51

7.93

1.6

8.74

7.02

u/l

0.71

166

1079

Basal cell carcinoma, including Hilmo

197

851

1.57

7.91

1.5

9.25

7.38

u/l

0.60

156

669

Thyrotoxicosis

129

752

1.72

7.90

1.5

5.76

6.67

u/l

0.37

602

Fracture of lower leg, including ankle

251

1677

1.47

7.90

1.6

1.5

5.55

7.27

u/l

1.44

205

1327

Other psoriatic arthropathies

245

2.30

7.82

1.4

1.6

10.74

5.30

u/l

1.35

200

Other abnormal findings of blood chemistry

3.33

7.80

1.6

19.65

5.79

u/l

1.13

Non-allergic asthma (mode), excluding more controls

379

2.02

7.77

1.7

1.5

3.09

5.96

u/l

2.26

303

Ankylosing spondylitis, ICD10

185

2.50

7.73

1.6

1.5

6.58

6.02

u/l

0.09

157

Non-selective monoamine reuptake inhibitors

174

1055

1.59

7.73

1.5

7.50

6.76

u/l

0.25

134

838

Diagnoses used for exclusion with ILD

121

698

1.74

7.70

1.6

1.5

9.40

6.35

u/l

0.72

544

Special screening examination for other diseases and disorders

259

2.25

7.69

1.4

1.5

13.87

6.68

u/l

1.62

199

Tubulo-interstitial nephritis, not specified as acute or chronic

128

2.83

7.68

1.8

1.6

6.56

6.32

u/l

0.03

105

Malignant neoplasm of prostate, including Hilmo

303

1.91

7.66

1.9

1.5

6.32

8.61

u/l

1.00

243

Other and unspecified local infections of skin and subcutaneous tissue

223

2.35

7.60

1.6

1.5

13.45

6.07

u/l

0.85

184

Basal cell carcinoma

190

829

1.57

7.56

1.5

9.89

7.46

u/l

0.83

151

652

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

200

874

1.55

7.54

1.6

1.5

7.80

7.39

u/l

0.12

153

691

Candidiasis

354

2.04

7.52

1.7

1.5

7.83

5.72

u/l

0.53

287

Open wound of lower leg

354

2.04

7.51

1.9

1.6

4.90

6.75

u/l

0.69

285

Secondary uncertain malignant neoplasm

275

2.19

7.50

1.6

1.4

5.90

8.02

u/l

0.82

220

Ankylosing spondylitis

194

2.44

7.48

1.6

1.5

6.49

7.02

u/l

0.09

159

Symptoms and signs involving the skin and subcutaneous tissue

315

2133

1.40

7.43

1.6

7.49

6.92

u/l

0.28

258

1685

Intracranial injury

246

1572

1.46

7.42

1.5

1.6

6.51

7.17

u/l

0.28

183

1268

Other infective otitis externa

131

2.77

7.38

1.5

1.6

7.74

5.07

u/l

0.40

109

Disorders of skin appendages

208

1377

1.51

7.37

1.6

1.5

7.16

6.76

u/l

0.17

175

1093

Diseases of the ear and mastoid process

475

1794

1.33

7.36

1.5

1.6

6.88

6.60

u/l

0.16

374

1431

Cerebral palsy and other paralytic syndromes

252

2.24

7.33

2.1

1.6

4.85

5.67

u/l

0.24

202

Faecal incontinence

240

2.27

7.29

1.4

1.6

9.14

5.94

u/l

0.72

197

Disorders of conjunctiva

355

2009

1.37

7.29

1.6

6.41

6.96

u/l

0.35

296

1584

Other and unspecified disorders of white blood cells

3.25

7.26

1.5

1.6

9.19

6.26

u/l

0.29

Pulmonary heart disease, diseases of pulmonary circulation

150

931

1.62

7.26

1.6

1.5

5.66

6.78

u/l

0.32

108

738

Other dorsopathies, not elsewhere classified

401

1536

1.36

7.23

1.6

1.5

6.16

6.87

u/l

0.50

327

1210

malignant neoplasm of male genital organs, including Hilmo

320

1.86

7.21

1.9

1.5

6.32

8.32

u/l

0.86

258

Missing teeth due to accident, extraction or parodontitis

283

1788

1.42

7.20

1.5

1.6

8.89

6.87

u/l

1.16

221

1423

Hypoglycaemia, other or unspecified

133

2.73

7.18

1.8

1.5

9.21

6.72

u/l

0.34

108

Fentanyl

229

2.28

7.14

1.7

1.4

6.16

7.34

u/l

0.31

178

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

355

2.01

7.10

1.5

5.53

7.57

u/l

0.99

282

243

1457

1.45

7.09

1.6

9.19

6.83

u/l

1.17

182

1178

Fracture of rib(s), sternum and thoracic spine

138

845

1.64

7.07

1.6

1.5

5.46

7.20

u/l

0.95

103

677

Arthrosis

284

1089

1.43

7.07

1.5

1.6

6.47

6.79

u/l

0.15

226

859

Caries of dentine, including avohilmo

324

1184

1.40

7.06

1.5

1.6

6.90

6.50

u/l

0.20

252

963

Ventral hernia

114

665

1.72

7.02

1.5

9.41

6.58

u/l

0.90

529

Coxarthrosis

220

953

1.49

7.01

1.6

7.55

6.80

u/l

0.33

175

750

Ischaemic heart disease, wide definition

344

1542

1.38

6.97

1.5

8.74

6.46

u/l

1.48

261

1232

Other follicular disorders

147

2.60

6.94

1.4

1.5

10.93

5.65

u/l

0.97

124

Arterial embolism and thrombosis

113

2.85

6.94

1.7

1.6

8.90

6.69

u/l

0.28

Dental caries, including avohilmo

300

1087

1.42

6.93

1.5

1.6

6.79

6.56

u/l

0.10

232

883

Chronic rhinitis, nasopharyngitis and pharyngitis

146

912

1.61

6.90

1.7

1.5

4.66

7.08

u/l

2.29

114

722

Biguanides

406

1834

1.34

6.88

1.5

1.6

8.00

6.47

u/l

1.17

314

1475

Cardiomyopathy

366

1.97

6.87

1.7

1.5

5.64

6.87

u/l

0.32

293

Diseases of external ear

159

1015

1.57

6.87

1.5

7.41

6.78

u/l

0.24

132

805

Coronary atherosclerosis

282

1257

1.42

6.85

1.5

1.6

9.42

6.19

u/l

2.00

216

1003

Other disorders involving the immune mechanism, not elsewhere classified

3.38

6.85

1.9

1.5

6.47

4.84

u/l

0.15

Thyrotoxicosis with diffuse goitre

367

1.97

6.84

1.5

6.19

6.24

u/l

0.01

303

Benign neoplasm: Transverse colon

273

2.14

6.84

1.6

5.21

6.84

u/l

0.48

219

Psychiatric diseases

400

1490

1.35

6.82

1.5

1.6

8.02

6.78

u/l

0.71

309

1216

Disorders of continuity of bone

228

2.25

6.82

1.6

1.5

6.49

5.73

u/l

0.23

187

Hepatocellular carcinoma

5.72

6.78

1.5

1.4

1.58

7.66

u/l

2.12

Candidiasis, including avohilmo

137

847

1.62

6.77

1.6

1.5

8.14

7.06

u/l

0.32

107

687

Weight loss

248

2.19

6.77

1.6

5.18

6.44

u/l

0.36

199

Trigger finger

411

1.91

6.73

1.6

1.5

11.76

6.18

u/l

1.62

338

Other anxiety disorders

181

1011

1.53

6.73

1.7

1.5

6.25

6.62

u/l

0.13

136

830

Asthma, including avohilmo

488

2067

1.30

6.70

1.6

6.28

7.20

u/l

0.77

389

1639

Cardiomyopathy, other and unspecified

144

2.59

6.69

1.8

1.5

2.82

7.37

u/l

2.24

120

Carbimazole or st.post thyroidectomy, condition for graves disease

104

600

1.74

6.69

1.5

6.63

6.29

u/l

0.10

486

229

1412

1.45

6.68

1.6

9.39

6.82

u/l

1.24

172

1144

Dermatophytosis

336

2.00

6.68

1.6

5.92

7.19

u/l

0.30

273

Non-allergic asthma (mode)

401

1.91

6.67

1.7

1.5

3.09

6.57

u/l

3.00

316

Open wound of head

228

1480

1.45

6.67

1.5

1.6

6.72

7.25

u/l

0.23

171

1201

Secondary and unspecified malignant neoplasm of lymph nodes

168

2.46

6.67

1.5

1.4

5.50

7.91

u/l

0.86

141

Fracture of forearm

253

1600

1.42

6.66

1.6

1.5

6.81

6.75

u/l

0.02

196

1274

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

366

1.94

6.65

1.7

1.6

8.28

5.89

u/l

0.63

298

Disorders of eyelid, lacrimal system and orbit

375

2054

1.34

6.63

1.6

6.74

6.99

u/l

0.13

301

1629

Extreme obesity with alveolar hypoventilation

3.13

6.60

1.3

1.6

8.24

6.56

u/l

0.24

Paracetamol or NSAID medication

134

2.23

6.59

1.5

1.7

5.70

6.25

u/l

0.09

106

Superficial injury of hip and thigh

365

1.95

6.59

1.7

1.5

3.25

7.15

u/l

4.18

296

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

340

1.98

6.58

1.8

1.6

8.38

5.95

u/l

0.61

279

Lung cancer and mesothelioma

343

1.91

6.53

1.8

1.4

3.89

7.02

u/l

2.01

265

Benign neoplasm: Colon, unspecified

120

725

1.66

6.52

1.6

1.5

7.34

7.04

u/l

0.07

571

Hernia

394

1972

1.33

6.52

1.6

6.81

6.72

u/l

0.04

306

1577

Paroxysmal tachycardia

383

1.85

6.50

1.9

1.5

3.31

5.72

u/l

2.16

326

Asthma, hospital admissions , main diagnosis only

341

2201

1.35

6.50

1.7

1.6

5.25

7.06

u/l

2.11

277

1743

Gonarthrosis

264

1049

1.42

6.48

1.5

1.6

6.14

6.76

u/l

0.34

202

827

Substance use, excluding alcohol

445

1.85

6.47

1.6

1.5

6.43

6.22

u/l

0.05

363

Giant cell arteritis

3.00

6.39

1.5

1.6

4.16

6.35

u/l

0.54

Bacterial pneumonia, not elsewhere classified

154

868

1.56

6.39

1.8

1.5

4.37

6.82

u/l

1.56

134

691

Diseases of pulp and periapical tissues and dental caries

263

948

1.42

6.36

1.5

1.6

6.35

6.58

u/l

0.10

210

768

Myalgia

106

624

1.70

6.36

1.6

1.5

5.67

6.37

u/l

0.26

502

Injuries to the ankle and foot

294

1827

1.38

6.35

1.6

7.65

6.72

u/l

0.49

231

1447

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

197

2.30

6.34

1.6

1.4

5.08

7.66

u/l

0.76

161

Polyuria

565

1.74

6.34

1.6

7.03

6.59

u/l

0.12

441

Seborrhoeic dermatitis

211

2.24

6.25

1.9

1.5

6.19

6.73

u/l

0.10

174

Dental operations

243

869

1.44

6.24

1.5

1.6

8.16

6.38

u/l

0.88

193

703

Other/unspecified rheumatoid arthritis

324

1.99

6.24

1.4

1.5

3.31

6.38

u/l

2.46

258

Abnormal weight loss

224

2.20

6.24

1.6

1.5

4.85

6.15

u/l

0.36

178

Bacterial pneumonia (organism specified)

186

1134

1.49

6.23

1.8

1.5

4.17

7.08

u/l

2.50

156

898

Type 1 diabetes, strict definition

103

2.82

6.22

1.8

1.5

9.41

4.44

u/l

0.70

Mental and behavioural disorders due to psychoactive substance use

236

1524

1.42

6.21

1.5

1.6

8.96

6.85

u/l

0.99

177

1226

Other diseases of the respiratory system

532

1.76

6.19

1.5

8.20

7.14

u/l

0.30

410

Other respiratory disorders and diseases

532

1.76

6.19

1.5

8.20

7.14

u/l

0.30

410

Malignant neoplasm of urinary organs

193

2.29

6.18

1.6

1.4

4.68

7.58

u/l

0.87

157

Dislocation, sprain and strain of joint and ligaments of hip

3.15

6.18

1.6

5.42

5.94

u/l

0.08

Duodenal ulcer

225

2.19

6.17

1.6

1.5

4.89

7.27

u/l

0.69

177

Colorectal cancer, including Hilmo

108

600

1.68

6.13

1.5

6.84

7.55

u/l

0.19

483

Exclusions for E4_PCOS_CONSORTIUM

304

1386

1.37

6.13

1.6

1.5

6.91

6.66

u/l

0.11

250

1109

Adrenocortical insufficiency

3.05

6.09

1.3

1.5

9.06

5.38

u/l

0.51

Malignant neoplasm of kidney, except renal pelvis

182

2.32

6.07

1.6

1.4

4.77

7.67

u/l

0.81

150

Rheumatism, unspecified

384

1.89

6.04

1.4

1.6

7.80

5.83

u/l

0.55

325

Juvenile arthritis (FINNGEN)

3.17

6.02

1.5

1.4

4.00

5.08

u/l

0.28

Dorsopathies

400

1539

1.32

5.98

1.7

1.5

6.33

6.87

u/l

0.33

330

1212

Asthma/COPD (KELA code 203)

384

1953

1.31

5.96

1.6

5.45

7.25

u/l

1.71

309

1553

Malignant neoplasm of urinary organs, including Hilmo

229

2.15

5.93

1.6

1.5

4.74

7.59

u/l

0.98

184

Myeloproliferative diseases

197

2.25

5.92

1.5

8.26

6.81

u/l

0.14

162

Other embolism and thrombosis

317

1.97

5.90

1.7

1.5

7.53

6.95

u/l

0.06

259

Idiopathic thrombocytopenic purpura

3.32

5.87

1.9

1.5

7.27

6.22

u/l

0.09

Other disorders of bone

446

1.80

5.84

1.7

1.5

6.60

5.93

u/l

0.16

362

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

447

1.80

5.80

1.5

7.73

7.40

u/l

0.07

356

Degeneration of macula and posterior pole

212

1143

1.43

5.77

1.5

1.6

6.00

6.60

u/l

0.33

156

918

Malignant melanoma, including Hilmo

398

1.84

5.73

1.7

1.5

9.02

7.56

u/l

0.21

316

Conjunctivitis

312

1876

1.34

5.70

1.7

1.5

6.08

6.83

u/l

0.50

261

1481

DVT of lower extremities and pulmonary embolism

183

1251

1.46

5.68

1.6

1.5

4.10

7.09

u/l

3.44

144

995

Mental and behavioural disorders due to tobacco

201

2.20

5.65

1.5

9.65

6.27

u/l

0.80

169

Injuries to the knee and lower leg

483

2054

1.27

5.64

1.6

6.29

7.17

u/l

0.58

387

1629

Vitamin D deficiency

4.80

5.63

2.1

1.5

7.12

8.31

u/l

0.09

Diseases of the myoneural junction and muscle

295

1.98

5.62

1.5

1.6

8.23

6.73

u/l

0.23

240

Obesity related asthma

149

984

1.52

5.62

1.5

5.94

6.80

u/l

0.41

112

784

Calculus of kidney and ureter

124

786

1.58

5.62

1.7

1.6

5.27

6.82

u/l

1.06

103

620

Reactive arthropathies

176

2.29

5.61

1.7

1.5

8.14

7.43

u/l

0.09

143

Other diseases of oesophagus

189

2.23

5.59

1.5

9.84

6.03

u/l

0.60

151

Smoking dependency

202

2.19

5.59

1.5

9.65

6.20

u/l

0.82

168

Other juvenile arthritis

3.42

5.59

1.5

1.4

4.21

8.56

u/l

1.08

Other disorders of lacrimal gland

172

1172

1.47

5.57

1.6

1.5

6.24

6.92

u/l

0.33

137

928

Family history of malignant neoplasm

262

2.03

5.56

1.8

1.5

5.28

6.22

u/l

0.34

215

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

442

1.72

5.56

1.7

1.5

3.68

8.09

u/l

4.17

350

Reactive arthropathies, FINNGEN

122

2.56

5.53

1.8

1.5

9.16

5.79

u/l

0.43

Etanercept

140

2.45

5.53

1.6

1.4

2.77

4.89

u/l

1.04

112

Other endocrine disorders

2.82

5.52

1.2

1.5

10.62

6.14

u/l

0.30

Fissure and fistula of anal and rectal regions

574

1.68

5.50

1.5

5.95

6.33

u/l

0.09

457

Cerebrovascular diseases

312

1622

1.34

5.47

1.6

1.5

7.80

6.96

u/l

0.45

256

1278

Benign neoplasm: Caecum

285

1.98

5.44

1.5

1.6

6.78

7.06

u/l

0.06

231

Substance abuse

224

1492

1.40

5.43

1.6

8.55

6.98

u/l

0.64

168

1205

Stroke, excluding SAH

253

1332

1.37

5.34

1.6

1.5

7.63

7.29

u/l

0.14

205

1055

Congenital malformations and deformations of the musculoskeletal system

160

2.31

5.34

1.6

4.91

5.71

u/l

0.20

133

Infections with a predominantly sexual mode of transmission

116

732

1.58

5.32

1.6

6.09

6.28

u/l

0.05

591

KRA_PSY_EATING, excluding more controls

100

2.68

5.32

2.0

1.6

9.40

6.70

u/l

0.32

Benign neoplasm: Small intestine

2.81

5.32

1.4

1.6

5.58

6.28

u/l

0.12

Temporal arteritis

2.94

5.31

1.6

4.22

6.00

u/l

0.38

Personality disorders

104

641

1.63

5.31

1.6

7.58

6.51

u/l

0.31

527

Other coagulation defects

162

2.30

5.27

1.8

1.6

2.55

6.08

u/l

1.92

137

Ischaemic Stroke, excluding all haemorrhages

237

1263

1.38

5.26

1.5

7.05

7.31

u/l

0.11

190

1003

Symptoms and signs involving the nervous and musculoskeletal systems

241

1762

1.37

5.26

1.6

1.5

7.69

6.92

u/l

0.38

187

1409

Inflammatory diseases of female pelvic organs

271

1371

1.35

5.23

1.6

1.5

6.36

6.73

u/l

0.17

206

1100

Type1 diabetes, definitions combined, early onset

2.71

5.22

1.8

1.4

6.58

6.27

u/l

0.04

Other diseases of peritoneum

2.77

5.21

1.4

1.6

6.25

6.81

u/l

0.06

Other blood glucose lowering drugs, excl. Insulins

411

1.78

5.21

1.6

1.5

9.43

7.08

u/l

0.57

332

Giant cell arteritis with polymyalgia rheumatica

2.91

5.20

1.6

4.22

6.76

u/l

0.59

Lactose intolerance

3.16

5.20

1.2

1.6

9.69

6.46

u/l

0.28

Urticaria

126

817

1.55

5.20

1.6

5.94

6.49

u/l

0.20

101

658

Chorioretinal inflammation

3.26

5.18

1.4

1.6

8.71

6.41

u/l

0.27

Other and unspecified psoriasis

151

2.33

5.17

1.7

1.6

10.88

5.64

u/l

0.48

125

Other diseases of hard tissues of teeth

212

774

1.42

5.16

1.5

1.6

7.57

6.77

u/l

0.35

175

623

Non-Hodgkin lymphoma, all, including Hilmo

270

1.97

5.15

1.5

1.4

8.68

7.37

u/l

0.22

215

Overexertion and strenuous or repetitive movements

216

2.09

5.14

1.9

1.6

2.72

5.67

u/l

2.01

179

Malignant neoplasm of endocrine gland, including Hilmo

177

2.22

5.12

1.7

1.5

5.96

7.06

u/l

0.23

145

Otitis externa

609

1.63

5.12

1.6

1.5

7.52

6.61

u/l

0.25

489

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

254

1.99

5.11

1.7

1.4

4.45

8.95

u/l

1.90

203

Pneumonia due to Streptococcus pneumoniae

3.02

5.10

1.7

1.6

4.15

6.29

u/l

0.45

Pulmonary embolism

130

854

1.53

5.07

1.6

1.5

4.44

6.86

u/l

1.46

674

Erythema intertrigo

3.31

5.04

1.3

1.6

11.15

5.12

u/l

0.86

Internal derangement of knee

145

966

1.49

5.03

1.5

1.6

9.36

7.02

u/l

0.62

114

761

Polyarthrosis

101

563

1.62

5.02

1.5

5.99

6.57

u/l

0.21

442

Urolithiasis

129

850

1.52

4.97

1.7

1.6

5.43

6.93

u/l

0.99

108

675

Keratitis

149

1012

1.48

4.96

1.7

1.5

5.98

7.06

u/l

0.50

123

803

Non-small cell lung cancer, adenocarcinoma

117

2.49

4.95

1.6

1.4

4.63

9.16

u/l

1.35

Pulmonary heart disease

130

859

1.52

4.94

1.6

1.5

4.44

7.01

u/l

1.57

677

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

224

1566

1.37

4.94

1.6

1.5

5.52

6.85

u/l

0.96

189

1237

Malignant neoplasm of colon, including Hilmo

424

1.74

4.91

1.4

1.5

3.94

7.84

u/l

3.44

338

Phobic anxiety disorders

233

2.02

4.90

1.9

1.6

5.97

6.76

u/l

0.15

204

Obsessive-compulsive disorder

100

2.61

4.88

1.7

1.5

10.02

5.83

u/l

0.45

L02BB Anti-androgens

181

2.17

4.87

2.3

1.5

3.13

7.79

u/l

2.91

142

Fracture of skull and facial bones

503

1.68

4.84

1.7

1.5

4.63

6.75

u/l

0.62

409

Fall on and from stairs and steps

115

744

1.55

4.83

1.6

1.5

6.54

6.84

u/l

0.08

593

Other pulmonary heart/vessel disease

2.65

4.82

1.7

1.6

11.58

5.71

u/l

0.38

Degenerative macular diseases

298

1.89

4.81

1.4

1.5

6.74

7.17

u/l

0.10

239

Use of pramipexole

104

659

1.58

4.79

1.6

8.00

6.97

u/l

0.24

531

Lymphoid leukaemia

113

2.50

4.79

1.5

1.6

3.87

5.99

u/l

0.59

Secondary right heart disease

2.76

4.78

1.7

1.6

12.94

6.28

u/l

0.39

Delirium, not induced by alcohol and other psychoactive substances

305

1.87

4.78

1.7

1.5

4.42

7.17

u/l

1.00

247

Sulfonylureas

141

754

1.49

4.76

1.6

9.74

6.66

u/l

1.40

116

603

Other disorders of nervous system

157

2.24

4.75

1.9

1.6

6.83

6.55

u/l

0.06

134

Familial hypercholesterolemia, with ischemic heart disease

203

2.08

4.74

1.3

1.5

9.24

7.02

u/l

0.37

154

Other diseases of upper respiratory tract

445

1848

1.26

4.72

1.6

1.5

6.54

7.08

u/l

0.39

356

1455

Atopic dermatitis

219

1275

1.37

4.69

1.6

1.5

6.74

6.69

u/l

0.02

183

1007

Malignant neoplasm of endocrine gland

158

2.23

4.68

1.7

1.5

6.39

7.62

u/l

0.23

128

Pericarditis

3.04

4.68

1.6

1.5

10.79

7.41

u/l

0.18

Chronic laryngitis and laryngotracheitis

381

1.77

4.67

1.6

1.5

11.02

6.86

u/l

0.76

312

Spinal stenosis

218

1173

1.37

4.66

1.6

1.5

5.78

7.07

u/l

0.85

167

919

Asthma and opportunity respiratory infection

109

2.50

4.63

1.7

1.5

6.41

6.63

u/l

0.02

Dysphagia

103

657

1.57

4.62

1.6

8.60

5.93

u/l

1.02

517

Malignant neoplasm of respiratory system and intrathoracic organs

401

1.68

4.61

1.5

4.02

8.10

u/l

3.13

317

Later onset COPD, excluding more controls

350

1.70

4.60

1.6

1.4

7.98

6.54

u/l

0.24

266

Alcohol-induced chronic pancreatitis

128

2.36

4.57

1.6

12.19

5.31

u/l

0.76

109

Viral warts

213

2.03

4.56

1.7

1.6

9.31

5.84

u/l

0.92

177

Allergic conjunctivitis

231

1654

1.35

4.54

1.6

5.71

6.85

u/l

0.79

195

1311

Hypertrophic disorders of skin

110

2.47

4.54

1.4

1.5

7.77

6.15

u/l

0.25

Iridocyclitis

606

1.59

4.52

1.5

8.11

6.98

u/l

0.29

483

Myocardial infarction, with ST-elevation

400

1.73

4.51

1.5

5.69

7.02

u/l

0.40

307

Disorder of lipoprotein metabolism, unspecified

298

1.85

4.50

1.8

1.5

9.62

6.40

u/l

0.66

236

Viral warts, including avohilmo

537

1.62

4.49

1.6

1.5

6.86

6.66

u/l

0.06

439

Colorectal cancer

552

1.60

4.47

1.5

7.21

7.70

u/l

0.11

442

Malignant melanoma

357

1.77

4.46

1.8

1.5

8.64

7.73

u/l

0.12

285

Other symptoms and signs involving cognitive functions and awareness

201

1301

1.37

4.44

1.5

1.6

7.05

6.78

u/l

0.09

155

1032

Benign neoplasm of other and unspecified endocrine glands

336

1.79

4.42

1.7

1.5

5.83

6.46

u/l

0.13

274

Undetermined asthma, excluding more controls

271

1.89

4.42

1.6

1.5

7.05

6.29

u/l

0.18

213

Impacted cerumen

280

1.87

4.35

1.3

1.5

10.74

6.95

u/l

0.89

226

Panic disorder

287

1.85

4.35

1.7

1.6

7.92

6.63

u/l

0.25

247

Fracture of shoulder and upper arm

154

1081

1.43

4.34

1.6

1.5

6.15

7.08

u/l

0.25

117

857

Generalized anxiety disorder

323

1.80

4.33

1.5

1.6

7.35

6.18

u/l

0.22

278

Traumatic subdural haemorrhage

295

1.81

4.32

1.5

7.56

6.76

u/l

0.11

236

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

117

2.36

4.30

1.8

1.4

2.48

7.01

u/l

2.31

Hypertrophic scar

101

2.49

4.30

1.4

1.6

6.95

5.86

u/l

0.14

Disorders of adult personality and behaviour

104

678

1.54

4.27

1.7

1.6

7.09

6.48

u/l

0.16

559

Nonorganic sleeping disorders, excluding more controls

461

1.65

4.22

1.5

6.18

6.43

u/l

0.04

388

Acute and subacute iridocyclitis

492

1.63

4.22

1.5

7.33

6.48

u/l

0.21

393

Other and unspecified urticaria

492

1.63

4.22

1.6

1.5

6.45

6.06

u/l

0.10

403

Other and unspecified disorders of vitreous body

193

1385

1.37

4.21

1.6

1.5

6.54

6.87

u/l

0.12

153

1097

Contact with and exposure to communicable diseases

101

654

1.54

4.19

1.5

1.6

6.99

6.43

u/l

0.20

537

Abnormalities of gait and mobility

299

1.81

4.15

1.7

1.6

3.15

7.31

u/l

2.84

242

Shoulder lesions

287

1326

1.30

4.14

1.5

8.37

6.45

u/l

1.30

239

1037

Injuries to unspecified part of trunk, limb or body region

228

1.94

4.14

1.9

1.6

5.53

6.32

u/l

0.14

185

Other viral diseases

103

673

1.53

4.13

1.7

1.5

4.66

6.98

u/l

1.50

545

Discitis, unspecified

4.06

4.12

1.6

7.07

6.63

u/l

0.05

Other disorders of ear

376

1944

1.25

4.08

1.5

1.6

7.10

6.70

u/l

0.21

298

1555

Postprocedural musculoskeletal disorders, not elsewhere classified

175

2.07

4.05

1.6

2.78

5.98

u/l

2.13

146

Other complications of surgical and medical care, not elsewhere classified

223

1.94

4.05

1.7

1.5

6.12

5.78

u/l

0.07

187

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

169

2.08

4.01

1.8

1.5

2.92

5.68

u/l

1.60

139

Abnormalities of heart beat

137

928

1.43

4.01

1.5

1.6

6.77

6.69

u/l

0.02

108

743

In situ neoplasms

171

1243

1.38

4.00

1.6

1.5

7.61

6.73

u/l

0.22

134

990

Specific personality disorders

538

1.58

4.00

1.6

7.84

6.37

u/l

0.39

437

Unspecified acute lower respiratory infection

332

1.75

4.00

1.6

1.5

5.04

6.94

u/l

0.51

269

Myeloproliferative diseases (CML excluded)

176

2.06

4.00

1.5

8.29

6.38

u/l

0.15

145

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

484

1.62

3.99

1.5

1.6

6.89

6.43

u/l

0.10

396

Mental and behavioural disorders due to alcohol

185

1296

1.36

3.99

1.5

1.6

9.37

7.09

u/l

0.85

136

1054

Stroke, including SAH

260

1434

1.30

3.98

1.6

1.5

8.09

7.14

u/l

0.49

211

1135

Carpal tunnel syndrome

255

1700

1.30

3.98

1.7

1.6

8.35

6.75

u/l

0.94

210

1354

Car occupant injured in other and unspecified transport accidents

424

1.66

3.94

1.4

1.6

7.91

6.12

u/l

0.47

353

Undetermined asthma

282

1.81

3.94

1.6

1.5

7.05

6.89

u/l

0.03

222

Other otitis externa (chronic)

157

2.11

3.94

1.3

1.6

10.00

5.03

u/l

0.82

130

Malignant neoplasm of small intestine, including Hilmo

3.15

3.93

1.6

1.4

3.60

9.22

u/l

1.30

Other viral diseases, including avohilmo

134

927

1.43

3.93

1.6

1.5

5.84

6.79

u/l

0.33

106

750

Bacterial, viral and other infectious agents

164

2.08

3.91

1.8

1.5

8.62

6.61

u/l

0.30

132

Injury of unspecified body region

171

2.06

3.90

1.9

1.5

5.04

5.75

u/l

0.12

141

Haemorrhoids and perianal venous thrombosis

131

907

1.44

3.89

1.5

6.33

6.61

u/l

0.10

717

Colorectal adenocarcinoma

466

1.61

3.87

1.5

7.31

7.94

u/l

0.13

368

Anterior Iridocyclitis

535

1.58

3.87

1.5

6.94

6.30

u/l

0.16

429

Other disorders of breast

396

1.67

3.87

1.6

1.5

5.49

6.63

u/l

0.37

321

Arterial embolism and thrombosis of lower extremity artery

2.79

3.85

1.6

8.17

5.74

u/l

0.26

Trochanteric bursitis

427

1.65

3.85

1.6

1.5

4.40

5.90

u/l

0.72

357

Menorrhagia

141

548

1.44

3.84

1.5

1.6

5.59

6.81

u/l

0.61

118

430

Dermatophytosis, including avohilmo

254

1929

1.29

3.83

1.6

6.18

7.29

u/l

0.65

201

1528

Restless leg syndrome

390

1.67

3.81

1.4

1.5

8.00

6.29

u/l

0.45

319

Benign neoplasm: Stomach

257

1.84

3.80

1.8

1.5

3.55

6.83

u/l

1.82

210

Soft tissue disorders related to use, overuse and pressure

116

796

1.46

3.78

1.6

1.5

5.30

6.48

u/l

0.66

622

therapeutic use

2.75

3.76

1.7

1.6

6.78

4.97

u/l

0.34

Suppurative and necrotic conditions of lower respiratory tract

108

2.33

3.76

2.1

1.5

6.17

7.10

u/l

0.09

Squamous cell neoplasms and carcinomas of the skin

194

1.97

3.75

1.9

1.4

3.43

8.79

u/l

1.99

155

Ganglion

555

1.55

3.75

1.5

4.33

6.23

u/l

0.89

450

Open wound of abdomen, lower back and pelvis

2.66

3.74

1.6

1.5

4.43

4.78

u/l

0.07

Dizziness and giddiness

302

1862

1.26

3.69

1.6

5.79

7.06

u/l

1.00

231

1489

Dermatitis due to substances taken internally

109

2.31

3.69

1.6

1.5

9.04

6.87

u/l

0.26

Disorders of lacrimal system

193

1426

1.33

3.68

1.6

1.5

6.43

6.80

u/l

0.17

156

1129

Fibroblastic disorders

622

1.52

3.67

1.6

8.27

6.35

u/l

0.53

494

Ovarian cyst

140

563

1.42

3.67

1.6

5.31

6.90

u/l

0.85

113

442

Familial hypercholesterolemia

334

1.71

3.66

1.4

1.6

9.15

6.10

u/l

0.60

264

Infections with a predominantly sexual mode of transmission, including avohilmo

138

898

1.41

3.66

1.6

6.39

6.44

u/l

0.01

110

722

Polymyalgia rheumatica

343

1.70

3.61

1.6

3.56

7.19

u/l

2.57

276

Coronary artery bypass grafting

441

1.53

3.60

1.7

1.6

8.42

6.82

u/l

0.45

341

Other headache syndromes

165

1212

1.36

3.58

1.5

1.6

7.07

6.74

u/l

0.12

130

961

Disorders of breast

209

1402

1.31

3.56

1.6

1.5

6.49

6.67

u/l

0.07

165

1122

Other secondary coxarthrosis

2.59

3.56

1.4

1.6

7.86

5.67

u/l

0.27

Other neurological diseases

290

1784

1.26

3.55

1.6

1.5

7.11

7.10

u/l

0.00

233

1412

Uterine polyps

127

517

1.44

3.53

1.5

1.6

7.73

6.82

u/l

0.28

408

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

201

1473

1.32

3.53

1.5

6.29

7.38

u/l

0.66

168

1155

Bacterial, viral and other infectious agents, including avohilmo

178

1.97

3.52

1.8

1.5

8.36

6.28

u/l

0.33

144

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

206

1.90

3.52

1.6

1.5

2.89

5.96

u/l

1.99

168

Colonic or urogenital fistula

107

734

1.46

3.52

1.5

6.22

6.62

u/l

0.10

588

Acute generalized exanthematous pustulosis

2.34

3.50

1.6

1.5

5.94

6.92

u/l

0.13

Other arthrosis

204

1035

1.32

3.50

1.6

5.62

6.83

u/l

0.80

167

817

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

125

884

1.42

3.50

1.5

1.6

9.71

6.63

u/l

1.37

102

718

Glucagon-like peptide-1 (GLP-1) analogues

125

884

1.42

3.50

1.5

1.6

9.71

6.63

u/l

1.37

102

718

Non-small cell lung cancer

204

1.90

3.50

1.6

1.4

3.78

7.97

u/l

1.94

163

severe traumatic brain injury, does not include concussion

549

1.53

3.49

1.5

8.54

6.60

u/l

0.43

432

Neuromuscular dysfunction of bladder

207

1.89

3.48

1.8

1.4

10.44

6.69

u/l

0.54

164

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

179

1.96

3.48

1.8

1.5

2.92

5.92

u/l

1.71

151

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

227

1.85

3.47

1.6

4.66

5.34

u/l

0.20

192

Open wound of forearm

194

1.91

3.42

1.5

10.03

6.64

u/l

0.52

156

Convulsions, not elsewhere classified

459

1.57

3.40

1.6

1.5

9.75

6.89

u/l

0.52

372

COPD

177

1076

1.34

3.40

1.6

1.5

6.20

7.36

u/l

0.44

135

851

Superficial injury of thorax

357

1.66

3.39

1.4

1.6

5.98

7.08

u/l

0.46

297

Hypopituitarism

133

2.11

3.39

1.6

1.5

9.45

6.10

u/l

0.56

112

Other specified and unspecified personality disorders

174

1.96

3.38

1.8

1.6

6.81

5.27

u/l

0.22

146

Other arterial embolism and thrombosis

2.85

3.36

1.7

1.6

9.00

6.87

u/l

—

Umbilical hernia

660

1.47

3.35

1.6

9.33

6.44

u/l

0.57

528

Other chronic obstructive pulmonary disease, including avohilmo

215

1362

1.30

3.34

1.5

5.84

7.24

u/l

0.70

161

1083

Anosmia

3.48

3.33

2.0

1.3

7.46

4.74

u/l

0.22

Lactose intolerance, other/unspecified

2.74

3.33

1.2

1.6

11.18

6.37

u/l

0.38

Status post-ami

491

1.49

3.32

1.5

1.6

11.10

6.61

u/l

1.41

380

Certain conditions originating in the perinatal period

118

2.11

3.32

2.0

1.5

4.66

6.60

u/l

0.37

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

4.39

3.32

1.5

1.4

2.70

13.14

u/l

—

Deforming dorsopathies

116

818

1.42

3.31

1.6

1.5

3.57

7.10

u/l

5.40

642

Complications of other internal prosthetic devices, implants and grafts

2.43

3.31

1.6

1.5

8.29

6.11

u/l

0.22

COPD, hospital admissions 3, with asthma pneumonia sepsis

104

614

1.45

3.30

1.7

1.6

5.45

7.00

u/l

0.38

480

Benign neoplasm: Adrenal gland

197

1.89

3.29

1.7

1.5

6.73

6.60

u/l

0.02

163

N06DA Anticholinesterases

851

0.65

3.28

1.4

1.6

6.22

7.04

u/l

0.19

672

Use of anticholinesterases

851

0.65

3.28

1.4

1.6

6.22

7.04

u/l

0.19

672

Non-small cell lung cancer, adenocarcinoma, helper endpoint

142

2.05

3.26

1.6

1.5

4.63

6.72

u/l

0.52

116

Other specified/unspecified bacterial intestinal infections

142

2.05

3.26

1.7

1.5

4.85

5.74

u/l

0.17

116

Diplopia

323

1.68

3.26

1.6

1.5

4.66

6.80

u/l

0.72

256

Nonischemic cardiomyopathy

219

1.83

3.25

1.5

4.24

7.47

u/l

1.39

172

Other diseases of lip and oral mucosa

173

1306

1.33

3.25

1.7

1.5

6.52

6.90

u/l

0.12

127

1041

Other abnormal uterine and vaginal bleeding

102

502

1.46

3.25

1.4

1.5

7.37

6.82

u/l

0.14

394

Benign thyroid growths and nodules

139

942

1.37

3.24

1.5

5.31

6.43

u/l

0.70

109

766

Coeliac disease

286

1.72

3.23

1.6

1.5

6.17

5.51

u/l

0.17

229

Hemiplegia

103

2.25

3.22

1.8

1.6

7.33

6.58

u/l

0.09

Superficial injury of ankle and foot

264

1.75

3.22

1.6

7.78

5.61

u/l

0.43

220

DVT of lower extremities

512

1.53

3.22

1.7

1.5

4.10

7.59

u/l

2.57

403

Malignant neoplasm of colon

355

1.64

3.21

1.5

3.67

8.05

u/l

3.08

282

Malignant neoplasm of bronchus and lung, including Hilmo

405

1.55

3.20

1.7

1.5

4.04

8.05

u/l

2.91

320

Corneal ulcer

457

1.56

3.20

1.9

1.5

6.16

6.29

u/l

0.03

369

Other and unspecified coagulation defects

110

2.20

3.19

1.8

1.5

2.05

6.30

u/l

1.98

Atopic dermatitis, strict definition with reimbursement

648

1.46

3.18

1.6

1.5

6.27

6.77

u/l

0.15

524

Amiodarone users

221

1.82

3.18

1.8

1.6

7.18

6.99

u/l

0.03

185

Non-follicular lymphoma

214

1.83

3.17

1.6

8.55

7.42

u/l

0.13

171

Special screening examination for infectious and parasitic diseases

313

1.59

3.16

1.6

1.5

5.77

5.76

u/l

0.00

237

Other skin changes

563

1.50

3.15

1.5

8.24

6.95

u/l

0.29

439

Sciatica+with lumbago

198

1352

1.30

3.15

1.6

1.5

6.69

6.95

u/l

0.10

153

1072

Disease of hard tissues of teeth, NOS

192

763

1.32

3.14

1.4

1.6

7.51

6.82

u/l

0.29

153

615

Other symptoms and signs involving the nervous and musculoskeletal systems

162

1218

1.33

3.14

1.5

1.6

9.82

6.66

u/l

1.89

127

972

Hyperaldosteronism

2.65

3.14

1.6

1.5

3.18

7.19

u/l

0.81

Symptoms and signs involving speech and voice

140

1030

1.36

3.14

1.5

7.45

6.66

u/l

0.28

114

819

Cardiomyopathy (excluding other)

244

1.77

3.13

1.7

1.5

6.78

6.63

u/l

0.02

194

Injury, poisoning and certain other consequences of external causes

194

740

1.32

3.11

1.6

1.5

4.94

6.90

u/l

1.43

154

599

Unspecific neurodegenerative disorder

935

0.69

3.10

1.4

1.5

5.55

7.15

u/l

0.56

740

Other disorders of bladder

275

1.72

3.09

1.4

1.5

8.63

7.08

u/l

0.24

215

Other predominantly sexually transmitted diseases, not elsewhere classified

367

1.61

3.08

1.5

1.6

7.89

5.71

u/l

0.54

300

Other congenital malformations of the digestive system, including avohilmo

2.24

3.07

2.2

1.5

6.85

5.86

u/l

0.09

Sequelae of injuries, of poisoning and of other consequences of external causes

607

1.47

3.07

1.5

1.6

6.61

6.65

u/l

0.01

497

Fracture of neck

132

2.06

3.06

1.6

6.20

6.26

u/l

0.01

107

Poisoning by medicine

494

1.52

3.06

1.6

4.49

6.14

u/l

0.75

412

Dermatographic urticaria

139

2.02

3.05

1.6

4.69

5.39

u/l

0.12

118

Hodgkin lymphoma, hilmo

2.60

3.05

1.3

1.6

8.73

4.79

u/l

0.59

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

617

1.46

3.04

1.5

1.6

6.26

6.37

u/l

0.03

505

Other chronic obstructive pulmonary disease

167

1034

1.32

3.04

1.6

1.5

6.32

7.30

u/l

0.33

127

814

Other specified/unspecified inflammatory spondylopathies

106

2.18

3.03

1.5

1.6

8.33

6.57

u/l

0.24

Aortic valve malfunction, age under 60 years

203

1.83

3.02

1.4

1.5

15.20

6.42

u/l

0.95

168

Macular pucker

432

1.56

3.02

1.6

1.5

4.92

7.13

u/l

0.91

340

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

618

1.46

3.00

1.6

1.5

6.16

6.54

u/l

0.11

504

Colon adenocarcinoma

270

1.71

3.00

1.5

4.18

8.17

u/l

1.90

214

Mixed and other personality disorders

154

1.96

2.99

1.8

1.5

5.62

5.82

u/l

0.02

126

Polyp of the female genital tract

128

523

1.39

2.98

1.5

1.6

6.89

6.78

u/l

0.03

103

411

Infective dermatitis

241

1.75

2.97

1.2

1.6

8.65

6.41

u/l

0.33

195

Other disorders of veins

176

1330

1.30

2.96

1.6

1.5

4.19

7.13

u/l

3.57

130

1060

Polycystic ovarian syndrome, consortium definition

290

1345

1.24

2.95

1.5

1.6

6.83

6.54

u/l

0.14

238

1065

Eating disorder

134

2.02

2.93

2.0

1.5

9.40

5.44

u/l

0.54

110

Respiratory insufficiency

148

1.96

2.92

1.3

1.4

6.84

7.71

u/l

0.12

113

Other/unspecified synovitis and tenosynovitis

303

1.66

2.91

1.5

1.6

7.40

6.59

u/l

0.12

261

Heartburn

250

1.73

2.91

1.4

1.6

6.37

5.38

u/l

0.26

207

Malignant neoplasm of thyroid gland

142

1.98

2.90

1.6

1.5

6.11

7.89

u/l

0.37

116

Other symptoms and signs involving the digestive system and abdomen

445

1.53

2.88

1.5

1.6

11.97

5.51

u/l

2.31

367

Visual disturbances and blindness

207

1631

1.27

2.85

1.6

1.5

6.20

7.01

u/l

0.45

172

1295

Other and unspecified abdominal hernia

2.30

2.84

1.9

1.7

4.69

5.76

u/l

0.12

Injuries to the neck

552

1.47

2.83

1.5

6.63

6.92

u/l

0.07

448

Mental and behavioural disorders due to alcohol, excluding acute intoxication

155

1168

1.32

2.82

1.6

8.66

7.15

u/l

0.44

112

936

Cardiomyopathies, Primary/intrinsic

238

1.73

2.80

1.6

1.5

7.06

6.65

u/l

0.06

189

Other enthesopathies

116

846

1.37

2.79

1.7

1.5

8.77

6.44

u/l

0.83

665

Other obstetric conditions, not elsewhere classified

360

1.47

2.78

1.6

5.37

6.83

u/l

0.63

298

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

425

1.53

2.78

1.5

1.6

7.59

5.79

u/l

0.46

345

Chronic sinusitis

163

1250

1.30

2.77

1.7

1.5

5.15

7.23

u/l

1.69

133

982

Superficial injury of abdomen, lower back and pelvis

354

1.59

2.77

1.7

1.5

5.28

6.50

u/l

0.38

289

Primary gonarthrosis, bilateral

222

1480

1.26

2.77

1.5

1.6

6.24

6.86

u/l

0.38

177

1178

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

117

2.06

2.77

2.0

1.5

1.76

5.75

u/l

2.69

Non-small cell lung cancer, including Hilmo

317

1.60

2.76

1.6

1.5

4.32

8.38

u/l

2.05

250

Stomatitis and related lesions

515

1.48

2.75

1.7

1.6

6.49

5.93

u/l

0.13

419

Other problems related to primary support group, including family circumstances

204

1.77

2.73

1.4

1.6

7.58

5.64

u/l

0.44

170

Visual disturbances

191

1502

1.27

2.72

1.7

1.5

5.50

7.08

u/l

1.13

157

1190

Nonsuppurative otitis media, including avohilmo

104

645

1.40

2.71

1.7

1.6

5.72

6.70

u/l

0.35

521

Alzheimer disease, including avohilmo

823

0.70

2.71

1.6

1.5

4.42

7.28

u/l

1.28

645

Abnormal spermatozoa

248

1.70

2.71

1.2

1.6

8.00

7.42

u/l

0.14

197

168

1167

1.30

2.71

1.6

1.5

10.95

6.82

u/l

1.44

131

923

Cardiac murmurs and other cardiac sounds

201

1.78

2.70

1.6

1.5

4.47

6.31

u/l

0.66

167

Disorders of ocular muscles, binocular movement, accommodation and refraction

174

1341

1.29

2.70

1.5

7.66

6.62

u/l

0.46

134

1069

COPD related to multimorbidity

150

964

1.32

2.69

1.6

6.35

7.08

u/l

0.21

116

761

Fracture of foot, except ankle

658

1.42

2.69

1.6

8.13

6.65

u/l

0.40

543

Other/unspecified enthesopathies of lower limb, excluding foot

175

1.84

2.68

1.7

1.5

2.22

7.14

u/l

3.91

146

Assault

250

1.68

2.64

1.8

1.6

5.09

5.68

u/l

0.17

205

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

343

1.47

2.64

1.6

5.54

6.85

u/l

0.52

284

Disorders of tooth development and eruption

277

1.59

2.63

1.8

1.6

4.57

6.66

u/l

0.53

231

Papillary adenocarcinoma of thyroid gland

113

2.05

2.61

1.5

1.4

7.13

8.26

u/l

0.18

Artrosis, including avohilmo

308

1391

1.21

2.61

1.5

1.6

5.74

6.96

u/l

0.96

241

1109

Exposure to other and unspecified inanimate mechanical forces

155

1.88

2.61

2.0

1.5

10.42

5.82

u/l

0.54

128

Melanoma in situ

100

2.11

2.59

1.5

1.6

16.38

6.54

u/l

0.48

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.65

2.58

2.6

1.5

6.44

9.02

u/l

—

Other and unspecified drugs and medicaments

192

1.78

2.58

1.6

1.5

3.04

5.89

u/l

1.47

160

Pulmonary oedema

3.63

2.58

1.9

1.5

16.78

6.42

u/l

—

Other disorders of the musculoskeletal system and connective tissue

393

1.53

2.57

1.7

1.6

3.61

6.76

u/l

1.65

322

Unspecified chronic bronchitis

2.37

2.56

2.1

1.6

13.80

5.58

u/l

—

Carcinoma in situ of skin of other and unspecified parts of face

200

1.76

2.55

1.6

1.5

3.19

7.25

u/l

2.22

163

Hyperfunction of pituitary gland

2.14

2.55

2.0

1.5

6.47

5.32

u/l

0.18

Infective bursitis

2.44

2.54

1.2

1.7

12.90

5.71

u/l

—

D07AA Corticosteroids, weak (group I)

338

1.57

2.54

1.6

5.35

5.69

u/l

0.08

277

COPD-related respiratory insufficiency

284

1.63

2.54

1.6

8.84

7.25

u/l

0.17

228

Benign neoplasm: Rectum

492

1.47

2.53

1.6

1.5

6.86

6.82

u/l

0.01

391

Benign neoplasm: Rectum, anus and anal canal

558

1.44

2.53

1.6

1.5

6.53

6.94

u/l

0.09

441

Phlebitis and thrombophlebitis (not including DVT)

633

1.41

2.52

1.7

1.5

4.76

7.61

u/l

1.95

507

Somatoform disorder

411

1.51

2.52

1.5

5.10

6.71

u/l

0.58

347

Glaucoma

230

1581

1.24

2.52

1.5

7.67

6.83

u/l

0.42

168

1262

Malignant neoplasm of bronchus and lung

362

1.50

2.52

1.5

4.53

8.25

u/l

2.14

287

Malignant neoplasm of head and neck

157

1.85

2.51

1.9

1.4

2.81

8.01

u/l

2.29

131

Fall on same level involving ice and snow

226

1830

1.24

2.51

1.6

1.5

6.88

7.09

u/l

0.06

175

1446

Antenatal screening

347

0.60

2.51

1.8

1.6

3.66

5.91

u/l

0.71

279

Hallux rigidus

388

1.53

2.50

1.5

4.80

7.02

u/l

1.11

306

Other disorders of conjunctiva

372

1.54

2.49

1.4

1.5

7.87

6.61

u/l

0.29

297

Transport accidents

159

1026

1.29

2.49

1.5

6.05

7.46

u/l

0.76

124

826

Adhesive capsulitis of shoulder

462

1.48

2.47

1.5

7.93

6.82

u/l

0.24

378

Other/unspecified reactive arthropathies

144

1.88

2.46

1.9

1.5

10.41

6.00

u/l

0.53

117

Injuries to the shoulder and upper arm

332

2152

1.19

2.46

1.6

6.53

6.95

u/l

0.15

261

1720

Other disorders of optic [2nd] nerve and visual pathways

130

1.93

2.45

1.5

6.06

6.07

u/l

0.00

107

Follicular cysts of skin and subcutaneous tissue

471

1.47

2.45

1.8

1.6

4.73

6.60

u/l

0.90

378

Malignant neoplasm of thyroid gland, including Hilmo

166

1.81

2.44

1.6

1.5

5.90

7.28

u/l

0.31

136

Other and unspecified myopathies

203

1.73

2.44

1.5

11.11

6.95

u/l

0.47

165

Left ventricular outflow tract obstruction (LVOTO), broad definition

218

1.70

2.44

1.4

1.5

15.20

6.14

u/l

1.00

180

Monoamine oxidase A inhibitors

295

1.60

2.44

1.7

1.6

3.59

6.55

u/l

1.59

242

Rotator cuff syndrome

229

1277

1.24

2.44

1.5

1.6

8.48

6.39

u/l

1.27

193

1000

Disturbances of skin sensation

102

748

1.37

2.43

1.7

1.5

7.12

6.28

u/l

0.22

597

Gonarthrosis,primary

358

1823

1.18

2.42

1.5

1.6

7.54

6.81

u/l

0.35

279

1451

Persistent mood disorders

497

1.45

2.42

1.6

1.5

9.20

6.52

u/l

0.61

400

Benign paroxysmal vertigo

123

929

1.33

2.42

1.5

10.49

6.86

u/l

0.79

747

Chondropathies

352

1.54

2.39

1.7

1.5

6.28

6.16

u/l

0.02

288

All dysplastic lesions of the vulva

2.07

2.37

1.4

1.5

6.50

6.82

u/l

0.05

Suppurative and unspecified otitis media

110

724

1.35

2.37

1.6

7.56

6.73

u/l

0.27

580

Dental pulpitis, including avohilmo

336

1813

1.19

2.36

1.5

1.6

7.33

6.91

u/l

0.15

247

1464

Intrahepatic Cholestasis of Pregnancy (ICP)

125

1.93

2.35

2.0

1.5

1.76

6.20

u/l

2.78

105

Orthopaedic devices associated with adverse incidents

2.85

2.35

1.3

1.7

9.73

6.72

u/l

0.31

Other congenital malformations of the digestive system

2.11

2.34

2.2

1.5

7.96

6.25

u/l

0.13

Diseases of salivary glands

125

951

1.32

2.34

1.7

1.5

5.92

6.74

u/l

0.32

772

Other intervertebral disc disorders

295

1465

1.20

2.34

1.5

7.36

6.92

u/l

0.23

235

1154

Early onset COPD

619

1.39

2.31

1.6

1.5

4.45

7.21

u/l

2.14

490

Simple and mucopurulent chronic bronchitis

2.19

2.31

1.9

1.6

6.58

5.34

u/l

0.15

Eating disorders

169

1.78

2.30

1.7

1.5

7.71

6.21

u/l

0.20

136

Alzheimer disease

722

0.70

2.30

1.6

1.5

4.41

7.17

u/l

0.98

565

Abnormal findings in nipple discharge synovial fluid wound secretions

2.97

2.29

2.0

1.5

8.70

5.10

u/l

—

Ankylosing spondylitis, strict definition

2.13

2.29

1.5

1.4

3.62

6.88

u/l

0.90

Other extrapyramidal and movement disorders in other diseases

101

749

1.35

2.26

1.5

7.46

6.90

u/l

0.16

604

Procreative management

122

763

1.32

2.26

1.8

1.5

4.44

6.74

u/l

1.76

611

COPD, hospital admission 2, with asthma infections

119

776

1.32

2.26

1.6

5.31

7.26

u/l

0.60

607

Carcinoma in situ of skin

208

1.69

2.26

1.8

1.6

5.24

6.85

u/l

0.30

174

Other hammer toe(s) (acquired)

465

1.43

2.26

1.4

1.5

3.51

7.11

u/l

4.19

369

Vulvovaginal ulceration/inflammation in other diseases

127

1.90

2.25

1.3

1.5

9.29

5.71

u/l

0.32

106

Nonorganic sleeping disorders

538

1.42

2.25

1.5

1.6

6.18

6.43

u/l

0.04

442

Leisure time condition

447

1.46

2.25

1.4

1.6

8.33

6.53

u/l

0.39

364

Epilepsy

109

816

1.33

2.25

1.5

1.6

7.08

6.71

u/l

0.10

648

Retinal detachment with retinal break

318

1.55

2.23

1.3

1.6

8.25

7.40

u/l

0.13

258

Carcinoma in situ of skin of ear and external auricular canal

3.13

2.23

1.7

1.6

6.00

6.13

u/l

—

Delivery, wide proxy

554

0.71

2.23

1.5

1.6

6.69

6.56

u/l

0.03

444

Behavioural syndromes associated with physiological disturbances and physical factors

356

2053

1.17

2.22

1.6

6.00

7.04

u/l

0.79

275

1639

Personal history of other diseases and conditions

178

1.74

2.22

1.6

1.5

4.00

5.64

u/l

0.56

148

Superficial injury of lower leg

718

1.35

2.21

1.5

5.04

7.16

u/l

0.96

578

Follow-up examination after treatment for malignant neoplasms

256

1.61

2.20

1.4

1.5

6.46

7.35

u/l

0.23

196

Focal brain injury

121

1.91

2.20

1.2

1.6

12.09

5.53

u/l

0.90

101

Dementia in Alzheimer disease

402

0.58

2.20

1.2

1.5

6.74

6.92

u/l

0.03

319

Herpesviral [herpes simplex] infections

272

1.59

2.19

1.7

1.5

7.81

6.04

u/l

0.28

220

Fibromyalgia

249

1.61

2.18

1.6

8.00

5.66

u/l

0.50

219

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

127

967

1.30

2.17

1.6

7.04

6.62

u/l

0.11

781

Actinic keratosis

151

1083

1.27

2.16

1.5

11.47

6.87

u/l

1.44

116

858

Acute suppurative otitis media

474

1.42

2.15

1.6

7.08

6.30

u/l

0.19

388

Ill-defined and unknown causes of mortality

219

1.65

2.15

1.4

1.6

16.35

6.50

u/l

1.41

179

Excessive earwax

243

1830

1.20

2.13

1.3

1.6

9.59

6.84

u/l

1.23

177

1465

Poisoning by drugs, medicaments and biological substances

578

1.39

2.13

1.6

4.28

6.58

u/l

1.33

479

Enthesopathies of lower limb, excluding foot

638

1.37

2.12

1.5

10.80

7.01

u/l

0.57

509

Malignant neoplasm of rectum, including Hilmo

259

1.59

2.11

1.5

9.56

7.62

u/l

0.30

205

Other inflammation of eyelid

404

1.46

2.11

1.7

1.5

6.97

6.61

u/l

0.10

329

Pain associated with micturition

299

1.54

2.10

1.3

1.6

7.26

5.97

u/l

0.27

240

Haemorrhagic disorder due to circulating anticoagulants

3.23

2.10

2.3

1.4

3.75

9.80

u/l

—

116

762

1.31

2.09

1.4

1.5

6.58

6.94

u/l

0.12

603

Other noninflammatory disorders of vulva and perineum

244

1.60

2.09

1.7

1.6

9.79

7.47

u/l

0.29

193

Malignant neoplasm, without specification of site, including Hilmo

2.14

2.08

1.8

1.5

5.55

8.44

u/l

0.37

Bipolar affective disorders

422

1.45

2.07

1.7

1.6

5.93

6.59

u/l

0.17

350

Malignant neoplasm of pancreas, including Hilmo

168

1.73

2.07

1.4

8.36

8.30

u/l

0.00

139

COPD, early/later onset

167

1124

1.25

2.06

1.6

1.5

6.32

7.31

u/l

0.34

127

894

Skin changes due to chronic exposure to nonionizing radiation

154

1109

1.26

2.06

1.5

1.6

11.45

6.87

u/l

1.48

119

878

Other strabismus

529

1.40

2.06

1.5

7.23

6.12

u/l

0.35

433

Injuries to the wrist and hand

379

2169

1.16

2.04

1.5

1.6

7.44

6.93

u/l

0.30

297

1729

Rash and other nonspecific skin eruption

238

1.60

2.04

1.7

1.5

4.75

5.19

u/l

0.09

194

Alcohol use disorder, ICD-based

138

1087

1.27

2.04

1.5

1.6

9.45

7.04

u/l

0.71

100

873

Otitis media, unspecified

183

1.66

2.03

1.6

9.11

5.80

u/l

0.64

150

Allergic contact dermatitis

334

1.50

2.03

1.4

1.6

7.21

5.66

u/l

0.33

275

Alcohol abuse, main dg, excluding more controls

294

1.53

2.02

1.4

1.6

7.50

6.38

u/l

0.22

248

COPD, hospital admissions

165

1117

1.25

2.01

1.6

1.5

6.29

7.27

u/l

0.33

126

887

Sequelae of injuries of head

111

1.90

2.01

1.5

1.6

3.25

7.10

u/l

1.14

Cerebral cysts

111

1.90

2.00

1.6

1.5

11.75

6.64

u/l

0.37

Fracture at wrist and hand level

120

928

1.29

2.00

1.5

5.94

7.10

u/l

0.58

750

Appendectomy

232

1841

1.20

2.00

1.7

1.5

5.91

7.08

u/l

0.78

177

1461

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

155

1.75

2.00

1.6

3.19

4.88

u/l

0.57

129

Pregnancy, childbirth and the puerperium

479

0.71

1.99

1.6

6.07

6.66

u/l

0.14

378

Malignant neoplasm of bladder, including Hilmo

213

1.63

1.99

1.3

1.5

7.68

8.06

u/l

0.06

170

Palmar fascial fibromatosis [Dupuytren]

360

1.48

1.99

1.7

1.5

6.89

6.98

u/l

0.01

279

Open wound of wrist and hand

150

1157

1.25

1.97

1.5

1.6

7.80

6.98

u/l

0.34

125

933

Benign neoplasm: Ascending colon

369

1.47

1.97

1.7

1.6

5.30

7.06

u/l

0.47

294

Otalgia

209

1.63

1.97

1.6

1.5

4.71

5.83

u/l

0.40

170

Crushed, pushed or stepped on by crowd or human stampede

141

1.78

1.96

1.7

1.5

13.71

5.91

u/l

0.49

110

Excessive attrition of teeth

217

1784

1.20

1.96

1.4

1.6

7.42

6.89

u/l

0.25

170

1414

Benign neoplasm: Sigmoid colon

528

1.39

1.96

1.7

1.5

7.95

7.08

u/l

0.20

420

Secondary polycythaemia

2.37

1.95

1.3

1.5

5.71

7.69

u/l

—

Ovarian dysfunction

105

1.91

1.95

1.5

3.19

6.69

u/l

1.22

Spondylolisthesis/Spondylolysis

537

1.38

1.95

1.6

1.5

2.99

7.10

u/l

5.90

429

Other specified/unspecified necrotizing vasculopathies

2.99

1.94

1.4

1.6

11.88

6.98

u/l

—

Abnormal findings on diagnostic imaging of breast

2.99

1.94

1.5

10.13

4.57

u/l

—

Disorders of optic nerve and visual pathways

210

1.62

1.94

1.5

1.6

5.61

5.24

u/l

0.08

176

Diseases of inner ear

212

1684

1.21

1.93

1.4

1.6

8.30

6.79

u/l

0.49

160

1345

Acute alcohol intoxication, ICD10

429

1.42

1.92

1.4

1.6

8.36

7.14

u/l

0.22

353

Use of rivastigmine

422

0.59

1.92

1.5

4.83

6.92

u/l

0.54

326

Voice disturbances

107

823

1.30

1.92

1.6

1.5

7.25

6.92

u/l

0.08

657

Strabismus

682

1.33

1.92

1.5

1.6

7.78

6.64

u/l

0.36

554

Erosion of teeth , including avohilmo

667

1.34

1.92

1.6

5.00

6.44

u/l

0.77

548

Conjunctivitis (acute, non atopic), including avohilmo

373

1951

1.15

1.91

1.7

1.5

6.08

7.20

u/l

0.91

294

1543

Gonarthrosis, primary, with knee surgery

236

1538

1.20

1.91

1.5

1.6

6.79

7.05

u/l

0.08

179

1221

Sleep disorders

340

2018

1.16

1.91

1.5

1.6

5.79

6.97

u/l

0.96

258

1609

Use of memantine

651

0.70

1.90

1.4

1.5

6.44

6.79

u/l

0.06

504

Use of other anti-dementia drugs

651

0.70

1.90

1.4

1.5

6.44

6.79

u/l

0.06

504

Malignant neoplasm of bladder

106

1.89

1.90

1.4

1.5

6.60

8.08

u/l

0.19

Idiopathic urticaria

0.00

1.89

0.0

1.5

—

7.24

—

Retinal detachments and breaks

131

1037

1.27

1.88

1.5

1.6

8.85

6.61

u/l

0.67

100

840

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

212

1.61

1.87

1.4

12.93

8.34

u/l

0.62

168

Sequelae of cerebrovascular disease

132

892

1.27

1.87

1.5

1.6

9.50

6.70

u/l

1.11

112

703

Emotionally unstable personality disorder

228

1.58

1.87

1.7

1.5

5.15

6.28

u/l

0.25

191

Toxic effects of substances chiefly nonmedicinal as to source

236

1.57

1.86

1.4

1.5

14.12

6.13

u/l

0.53

196

Diffuse brain injury

2.09

1.86

1.7

1.4

5.56

3.79

u/l

—

Benign neoplasm of eye and adnexa

276

1.53

1.86

1.6

1.5

6.09

6.30

u/l

0.04

228

Allergic asthma (mode), excluding more controls

438

1.41

1.85

1.7

1.5

5.18

6.08

u/l

0.28

346

Pyothorax

1.99

1.85

2.2

1.6

9.25

6.67

u/l

0.18

Maternal care related to the fetus and amniotic cavity and possible delivery problems

110

828

0.78

1.83

1.4

1.6

7.67

6.08

u/l

0.65

665

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

351

1.46

1.82

1.6

6.32

5.53

u/l

0.20

291

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

183

1.65

1.81

1.6

1.5

6.72

5.51

u/l

0.24

151

Coxarthrosis, primary, with hip surgery

186

1424

1.21

1.81

1.6

1.5

8.08

6.84

u/l

0.62

149

1124

Other peripheral vascular diseases

183

1.64

1.81

1.6

1.5

7.29

5.80

u/l

0.28

150

Benign neoplasm of breast

335

1.47

1.81

1.5

4.82

6.26

u/l

0.59

269

Thoracic aortic aneurysm

335

1.47

1.81

1.6

5.11

6.77

u/l

0.60

260

Other ill-defined and unspecified causes of mortality

199

1.61

1.80

1.4

1.5

12.10

7.01

u/l

0.85

161

Degenerative diseases of the nervous system

824

0.76

1.80

1.6

1.5

4.35

7.26

u/l

1.39

645

Other viral diseases, not elsewhere classified

417

1.41

1.79

1.7

1.6

5.64

6.21

u/l

0.14

343

Other keratitis

255

1.53

1.78

1.5

6.47

5.67

u/l

0.12

211

Other bursopathies

345

1.45

1.77

1.7

1.5

8.61

6.98

u/l

0.24

285

Cervicocranial syndrome

304

1.48

1.77

1.5

7.32

7.64

u/l

0.04

246

Conjunctivitis (acute, non atopic)

734

1.30

1.77

1.8

1.5

6.96

6.83

u/l

0.03

581

Superficial injury of forearm

200

1.60

1.76

1.5

8.95

5.80

u/l

0.66

163

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

100

773

1.30

1.76

1.6

1.5

7.23

6.82

u/l

0.11

627

Pain in thoracic spine

414

1.40

1.72

1.5

4.37

6.96

u/l

1.45

332

Mesothelioma, including Hilmo

3.87

1.72

1.6

1.5

3.20

19.50

u/l

—

Fenamates

245

1.45

1.72

1.4

1.6

3.92

8.86

u/l

2.38

189

Benign neoplasm: Choroid

163

1.66

1.71

1.6

1.5

5.27

6.34

u/l

0.21

136

Unspecified/other endometriosis

167

1.65

1.71

1.7

1.6

3.20

7.88

u/l

2.63

140

Myocardial infarction, unclassifiable

468

1.36

1.70

1.5

1.6

9.54

6.85

u/l

0.82

363

Intracerebral haemorrhage

291

1.48

1.68

1.7

1.5

8.74

7.14

u/l

0.28

232

Unspecified mental disorder

133

1071

1.24

1.68

1.4

1.6

6.96

6.83

u/l

0.04

861

Lung diseases due to external agents

324

1.45

1.68

1.6

1.5

7.62

7.00

u/l

0.10

256

Disorders of vestibular function (Vertigo)

183

1483

1.20

1.68

1.4

1.6

8.83

6.71

u/l

0.64

136

1182

Unknown and unspecified causes of morbidity

126

1.75

1.67

1.7

1.5

5.29

5.56

u/l

0.05

108

Multiple delivery

241

0.50

1.67

1.5

1.6

9.54

6.39

u/l

0.32

195

Memory loss

219

1.56

1.67

1.8

1.5

3.29

6.54

u/l

1.32

179

Aortic aneurysm

542

1.34

1.66

1.6

5.27

6.85

u/l

0.69

418

Ocular pain

196

1.59

1.65

1.8

1.5

12.04

5.71

u/l

0.40

164

Raynaud syndrome

204

1.57

1.65

1.7

1.6

8.85

5.11

u/l

0.94

168

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

1.94

1.64

1.5

1.4

9.09

7.87

u/l

0.07

Adenocarcinoma and papilloma adenocarcinoma of rectum

204

1.57

1.64

1.5

1.4

11.11

8.27

u/l

0.37

163

Small cell lung cancer, including Hilmo

2.45

1.64

1.2

1.4

5.60

6.25

u/l

—

Small cell lung cancer

2.45

1.64

1.2

1.4

5.60

6.25

u/l

—

Retinal vascular disorders

293

1.47

1.64

1.7

1.5

6.33

7.32

u/l

0.19

237

Acne

172

1.62

1.63

2.0

1.5

8.05

5.14

u/l

0.58

133

Supplementary factors related to causes of morbidity and mortality classified elsewhere

109

862

1.27

1.63

1.4

1.5

11.56

6.55

u/l

1.98

685

Spirochaetal infections, other/unspecified

229

1.53

1.62

1.6

1.5

10.20

6.57

u/l

0.52

186

Oter anti-inflammatory and antirheumatic agents, non-steroids

320

1.34

1.62

1.6

1.5

5.62

8.10

u/l

0.76

249

Use of donepezil

556

0.68

1.61

1.4

1.5

5.74

7.19

u/l

0.21

436

Retinal vascular occlusion

286

1.47

1.61

1.7

1.5

6.52

7.44

u/l

0.17

233

Conductive and sensorineural hearing loss

302

1739

1.15

1.61

1.5

1.6

7.37

6.71

u/l

0.32

239

1394

Somnolence, stupor and coma

1.88

1.60

1.5

1.6

5.94

5.61

u/l

0.06

Benign lipomatous neoplasm

893

0.75

1.59

1.4

1.5

7.86

6.76

u/l

0.21

708

Caries of enamel

352

2022

1.14

1.57

1.7

1.5

5.69

7.32

u/l

1.65

278

1613

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

293

1.43

1.57

1.6

7.35

6.12

u/l

0.28

238

Radiculopathy

439

1.37

1.56

1.5

3.99

7.90

u/l

2.35

341

Other secondary gonarthrosis

129

1.71

1.56

1.5

1.6

16.41

6.02

u/l

0.44

106

Insomnia

329

2003

1.14

1.56

1.6

5.65

7.01

u/l

1.18

251

1600

Alzheimer’s disease, strict definition

600

0.72

1.56

1.5

5.85

7.14

u/l

0.26

472

Other viral diseases, not elsewhere classified, including avohilmo

651

1.30

1.56

1.6

1.5

7.18

6.58

u/l

0.12

532

Seborrhoeic keratosis

761

1.28

1.56

1.6

1.5

8.72

6.84

u/l

0.35

603

Other fall from one level to another

516

1.34

1.56

1.8

1.5

6.61

6.91

u/l

0.07

414

Alzheimer’s disease (Late onset)

554

0.71

1.56

1.5

6.06

6.85

u/l

0.12

434

Disorders of globe

2.28

1.56

1.6

1.5

11.96

7.55

u/l

—

Excessive, frequent and irregular menstruation

134

577

1.24

1.55

1.6

4.63

6.83

u/l

1.89

110

453

Other congenital malformations, including avohilmo

272

1.47

1.55

1.5

1.6

4.89

5.80

u/l

0.30

226

Alcohol-induced acute pancreatitis

1.98

1.54

1.3

1.6

14.50

4.55

u/l

—

Spontaneous rupture of synovium and tendon

216

1.53

1.5

1.6

4.92

6.57

u/l

0.47

187

Anogenital herpesviral [herpes simplex] infection, including avohilmo

224

1.52

1.53

1.6

1.5

8.01

6.22

u/l

0.25

187

Superficial injury of head

639

1.30

1.53

1.5

5.52

7.04

u/l

0.51

516

Striking against or struck by other objects

104

825

1.26

1.51

1.6

1.5

6.94

6.91

u/l

0.00

654

Type of accident

102

809

1.26

1.51

1.5

11.65

6.51

u/l

1.86

647

Allergic asthma (mode)

456

1.35

1.51

1.7

1.5

5.18

6.66

u/l

0.51

361

Coxarthrosis, primary

234

1667

1.17

1.51

1.5

7.63

6.85

u/l

0.42

189

1315

Kela-code for severe mental illness

118

954

1.24

1.48

1.4

1.6

6.25

6.87

u/l

0.21

777

Carcinoma in situ of breast, intraductal

267

1.47

1.48

1.6

1.5

3.86

6.19

u/l

0.90

216

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

714

1.28

1.48

1.6

6.16

6.47

u/l

0.09

587

Atypical facial pain

124

1.70

1.47

1.4

1.6

4.40

4.66

u/l

0.05

104

Macular hole

155

1.62

1.47

1.6

1.5

6.76

7.42

u/l

0.08

129

Colon adenocarcinoma, helper endpoint

326

1.41

1.46

1.5

4.18

7.18

u/l

1.38

260

Dementia, including avohilmo

123

1028

0.81

1.45

1.5

1.6

8.60

7.09

u/l

0.40

814

Malignant neoplasm of head and neck, including Hilmo

195

1.54

1.45

1.9

1.4

3.28

7.84

u/l

1.96

159

Sequelae of injuries of neck and trunk

1.98

1.43

1.5

4.50

7.00

u/l

—

Allergic urticaria

172

1.57

1.42

1.7

1.5

4.67

5.43

u/l

0.12

144

False labour

476

0.74

1.42

1.4

1.6

7.03

6.29

u/l

0.22

388

Injury of eye and orbit

295

1.43

1.41

1.5

1.6

7.94

6.94

u/l

0.16

246

Other noninflammatory disorders of uterus, except cervix

477

1.27

1.40

1.7

1.6

5.88

6.58

u/l

0.23

373

Nummular dermatitis

181

1.55

1.39

1.9

1.5

3.35

6.45

u/l

1.35

150

Nonsuppurative otitis media

403

1.34

1.39

1.7

1.6

7.04

6.56

u/l

0.10

325

Atopic dermatitis, strict definition

696

1.27

1.38

1.6

6.41

6.43

u/l

0.01

572

Ptosis of eyelid

305

1.41

1.38

1.7

1.5

4.61

6.48

u/l

0.66

237

574

1.29

1.37

1.5

6.34

6.92

u/l

0.17

452

Alcohol abuse, main dg

322

1.40

1.37

1.4

1.6

7.50

6.46

u/l

0.20

263

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

2.63

1.37

1.3

7.00

8.53

u/l

—

Pneumothorax

135

1.63

1.35

1.5

1.6

7.55

7.12

u/l

0.05

108

Disorders of muscles

248

1.45

1.35

1.8

1.5

5.05

6.73

u/l

0.54

208

Supervision of high-risk pregnancy

332

0.70

1.34

1.6

3.31

5.88

u/l

1.68

268

Dementia due to Parkinson's disease

2.14

1.34

2.1

1.8

3.40

5.58

u/l

—

Other and unspecified injuries of lower leg

168

1.55

1.31

1.9

1.6

4.57

5.61

u/l

0.24

140

Sensorineural hearing loss

284

1665

1.14

1.31

1.5

1.6

7.59

6.79

u/l

0.39

218

1331

Traumatic subarachnoid haemorrhage

1.85

1.30

1.5

1.6

5.44

4.10

u/l

—

Other disorders of eye and adnexa

377

1.36

1.30

1.7

1.5

11.70

6.05

u/l

0.61

308

Primary coxarthrosis, bilateral

107

872

1.23

1.29

1.5

9.16

6.73

u/l

1.10

686

Recurrent aphthous stomatitis , including avohilmo

360

1.36

1.29

1.7

1.5

4.82

6.25

u/l

0.30

290

Mouth breathing

132

1097

1.20

1.29

1.6

5.48

6.76

u/l

0.78

101

878

Dentofacial anomalies [including malocclusion]

248

1695

1.14

1.29

1.6

5.54

6.95

u/l

1.28

188

1361

Gastrojejunal ulcer

2.79

1.29

1.8

7.00

4.47

u/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

169

1.54

1.28

1.6

1.5

7.53

6.92

u/l

0.07

136

Maternal care for other conditions predominantly related to pregnancy

486

1.31

1.28

1.6

4.69

6.41

u/l

0.72

391

Carrier of infectious disease

2.09

1.28

1.4

1.5

7.40

6.15

u/l

—

Unstable angina pectoris

122

791

1.21

1.27

1.6

1.5

6.85

6.41

u/l

0.08

612

Other symptoms and signs involving the urinary system

235

1.45

1.26

1.6

9.85

6.20

u/l

0.40

187

Other and unspecified vascular occlusions

227

1.46

1.26

1.6

7.39

7.52

u/l

0.02

187

Thyrotoxicosis with toxic multinodular goitre

162

1.55

1.26

1.8

1.5

2.95

7.13

u/l

2.04

132

Salpingitis and oophoritis

563

1.28

1.25

1.7

1.5

6.08

6.38

u/l

0.06

452

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.23

1.24

1.6

1.5

12.38

5.52

u/l

—

Other inflammation of eyelid, including avohilmo

155

1316

1.18

1.23

1.8

1.5

6.94

6.87

u/l

0.03

128

1040

Herpesviral [herpes simplex] infections, including avohilmo

689

1.25

1.23

1.6

1.5

6.04

6.64

u/l

0.16

560

Abscess of anal and rectal regions

163

1.54

1.22

1.8

1.5

5.79

5.67

u/l

0.02

136

Haemorrhage in early pregnancy

755

0.77

1.22

1.6

1.5

7.18

6.59

u/l

0.11

600

Pregnancy hypertension

140

1052

1.19

1.22

1.5

1.6

9.02

6.42

u/l

0.99

109

833

Dilated cardiomyopathy

262

1.42

1.22

1.7

1.6

6.50

7.75

u/l

0.17

212

Oral leukoplakia, including avohilmo

1.97

1.22

2.5

1.5

10.73

6.15

u/l

0.37

Dementia

117

964

0.83

1.21

1.5

1.6

6.37

7.15

u/l

0.23

767

Adverse effects, not elsewhere classified

495

1.29

1.21

1.7

1.6

3.36

6.01

u/l

2.74

408

Alcohol dependence

619

1.26

1.21

1.6

7.75

6.65

u/l

0.23

497

Other and unspecified tonsillitis

543

1.26

1.20

1.6

1.5

6.60

7.06

u/l

0.11

438

Acetic acid derivatives and related substances

367

1.25

1.20

1.5

1.6

6.95

7.64

u/l

0.17

288

Postmenopausal bleeding

113

485

1.22

1.19

1.4

1.6

7.22

6.72

u/l

0.17

377

Corneal degeneration

2.12

1.18

1.5

7.22

5.71

u/l

—

Urethral stricture

109

1.66

1.18

1.5

1.6

2.67

6.28

u/l

1.55

Other hearing loss

102

810

1.22

1.18

1.6

10.52

6.35

u/l

1.20

638

Mixed conductive and sensorineural hearing loss

315

1.37

1.18

1.6

1.5

4.24

6.58

u/l

1.39

251

Plantar fascial fibromatosis

281

1.39

1.18

1.5

1.6

9.83

5.46

u/l

0.77

247

Cervicalgia

586

1.26

1.18

1.6

1.5

8.08

7.15

u/l

0.13

466

Medical abortion

236

1118

1.14

1.17

1.6

1.5

6.99

6.57

u/l

0.18

191

884

Oxicams

340

1.27

1.16

1.4

1.6

5.08

7.98

u/l

1.47

266

Vertigo of central origin

0.00

1.16

0.0

1.6

—

7.34

—

Other sleep disorders

265

1.40

1.16

1.4

1.6

11.13

6.53

u/l

0.79

220

Other congenital malformations

166

1.51

1.14

1.5

5.38

5.88

u/l

0.11

137

Melanocytic naevi

106

877

1.21

1.14

1.6

1.5

8.91

6.81

u/l

0.45

700

Use of antiglaucoma preparations and miotics

191

1.47

1.13

1.7

1.5

6.79

6.88

u/l

0.01

154

Other disorders of eyelid

172

1400

1.16

1.13

1.5

6.86

6.76

u/l

0.03

134

1105

Otitis externa, unspecified

258

1.40

1.13

1.5

1.6

8.70

5.58

u/l

0.46

214

Supervision of normal pregnancy

337

0.74

1.12

1.7

1.6

5.58

5.89

u/l

0.07

272

Unspecified event, undetermined intent

1.91

1.12

1.5

4.22

6.44

u/l

0.38

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

209

1419

1.14

1.12

1.6

5.06

7.00

u/l

1.81

160

1129

Erectile dysfunction

151

1.53

1.11

1.7

4.81

7.15

u/l

0.44

126

Irregular menses

169

1093

1.16

1.11

1.6

7.10

6.80

u/l

0.12

140

862

Other and unspecified follicular disorders

1.71

1.11

1.3

1.5

8.44

4.53

u/l

—

Coxibs

372

1.24

1.11

1.4

1.6

6.90

7.59

u/l

0.16

292

Other and unspecified paralytic syndromes

2.27

1.10

1.4

1.5

8.57

8.50

u/l

—

Extrapyramidal and movement disorders

141

1202

1.17

1.10

1.5

1.6

7.16

6.72

u/l

0.16

106

958

Acne, including avohilmo

306

1.32

1.10

1.9

1.6

5.34

6.03

u/l

0.17

248

Disorders of refraction and accommodation

751

1.22

1.09

1.6

1.5

7.84

6.17

u/l

0.62

604

Necrosis of pulp, including avohilmo

198

1711

1.14

1.09

1.5

1.6

7.89

6.87

u/l

0.43

162

1349

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

138

0.51

1.09

1.7

1.6

15.71

5.05

u/l

—

111

Lumbar disc prolapse

217

1411

1.14

1.09

1.5

6.98

6.90

u/l

0.03

173

1111

Diseases of middle ear and mastoid

180

1275

1.15

1.09

1.6

1.5

6.61

6.98

u/l

0.14

153

1003

Single spontaneous delivery

109

691

0.83

1.08

1.6

5.11

6.91

u/l

1.05

550

Other and unspecified rosacea

235

1.41

1.08

1.6

1.5

5.62

5.56

u/l

0.01

193

Synovial cyst of popliteal space [Baker]

185

1.46

1.08

2.0

1.6

8.10

6.32

u/l

0.16

159

Other congenital malformations of skin, including avohilmo

185

1.46

1.08

1.3

1.5

4.89

5.75

u/l

0.21

153

Injury of muscle and tendon at hip and thigh level

227

1.41

1.07

1.5

1.6

7.80

6.66

u/l

0.19

192

Paralytic strabismus

153

1.51

1.06

1.3

1.5

10.75

6.14

u/l

0.58

124

Pedal cyclist injured in transport accident

580

0.76

1.06

1.6

4.31

6.25

u/l

1.30

468

Unspecified lump in breast

481

1.27

1.03

1.7

1.5

5.55

6.52

u/l

0.26

390

Other superficial mycoses

1.97

1.03

2.0

1.5

2.61

4.87

u/l

—

Leiomyoma of uterus

243

1208

1.13

1.03

1.5

6.34

6.48

u/l

0.06

191

969

Other/unspecified enthesopathies, not elsewhere classified

212

1.42

1.03

1.8

1.6

7.38

6.93

u/l

0.07

183

Thyroiditis

179

1.46

1.03

1.4

1.5

4.97

5.80

u/l

0.17

147

Other female pelvic inflammatory diseases

464

1.27

1.02

1.7

1.5

7.78

6.61

u/l

0.26

381

Otosclerosis

196

1.43

1.02

1.5

1.6

4.96

7.11

u/l

0.49

163

Visual field defects

196

1.43

1.02

1.6

1.5

8.45

7.00

u/l

0.17

157

Dislocation, sprain and strain of joints and ligaments at neck level

324

1.33

1.02

1.4

1.6

8.31

6.11

u/l

0.45

274

Acute alcohol intoxication

599

1.24

1.01

1.5

1.6

8.03

6.37

u/l

0.41

479

Use of amantadine

2.01

1.00

1.6

1.5

6.14

8.85

u/l

—

Asthma and allergy, excluding more controls

211

1.41

0.99

1.9

1.5

5.67

5.46

u/l

0.03

169

Acute pharyngitis

263

1.36

0.98

1.5

1.6

5.66

6.43

u/l

0.20

213

Transient ischemic attack

186

1301

1.14

0.97

1.5

1.6

6.60

6.96

u/l

0.14

155

1034

Other enthesopathy of foot (+metatarsalgia)

292

1.34

0.97

1.7

1.6

11.48

5.74

u/l

0.97

252

Other meningitis

1.95

0.97

1.9

1.4

1.57

9.25

u/l

—

Small cell lung cancer, helper endpoint

1.86

0.96

1.2

1.6

5.60

4.73

u/l

—

Hallux valgus (acquired)

118

716

1.18

0.96

1.5

5.80

6.70

u/l

0.36

561

Sequelae of infectious and parasitic diseases

157

1.47

0.96

1.7

1.6

7.13

5.92

u/l

0.16

127

Suicide or other Intentional self-harm

613

1.22

0.95

1.6

6.11

6.55

u/l

0.12

503

Benign neoplasm of meninges

285

1.34

0.94

1.4

1.6

6.19

6.13

u/l

0.01

236

Benign neoplasm of mouth and pharynx

268

1.35

0.94

1.9

1.5

6.19

6.74

u/l

0.09

216

Presbycusis

368

1.29

0.94

1.3

1.5

12.21

6.33

u/l

1.04

284

Dementia in other diseases classified elsewhere

109

1.56

0.93

2.1

1.5

2.82

6.08

u/l

1.08

Temporomandibular joint disorders, including avohilmo

148

1246

1.15

0.93

1.5

1.6

6.48

6.82

u/l

0.13

109

1003

Postpartum care and examination

170

0.66

0.92

1.6

11.59

6.17

u/l

0.83

137

Other disorders of penis

192

1.41

0.91

1.5

6.05

5.38

u/l

0.09

152

Other abnormal products of conception

562

0.82

0.91

1.6

10.02

6.36

u/l

1.01

451

Meniscus derangement

179

1045

1.14

0.91

1.5

1.6

5.21

6.78

u/l

1.20

141

825

Other congenital malformations of skin

1.63

0.91

1.2

1.5

5.37

6.99

u/l

—

Primary open-angle glaucoma

115

946

1.17

0.90

1.4

1.5

6.71

6.83

u/l

0.05

750

Anti-inflammatory and antirheumatic products, non-steroids

385

1.20

0.90

1.5

1.6

6.97

7.36

u/l

0.08

303

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

156

1183

1.14

0.90

1.5

1.6

9.74

6.36

u/l

1.41

122

941

Perineal laceration during delivery

254

0.70

0.90

1.4

1.7

5.62

6.17

u/l

0.14

209

Laparoscopic right hemicolectomy

135

1.49

0.89

1.6

1.5

3.29

6.39

u/l

0.91

112

Other and unspecified nonorganic psychotic disorders

412

1.26

0.88

1.4

1.6

7.22

5.66

u/l

0.30

339

Other and unspecified visual disturbances

254

1.34

0.88

1.7

1.5

4.25

6.26

u/l

0.52

207

Hypertrophy of breast

511

1.23

0.88

1.5

6.60

6.17

u/l

0.11

412

malignant neoplasm of female genital organs, including Hilmo

450

0.76

0.87

1.6

1.5

7.28

7.01

u/l

0.04

363

Impotence

111

1.54

0.87

1.4

1.6

11.00

5.30

u/l

0.64

Thiazolidinediones

263

1.33

0.87

1.6

9.60

7.64

u/l

0.27

221

Subjective visual disturbances

730

1.19

0.87

1.7

1.5

4.53

6.76

u/l

1.42

594

Primary open-angle glaucoma, strict

804

1.18

0.84

1.4

1.5

7.00

6.87

u/l

0.04

629

Artificial joint operation, meniscal resection

335

1962

1.09

0.83

1.5

1.6

6.32

6.99

u/l

0.31

261

1566

Metatarsalgia

274

1.32

0.83

1.8

1.6

12.13

5.84

u/l

1.01

235

Organic, including symptomatic, mental disorders

183

1143

1.13

0.83

1.6

6.53

7.21

u/l

0.25

137

915

Asthma and allergy

219

1.35

0.83

1.9

1.5

5.67

5.91

u/l

0.04

175

Benign neoplasm of thyroid gland

1.70

0.82

1.4

8.76

7.94

u/l

—

Diabetes mellitus in pregnancy

470

1.19

0.82

1.6

7.52

6.24

u/l

0.45

380

Hyperplasia of prostate

100

478

1.18

0.82

1.5

1.6

9.64

7.55

u/l

0.46

380

Sequelae of infectious and parasitic diseases, including avohilmo

163

1.41

0.82

1.7

1.6

7.13

5.76

u/l

0.19

131

Pleural plaque without asbestos

1.65

0.81

1.4

1.6

10.58

7.84

u/l

0.20

Delivery

113

691

0.86

0.81

1.6

5.09

6.91

u/l

1.08

550

Anankastic personality disorder

1.61

0.81

1.3

1.4

16.40

6.38

u/l

—

Burns and corrosions

293

1.30

0.81

1.9

1.5

5.30

6.18

u/l

0.16

239

Pain and other conditions associated with female genital organs and menstrual cycle

431

1.22

0.80

1.5

1.6

5.08

7.54

u/l

1.27

338

Triptan medication for migraine, single purchase ok

260

1598

1.10

0.80

1.5

1.6

6.91

6.63

u/l

0.14

209

1271

Migraine, single triptan purchase ok & required. ICD-code if available is included

260

1598

1.10

0.80

1.5

1.6

6.91

6.63

u/l

0.14

209

1271

Hypertrophy of breast in women and men

572

1.21

0.80

1.5

5.92

6.12

u/l

0.05

465

Sequelae of injuries of lower limb

224

1.34

0.79

1.6

7.38

5.73

u/l

0.30

190

Burns and corrosions of external body surface, specified by site

224

1.34

0.79

1.9

1.5

3.49

6.27

u/l

1.15

186

Endometriosis

111

555

1.16

0.79

1.7

1.6

4.07

6.91

u/l

2.20

437

Fall on and from ladder

156

1.41

0.78

1.5

1.7

4.24

7.45

u/l

1.07

130

All dysplastic lesions of the cervix uteri, vagina or vulva

729

1.18

0.78

1.6

7.08

6.56

u/l

0.09

590

Ovarian hyperstimulation (induction)

0.00

0.78

0.0

1.4

—

5.58

—

malignant neoplasm of female genital organs

398

0.76

0.78

1.5

8.36

7.32

u/l

0.14

319

Wet age-related macular degeneration

457

1.22

0.77

1.3

1.5

7.83

7.08

u/l

0.18

359

COPD, hospital admissions 1, only main diagnosis

112

834

1.15

0.77

1.6

4.95

7.25

u/l

1.60

655

Cellulitis of external ear

0.00

0.76

0.0

1.4

—

5.90

—

Dysplasia of cervi uteri

442

1.19

0.75

1.6

5.35

7.33

u/l

0.77

349

Endometriosis of ovary

431

1.22

0.75

1.7

1.6

5.91

6.93

u/l

0.25

336

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

1.61

0.75

1.3

1.5

12.43

7.08

u/l

—

Psychotic depression

124

1.45

0.75

1.3

1.7

12.00

5.84

u/l

0.56

108

Trigeminal neuralgia

141

1.42

0.74

1.4

1.6

4.80

4.98

u/l

0.05

120

Other and unspecified acute skin changes due to ultraviolet radiation

1.64

0.73

2.0

1.6

3.33

7.39

u/l

—

Congenital malformations of the circulatory system

298

1.27

0.73

1.7

1.6

8.42

6.08

u/l

0.55

248

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.01

0.73

2.4

1.6

3.00

3.86

u/l

—

Effects of foreign body entering through natural orifice

561

1.20

0.72

1.6

1.5

7.30

6.96

u/l

0.06

441

Diseases of appendix

247

2016

1.10

0.72

1.6

6.55

7.25

u/l

0.42

192

1606

Pre-eclampsia or eclampsia

598

1.19

0.72

1.5

1.6

9.27

6.13

u/l

1.18

480

Use of galantamine

183

0.65

0.72

1.3

1.6

10.86

7.50

u/l

—

146

Bacterial meningitis

1.58

0.71

2.0

1.6

8.03

6.32

u/l

0.17

Redundant prepuce, phimosis and paraphimosis

427

1.22

0.71

1.7

1.6

7.36

6.31

u/l

0.14

340

LSIL lesion of the cervix uteri, vagina or vulva

335

1.26

0.71

1.7

1.5

4.03

6.62

u/l

1.26

276

Benign neoplasm: Skin of lower limb, including hip

1.58

0.71

2.1

1.6

3.11

7.78

u/l

—

Other symptoms and signs involving the circulatory and respiratory systems

134

1.42

0.71

1.4

1.6

8.32

5.82

u/l

0.33

112

Focal epilepsy

536

1.19

0.69

1.5

1.6

6.02

6.38

u/l

0.10

429

Embedded and impacted teeth

387

0.80

0.69

1.7

1.6

5.81

5.97

u/l

0.03

319

Sixth [abducent] nerve palsy

1.56

0.68

1.2

1.6

11.86

5.33

u/l

—

Other and unspecified effects of external causes

703

1.17

0.68

1.7

1.6

3.98

6.65

u/l

2.60

572

Other and unspecified mononeuropathies, also in other diseases

1.60

0.68

1.5

1.7

3.36

4.96

u/l

0.42

Benign neoplasm: Vulva

1.63

0.67

1.7

1.5

4.86

7.47

u/l

—

Follow-up care involving plastic surgery

1.49

0.66

1.7

1.5

5.44

6.43

u/l

0.16

Other contact dermatitis

162

1.36

0.66

1.5

5.75

6.12

u/l

0.07

135

Other and unspecified injuries of ankle and foot

1.52

0.66

1.3

1.4

10.63

7.35

u/l

—

Alzheimer’s disease (Late onset), excluding more controls

258

0.78

0.66

1.5

8.68

6.39

u/l

0.27

203

Nontoxic goitre/thyroid nodule

107

940

1.14

0.65

1.5

5.75

6.73

u/l

0.46

762

Flat foot [pes planus] (acquired)

259

1.28

0.65

1.4

1.5

3.21

7.36

u/l

3.11

211

Migraine

160

1120

1.11

0.64

1.6

6.51

6.84

u/l

0.12

134

884

Abdominal aortic aneurysm (AAA)

196

1.32

0.64

1.6

5.06

7.23

u/l

0.41

153

Nontoxic single thyroid nodule

189

1.33

0.64

1.4

1.5

8.49

6.15

u/l

0.40

154

!Aliquae complicationes praecoces traumatis

1.48

0.64

1.6

1.5

5.25

6.87

u/l

—

Early complications of trauma

1.48

0.64

1.6

1.5

5.25

6.87

u/l

—

Migraine without aura

477

1.20

0.64

1.5

1.6

6.37

u/l

0.00

390

HSIL lesion of the cervix uteri, vagina or vulva

487

1.19

0.63

1.7

1.6

9.31

6.47

u/l

0.38

403

Glucosamine medication

144

1279

0.90

0.63

1.4

1.5

8.62

6.60

u/l

0.77

111

1004

Car occupant injured in noncollision transport accident

1.52

0.62

1.7

1.5

12.29

6.48

u/l

—

Malignant neoplasm of pancreas

138

1.38

0.62

1.4

13.33

7.32

u/l

0.35

117

Endometriosis diagnosis and infertility diagnosis occurring together

226

1.28

0.61

1.8

1.5

5.67

6.20

u/l

0.07

190

Localized swelling, mass and lump of skin and subcutaneous tissue

106

937

1.13

0.60

1.6

1.5

7.63

6.59

u/l

0.32

736

Bronchitis, not specified as acute or chronic

191

1.31

0.60

1.4

1.6

6.05

6.97

u/l

0.17

156

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

0.60

0.0

1.5

—

3.08

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.60

0.0

1.4

—

6.54

—

Lichen planus

371

1.21

0.60

1.6

1.5

8.68

6.21

u/l

0.58

301

LSIL lesion of the cervix uteri

236

1.27

0.59

1.7

1.6

2.87

6.57

u/l

1.95

200

Ankyloglossia

0.00

0.59

0.0

1.4

—

2.76

—

Melanocytic naevi of trunk

281

1.25

0.59

1.5

1.6

10.63

6.44

u/l

0.27

234

Melanocytic naevi of upper limb, including shoulder

1.51

0.58

1.6

1.5

7.89

8.82

u/l

—

Postmenopausal atrophic vaginitis

102

489

1.14

0.58

1.5

1.6

5.56

6.74

u/l

0.62

384

Contact with other sharp object(s)

140

1.36

0.58

1.7

1.5

8.60

5.40

u/l

0.79

114

Benign neoplasm: Cerebral meninges

255

1.26

0.58

1.3

1.6

5.68

6.18

u/l

0.12

209

Endometriosis ASRM stages 1,2

486

0.82

0.58

1.8

1.5

3.35

6.34

u/l

1.70

403

Intussusception

1.72

0.57

1.8

1.4

0.50

8.48

u/l

—

Acute appendicitis

227

1943

1.08

0.57

1.6

6.48

7.15

u/l

0.37

173

1550

Residual foreign body in soft tissue

106

1.42

0.57

1.3

1.5

3.80

6.27

u/l

—

Acute appendicitis, no complications

175

1587

1.10

0.57

1.6

7.11

7.14

u/l

0.01

131

1260

Periodontal disease, other/unspecified

1.48

0.57

1.1

1.6

9.87

6.02

u/l

—

Graves ophthalmopathy

1.46

0.56

1.6

1.5

1.64

6.13

u/l

—

Appendicitis, broad definition

242

2011

1.08

0.56

1.6

6.49

7.22

u/l

0.44

187

1601

Ethmoidectomy

311

1.22

0.55

1.3

1.5

8.65

6.28

u/l

0.55

258

Hypermobility syndrome

1.45

0.55

1.8

1.5

0.88

5.50

u/l

—

Acute lymphadenitis

107

1.40

0.55

1.7

1.5

3.10

6.65

u/l

—

Tonsillectomy and adenotomy

132

1018

0.90

0.55

1.7

1.6

5.92

6.82

u/l

0.43

106

814

Poor fetal growth

212

1.27

0.55

1.5

1.7

12.35

5.99

u/l

0.99

175

Preterm labour and delivery

756

1.14

0.55

1.6

8.39

6.14

u/l

0.85

604

Optic atrophy, wide definition

1.58

0.54

1.7

1.5

3.33

5.32

u/l

—

Labour and delivery complicated by fetal stress [distress]

286

0.82

0.54

2.0

1.6

7.84

6.11

u/l

0.27

235

Vestibular neuronitis

222

1.26

0.53

1.4

1.5

7.37

6.93

u/l

0.06

185

Schizophrenia or delusion, excluding more controls

702

1.14

0.53

1.4

1.6

6.51

6.41

u/l

0.02

585

HSIL lesion of the cervix uteri

405

1.19

0.52

1.7

1.6

9.90

6.44

u/l

0.40

336

Other obstructed labour

196

1.28

0.52

1.5

1.6

12.49

5.45

u/l

0.86

159

Gestational diabetes (for exclusion)

592

1.13

0.52

1.6

6.15

6.79

u/l

0.22

478

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

143

1.33

0.52

1.8

1.6

2.50

6.00

u/l

1.37

115

Atrophic disorders of skin

461

1.17

0.52

1.5

6.46

6.31

u/l

0.03

371

Idiopathic pulmonary fibrosis

161

1.31

0.51

1.2

1.6

10.13

7.10

u/l

0.44

134

Other surgical follow-up care

1.41

0.51

1.8

1.5

3.11

7.15

u/l

—

Premature rupture of membranes

341

0.83

0.50

1.6

7.01

6.12

u/l

0.17

291

Entropion and trichiasis of eyelid

215

1.26

0.50

1.6

7.29

7.78

u/l

0.06

170

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

369

0.81

0.50

1.4

1.5

4.18

6.66

u/l

1.39

303

Nontraumatic intracranial haemmorrhage

547

1.15

0.49

1.6

1.5

9.49

6.67

u/l

0.83

429

Pre-eclampsia or poor fetal growth

789

1.12

0.49

1.6

8.54

6.58

u/l

0.72

641

Cervical polyps

289

1.21

0.48

1.5

1.6

7.10

7.22

u/l

0.02

226

Glaucoma suspect

131

1192

1.10

0.48

1.5

6.93

7.13

u/l

0.06

944

Maternal care for known or suspected abnormality of pelvic organs

423

0.86

0.48

1.7

1.6

6.59

5.73

u/l

0.17

347

Nasal polyp

485

0.84

0.47

1.6

1.5

5.31

6.67

u/l

0.35

386

Pregnancy with abortive outcome

232

1125

1.07

0.47

1.5

7.10

6.53

u/l

0.25

193

891

Mixed hyperlipidaemia

1.41

0.47

1.6

1.5

13.67

5.71

u/l

1.01

Graves ophthalmopathy, strict

1.46

0.47

1.7

1.5

1.73

5.87

u/l

—

Carcinoma in situ of skin of lower limb, including hip

1.43

0.46

1.7

40.14

6.78

u/l

—

Female genital prolapse

103

515

1.11

0.45

1.4

1.6

6.94

6.84

u/l

0.03

406

183

1.26

0.44

1.7

1.5

12.61

8.30

u/l

0.33

144

Vasomotor and allergic rhinitis

112

996

1.10

0.43

1.6

1.5

6.50

6.97

u/l

0.14

784

Malignant neoplasm of tongue

1.62

0.43

2.8

1.4

6.60

10.84

u/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

433

1.15

0.42

1.8

1.6

3.15

7.09

u/l

2.72

350

All dysplastic lesions of the cervix uteri

621

1.13

0.42

1.7

1.6

7.52

6.76

u/l

0.11

501

Cerebral aneurysm, nonruptured

212

1.23

0.42

1.5

4.25

7.09

u/l

1.18

181

Tuberculosis

131

1.30

0.42

1.6

2.17

6.57

u/l

2.19

106

Hydrocele

249

1.21

0.41

1.3

1.6

7.00

6.48

u/l

0.07

194

Other congenital malformations, not elsewhere classified

0.00

0.41

0.0

1.5

—

3.44

—

Other abortion

0.00

0.41

0.0

1.4

—

7.49

—

Peritonsillar abscess

463

1.15

0.41

1.5

1.6

5.74

7.02

u/l

0.47

373

Viral pneumonia (known virus, not influenza)

1.36

0.41

2.3

1.6

4.50

6.66

u/l

—

Spirochaetal infections, other/unspecified, including avohilmo

1036

0.91

0.41

1.6

1.5

7.57

6.71

u/l

0.24

818

Pre-eclampsia

548

1.13

0.41

1.5

1.6

10.57

5.81

u/l

1.85

441

Other degenerative diseases of the nervous system

571

1.11

0.41

1.6

1.5

5.85

7.12

u/l

0.35

471

Other and unspecified glaucoma

168

1.25

0.40

1.6

1.5

3.38

6.55

u/l

1.36

136

Malignant neoplasm of renal pelvis, including Hilmo

0.00

0.40

0.0

1.4

—

15.19

—

Benign neoplasm of major salivary glands

241

1.20

0.40

1.6

1.5

7.20

7.26

u/l

0.01

200

Foreign body on external eye

278

1.19

0.39

1.4

1.5

8.22

7.33

u/l

0.12

222

Other condition

343

1.17

0.39

1.6

14.86

5.99

u/l

1.66

282

Pollen allergy

384

1.16

0.39

1.4

1.6

7.76

5.84

u/l

0.48

316

Parkinson's disease, including avohilmo

411

0.85

0.39

1.7

1.5

5.43

7.25

u/l

0.64

318

Xerosis cutis

1.43

0.39

1.6

1.7

5.80

8.19

u/l

—

Periapical abscess

152

1412

1.08

0.39

1.6

5.72

7.04

u/l

0.33

116

1127

Lyme disease

1032

0.91

0.38

1.6

1.5

7.57

6.68

u/l

0.25

816

Lyme disease, including avohilmo

1032

0.91

0.38

1.6

1.5

7.57

6.68

u/l

0.25

816

Non-invasive ventilation

434

1.13

0.38

1.5

1.6

8.36

5.36

u/l

1.08

357

Rosacea

354

1.16

0.38

1.6

1.5

6.00

5.83

u/l

0.03

289

Nontoxic multinodular goitre

580

1.12

0.38

1.4

1.5

6.27

6.62

u/l

0.10

470

Anomalies of dental arch relationship, including avohilmo

430

1.14

0.38

1.6

4.27

5.87

u/l

0.76

351

Other spirochaetal diseases

1041

0.91

0.38

1.6

1.5

7.48

6.68

u/l

0.23

822

Combinations of oral blood glucose lowering drugs

761

1.10

0.37

1.6

7.20

6.60

u/l

0.13

619

Acute nasopharyngitis (common cold)

232

1.20

0.37

1.5

9.69

7.04

u/l

0.24

181

Pyogenic granuloma

1.35

0.37

1.8

1.4

5.90

7.01

u/l

—

Other spirochaetal diseases, including avohilmo

1050

0.91

0.37

1.6

1.5

7.49

6.67

u/l

0.24

830

Inguinal hernia, bilateral

225

1.20

0.37

1.5

1.6

6.25

7.10

u/l

0.16

179

Benign neoplasm of brain and other parts of central nervous system

143

1.26

0.37

1.4

1.5

4.13

6.35

u/l

0.68

118

Inguinal hernia

143

1022

0.93

0.36

1.6

7.04

6.81

u/l

0.06

109

812

Blepharochalasis

106

974

1.09

0.36

1.5

6.00

7.07

u/l

0.40

775

Other and unspecified corneal deformities and disorders

1.27

0.36

1.7

1.5

7.22

7.66

u/l

—

Spontaneous abortion

132

953

0.93

0.36

1.6

1.5

6.95

6.61

u/l

0.10

111

758

Placenta praevia

0.66

0.35

1.6

10.98

6.36

u/l

—

Abnormal involuntary movements

347

1.15

0.35

1.8

1.6

3.77

6.66

u/l

1.14

284

Any dementia

114

854

0.92

0.35

1.6

5.54

7.17

u/l

0.58

674

Myopia

282

1.17

0.35

1.5

1.6

6.39

5.49

u/l

0.19

234

Routine general health check-up of defined subpopulation

1.40

0.35

1.5

1.7

9.33

6.29

u/l

—

FESS (DNB20)

301

1.16

0.35

1.3

1.5

9.47

6.31

u/l

0.73

250

Inflammatory disease of uterus

339

1.15

0.34

1.7

1.6

3.47

6.00

u/l

1.42

280

Carcinoma in situ of other and unspecified digestive organs

1.32

0.33

1.5

1.6

2.83

7.14

u/l

1.40

Deep bite

216

1.18

0.33

1.4

1.6

3.64

5.21

u/l

0.68

177

Ectopic pregnancy

520

0.88

0.33

1.4

1.5

6.25

6.26

u/l

0.00

415

Acute and transient psychotic disorders

256

1.17

0.33

1.3

1.6

4.30

5.95

u/l

0.74

213

Maternal care for known or suspected malpresentation of fetus

265

0.86

0.32

1.5

1.6

6.02

6.18

u/l

0.04

221

Other benign neoplasms of connective and other soft tissue

238

1.18

0.32

1.4

1.6

10.26

6.05

u/l

0.60

198

Inguinal or femoral hernia, bilateral

229

1.18

0.32

1.5

6.25

7.07

u/l

0.15

181

Maternal care for other known or suspected fetal problems

306

0.88

0.32

1.4

1.6

9.84

6.06

u/l

0.96

252

Complications of labour and delivery

191

1123

0.94

0.31

1.4

1.6

8.27

6.20

u/l

0.90

150

896

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

779

0.91

0.31

1.4

1.5

7.73

7.15

u/l

0.13

623

Migraine with aura and triptan purchases

361

1.14

0.31

1.8

1.6

6.74

5.84

u/l

0.19

300

Vascular dementia

213

1.18

0.30

1.4

1.5

5.48

7.07

u/l

0.32

177

Dislocation, sprain and strain of joints and ligaments of knee

168

1608

0.94

0.30

1.5

1.6

7.04

7.30

u/l

0.06

137

1277

Undefined dementia

241

0.84

0.30

1.2

1.5

9.82

6.69

u/l

0.34

193

Pedal cyclist injured in other and unspecified transport accidents

261

0.84

0.30

1.7

1.6

5.08

5.87

u/l

0.25

219

Malignant neoplasm of oesophagus, including Hilmo

1.27

0.30

1.4

9.14

8.48

u/l

—

Adenomyosis (Endometriosis of uterus)

377

0.87

0.29

1.7

1.5

3.75

7.14

u/l

1.41

292

Benign neoplasm: Skin of eyelid, including canthus

430

0.88

0.29

1.5

6.27

6.85

u/l

0.13

347

Alzheimer’s disease (Early onset)

110

0.73

0.28

1.8

1.5

3.75

7.04

u/l

—

Bitten or struck by other mammals

260

1.15

0.28

1.6

4.72

5.69

u/l

0.31

214

Lesion of ulnar nerve

345

1.13

0.28

1.7

1.6

5.26

6.06

u/l

0.20

282

Angina pectoris

183

1150

1.06

0.28

1.6

1.5

7.09

6.36

u/l

0.28

152

915

Focal epilepsy, strict definition

498

1.10

0.27

1.5

1.6

6.31

6.52

u/l

0.05

398

Other facial nerve disorders

1.23

0.27

1.8

1.6

6.50

5.03

u/l

—

Other specified/unspecified hearing loss

224

1.16

0.27

1.8

1.5

3.60

7.25

u/l

1.60

183

Carcinoma in situ of colon

1.21

0.26

1.5

1.6

1.38

8.88

u/l

—

Retinal breaks without detachment

458

0.89

0.26

1.5

1.6

7.23

6.75

u/l

0.05

369

Gestational [pregnancy-induced] hypertension

633

1.09

0.26

1.4

1.6

9.03

6.29

u/l

0.50

507

Benign neoplasm: salivary glands, exclude unknown (D119)

206

1.17

0.26

1.7

1.5

7.73

6.70

u/l

0.09

167

Obstructed labour due to malposition and malpresentation of fetus

501

0.90

0.26

1.3

1.6

9.06

5.92

u/l

0.74

407

Male infertility

0.67

0.26

1.8

1.6

5.80

5.28

u/l

—

Parkinson's disease

394

0.89

0.26

1.7

1.5

5.43

7.36

u/l

0.68

308

Polypectomy (DHB20)

138

0.80

0.25

2.0

1.5

5.73

6.10

u/l

0.03

114

Excessive vomiting in pregnancy

160

1.19

0.25

1.2

1.6

10.40

5.46

u/l

0.76

134

Medical treatment for female infertility

452

0.90

0.25

2.0

1.6

9.69

6.46

u/l

0.78

367

Disorder of external ear, unspecified

1.22

0.25

1.3

1.6

5.33

6.40

u/l

—

Tooth eruption problems

227

1.15

0.25

1.9

1.5

3.48

5.76

u/l

0.69

184

Diseases of male genital organs

126

597

1.06

0.25

1.5

1.6

8.70

6.95

u/l

0.58

482

Viral meningitis, including avohilmo

1.19

0.24

2.2

1.4

4.44

7.44

u/l

—

Sudden idiopathic hearing loss

245

1.14

0.24

1.9

1.6

14.50

5.94

u/l

0.88

202

Injury of muscle and tendon at shoulder and upper arm level

1056

0.94

0.24

1.5

1.6

8.14

7.43

u/l

0.11

846

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

191

0.84

0.24

1.3

1.6

20.44

5.80

u/l

—

157

Non-allergic asthma

190

0.84

0.23

1.7

1.5

0.73

7.15

u/l

7.31

152

Other and unspecified nerve root and plexus disorders, also in other diseases

568

0.92

0.23

1.4

1.5

7.03

5.98

u/l

0.37

462

Optic atrophy

1.32

0.23

1.6

1.5

3.80

5.32

u/l

—

Malignant neoplasm of oesophagus

1.32

0.23

1.6

1.4

11.00

9.34

u/l

—

Contraceptive management

129

853

1.06

0.23

1.6

6.57

6.36

u/l

0.07

104

690

Malignant neoplasm of corpus uteri

211

0.85

0.23

1.4

1.5

8.31

8.58

u/l

0.03

167

Focal epilepsy, mode (most common among epilepsy diagnosis)

466

1.09

0.23

1.5

6.89

6.73

u/l

0.04

373

Other benign neoplasm of uterus: Other parts/unspecified

1.25

0.22

1.4

1.5

0.40

6.11

u/l

—

Parkinson's disease, strict definition

358

0.89

0.22

1.7

1.5

4.93

7.28

u/l

0.92

284

Benign leiomyoma with endometriosis

493

0.91

0.22

1.7

1.5

3.38

6.63

u/l

2.67

395

Lichen ruber planus, wide definition including periferal and oral lichen planus

700

1.07

0.21

1.6

1.5

8.12

6.64

u/l

0.44

567

Other peripheral vertigo

248

1.13

0.21

1.3

1.5

6.46

7.05

u/l

0.09

202

Propionic acid derivatives

385

1.07

0.21

1.5

1.6

7.27

7.36

u/l

0.02

303

Congenital malformations of spine and bony thorax

0.00

0.21

0.0

1.5

—

1.90

—

Benign neoplasm: Eye, unspecified

0.00

0.21

0.0

1.8

—

5.63

—

Tuberculosis, wide

154

1.17

0.21

1.9

1.6

1.85

6.09

u/l

2.47

126

Tuberculosis, wide, including avohilmo

154

1.17

0.21

1.9

1.6

1.85

6.09

u/l

2.47

126

Emphysema

154

1.17

0.21

1.4

1.6

7.15

7.58

u/l

0.04

125

Other menopausal disorders

487

1.06

0.21

1.6

5.37

6.78

u/l

0.44

383

Other sexually transmitted chlamydial diseases

1.24

0.21

1.8

1.5

6.09

5.46

u/l

0.05

Aneurysms, operations, SAH

449

0.91

0.20

1.4

1.5

7.85

6.94

u/l

0.21

363

Triptan medication for migraine, min. 3 purchases

164

1277

0.96

0.19

1.6

6.53

6.69

u/l

0.06

127

1022

Lichen planus, including avohilmo

578

1.07

0.19

1.6

1.5

7.67

6.60

u/l

0.26

468

Long labour

493

0.93

0.19

1.6

7.37

6.11

u/l

0.31

395

Persistent delusional disorders

175

0.86

0.18

1.3

1.6

5.11

5.49

u/l

—

145

Patent foramen ovale

1.13

0.18

1.7

1.6

2.67

5.20

u/l

—

Glaucoma, exfoliation

280

1.11

0.18

1.4

1.5

5.80

7.43

u/l

0.46

228

Fitting and adjustment of other devices

109

914

1.05

0.18

1.4

1.5

8.88

6.54

u/l

1.03

103

709

Recurrent dislocation and subluxation of joint

119

1.18

0.17

1.6

1.5

4.43

7.29

u/l

0.72

101

Congenital malformations of heart and great arteries

263

1.11

0.17

1.7

1.6

8.78

5.63

u/l

0.54

219

Unspecified dementia

222

0.89

0.17

1.2

1.5

9.82

7.46

u/l

0.24

182

Other intracranial haemorrhages

1.11

0.17

1.9

1.5

4.71

7.98

u/l

—

Chondromalacia

0.73

0.17

1.6

1.5

2.60

7.14

u/l

—

Lateral epicondylitis

369

1.08

0.16

1.6

7.48

5.97

u/l

0.28

308

Occupational exposure to risk-factors

1.14

0.16

1.4

1.6

11.50

4.83

u/l

—

Migraine with aura

632

1.06

0.15

1.8

1.6

5.57

6.82

u/l

0.44

511

Varicose veins

199

1550

0.97

0.15

1.5

6.18

6.99

u/l

0.45

148

1235

Benign neoplasm: Parotid gland

188

1.12

0.14

1.6

1.5

8.92

6.72

u/l

0.18

153

Use of disulfiram, acamprosate or naltrexone

192

0.88

0.14

1.0

1.6

8.75

6.18

u/l

0.73

159

Endometriosis of pelvic peritoneum

391

0.93

0.14

1.8

1.6

3.35

7.39

u/l

2.38

309

Covid-19 suspected case

538

1.06

0.14

1.9

1.6

5.84

6.66

u/l

0.17

439

Scabies, including avohilmo

295

1.08

0.13

1.4

1.6

10.91

5.55

u/l

0.36

244

Open bite

100

0.80

0.13

1.5

1.4

7.75

5.72

u/l

—

Other benign neoplasms of uterus

128

0.86

0.13

1.4

1.5

0.40

5.85

u/l

—

103

Ménière disease

257

1.09

0.13

1.3

1.5

5.77

6.68

u/l

0.24

212

Brain meningioma, including Hilmo

113

1.15

0.13

1.3

1.5

9.13

8.80

u/l

—

Benign neoplasm of other and unspecified female genital organs

110

0.82

0.13

1.7

1.5

7.56

6.46

u/l

—

Parkinson's disease, excluding more controls

299

1.08

0.13

1.7

1.6

5.43

5.62

u/l

0.05

243

Endometriosis ASRM stages 3,4

638

1.05

0.12

1.7

1.5

5.41

6.65

u/l

0.39

520

Benign mammary dysplasia

437

0.94

0.12

1.7

1.5

7.78

6.61

u/l

0.14

352

Hydrocephalus

171

1.11

0.12

1.5

1.6

7.64

6.29

u/l

0.16

143

Superficial injury of wrist and hand

521

1.06

0.12

1.5

5.56

6.77

u/l

0.42

426

Puerperal sepsis

416

0.94

0.12

1.4

1.6

6.21

5.82

u/l

0.10

339

Any dementia, excluding more controls

106

754

0.96

0.12

1.6

1.5

5.96

6.59

u/l

0.17

603

Alzheimer disease, excluding more controls

315

0.94

0.11

1.6

1.5

5.41

6.62

u/l

0.20

252

Malignant neoplasm of corpus uteri, including Hilmo

239

0.92

0.10

1.4

1.5

7.88

8.29

u/l

0.05

188

Postprocedural disorders of nervous system

144

1.11

0.10

1.2

1.5

13.81

5.47

u/l

—

120

Bell's palsy

290

0.93

0.10

1.4

1.6

7.11

5.88

u/l

0.28

234

Adenocarcinoma of pancreas

1.14

0.10

1.2

1.5

12.60

9.45

u/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

154

1.10

0.09

1.4

1.5

9.44

6.69

u/l

0.34

130

Disorders of optic nerve, not elsewhere classified

1.09

0.09

2.0

1.5

4.04

5.94

u/l

—

Epiphora

1.04

0.09

1.2

1.5

5.00

7.35

u/l

—

Lichen sclerosus et atrophicus

338

0.95

0.08

1.4

1.5

6.87

6.60

u/l

0.06

269

Use of levodopa decarboxylase inhibitor

358

0.95

0.08

1.7

1.5

4.74

7.24

u/l

1.03

279

Specific development disorders of scholastic skills

0.82

0.07

2.0

1.5

10.10

5.73

u/l

—

Viral meningitis

1.08

0.07

2.3

1.5

5.00

7.33

u/l

—

Other benign neoplasms of skin

117

1143

1.02

0.07

1.6

1.5

5.32

6.72

u/l

0.86

101

902

Parkinson's disease, strict definition, excluding more controls

283

1.05

0.07

1.7

1.5

4.93

5.71

u/l

0.23

228

Normotensive glaucoma

235

0.94

0.07

1.4

1.5

6.08

7.02

u/l

0.13

188

Noninflammatory disorders of female genital tract

118

578

1.02

0.07

1.4

1.6

5.50

6.81

u/l

0.59

454

Chronic diseases of tonsils and adenoids

245

1521

1.02

0.07

1.5

7.03

6.97

u/l

0.02

204

1206

Pilonidal cyst

147

1.09

0.07

1.3

1.5

9.80

5.92

u/l

—

125

Later onset COPD

632

1.03

0.07

1.6

8.29

7.17

u/l

0.19

493

Abrasion of teeth

110

1125

0.98

0.07

1.5

5.80

6.90

u/l

0.51

899

Obstructed labour due to maternal pelvic abnormality

478

0.96

0.06

1.7

1.6

5.82

6.02

u/l

0.05

378

Other maternal disorders predominantly related to pregnancy

178

1132

0.98

0.06

1.6

1.5

7.08

6.60

u/l

0.20

145

895

Other shoulder lesions

247

1.05

0.05

1.7

1.6

6.63

6.23

u/l

0.05

216

Persons encountering health services in circumstances related to reproduction

180

1190

1.01

0.05

1.6

1.5

5.79

6.75

u/l

0.46

137

955

Pediculosis, acariasis and other infestations

120

1.08

0.04

1.4

1.6

21.00

6.44

u/l

—

Pediculosis, acariasis and other infestations, including avohilmo

372

0.97

0.04

1.4

1.6

9.88

6.00

u/l

0.28

310

Impingement syndrome of shoulder

654

0.98

0.04

1.5

1.6

6.44

6.16

u/l

0.08

520

Acute appendicitis, with complications

533

0.98

0.04

1.7

1.6

4.52

6.57

u/l

0.85

431

Haemangioma and lymphangioma, any site

220

1.05

0.03

1.6

1.5

3.53

6.02

u/l

0.57

182

Schizoaffective disorder

159

0.94

0.03

1.4

1.5

13.78

6.05

u/l

—

134

Cervical disc disorders

107

1056

1.01

0.03

1.7

1.5

4.73

7.03

u/l

1.88

833

Cervicobrachial syndrome

628

1.02

0.03

1.5

9.97

6.86

u/l

0.35

504

Haemangioma, any site

201

1.05

0.03

1.6

1.5

3.78

6.22

u/l

0.51

166

Benign neoplasm of ovary

561

0.98

0.03

1.5

6.91

6.63

u/l

0.05

455

Allergic rhinitis

768

1.02

0.02

1.5

6.78

6.50

u/l

0.06

619

Female infertility, cervical, vaginal, other or unspecified origin

455

0.98

0.02

1.9

1.6

4.70

7.11

u/l

0.93

362

Tinnitus

689

1.02

0.02

1.7

1.5

4.58

6.81

u/l

1.63

552

Retained placenta and membranes, without haemorrhage

359

0.97

0.02

1.5

1.6

15.10

6.13

u/l

1.08

290

Female infertility

462

0.99

0.02

1.8

1.6

4.68

7.10

u/l

1.00

367

Schizophrenia

362

1.02

0.01

1.3

1.6

9.27

6.55

u/l

0.41

298

Deviated nasal septum

868

0.99

0.01

1.8

1.6

5.08

7.09

u/l

1.18

697

Single delivery by caesarean section

278

0.98

0.01

1.5

1.7

6.97

7.11

u/l

0.03

229

Schizophrenia or delusion

803

1.01

0.01

1.4

1.6

6.51

6.67

u/l

0.03

657

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

234

1.03

0.00

1.5

13.94

5.90

u/l

1.00

186

Complications predominantly related to the puerperium

716

0.99

0.00

1.6

7.56

6.46

u/l

0.28

578

Injury of muscle and tendon at lower leg level

337

1.01

0.00

1.4

1.5

6.88

7.55

u/l

0.12

274

Crowding of teeth, including avohilmo

125

0.99

0.00

1.6

2.00

6.27

u/l

—

102

Mandibular retrognathia

130

1.00

0.00

1.5

8.50

5.47

u/l

—

106

Oral lichen planus, including avohilmo , including avohilmo

196

1.02

0.00

1.5

11.58

6.65

u/l

0.61

158

Varicose veins of other sites

142

0.99

0.00

1.6

1.5

11.43

6.26

u/l

0.61

116

Schizophrenia, schizotypal and delusional disorders

805

0.99

0.00

1.4

1.6

6.61

6.65

u/l

0.01

661

Migraine without aura and triptan purchases

401

1.00

0.00

1.6

6.43

5.96

u/l

0.09

331

Scabies

100

1.00

0.00

1.3

1.6

32.40

6.35

u/l

—

Brain meningioma

112

0.98

0.00

1.3

1.4

6.50

8.90

u/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

154

1130

1.00

0.00

1.6

1.5

4.19

7.02

u/l

3.33

127

899

Spermatocele

157

1.02

0.00

1.4

1.5

15.20

6.27

u/l

—

120

Benign neoplasm: Vertebral column

0.00

0.0

1.6

—

13.00

—

Benign neoplasm: Floor of mouth

0.00

0.0

1.4

—

11.30

—

Lesion of medial popliteal nerve

0.00

0.0

1.5

—

8.63

—

Benign neoplasm: Female genital organ, unspecified

0.00

-0.00

0.0

1.5

—

10.50

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

0.89

-0.00

1.4

1.6

6.60

4.74

u/l

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.7

—

2.71

—

Defect, injury or illness of lumbar spine

0.00

-0.00

0.0

2.0

—

10.80

—

Cicatricial pemphigoid

0.00

-0.00

0.0

1.8

—

9.50

—

Enteritis due to Yersinia enterocolitica

0.00

-0.00

0.0

1.4

—

8.94

—

Other cestode infections

0.00

-0.00

0.0

1.5

—

10.50

—

Other and unspecified syphilis, including avohilmo

0.00

-0.00

0.0

1.3

—

10.07

—

Congenital varicose veins

0.00

-0.00

0.0

1.4

—

12.00

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.5

—

10.50

—

Cyclic neutropenia

0.00

-0.00

0.0

1.4

—

11.00

—

Achilles tendinitis

280

1.00

-0.00

1.4

1.5

22.45

7.16

u/l

0.78

224

Carcinoma in situ of endometrium

0.00

-0.00

0.0

1.3

—

10.60

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.6

—

8.71

—

Bradycardia, unspecified, drug-induced

0.00

-0.00

0.0

1.4

—

20.00

—

Alzheimer’s disease (Early onset), excluding more controls

0.90

-0.00

1.7

1.5

3.75

4.76

u/l

—

Exposure to other and unspecified animate mechanical forces

0.95

-0.00

1.5

5.05

6.08

u/l

—

Interstitial cystitis (chronic), drug-induced

0.00

-0.00

0.0

1.9

—

3.21

—

Congenital malformation of biliary tract

0.00

-0.00

0.0

1.8

—

0.60

—

Cleft hard palate NOS

0.00

-0.00

0.0

1.4

—

2.60

—

Cerebral arteritis

0.00

-0.00

0.0

1.2

—

5.30

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

1.4

—

3.70

—

Thyrotoxicosis factitia

0.00

-0.00

0.0

1.4

—

11.00

—

Other and unspecified syphilis

0.00

-0.00

0.0

1.2

—

11.75

—

Burn and corrosion of other internal organs

0.00

-0.00

0.0

1.4

—

5.10

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS